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SUMMARY
The presence or absence of various plasma membrane receptors on
human monocytes, mouse peritoneal macrophages and guinea pig alveolar
macrophages has been described and compared. The receptors include
those for the complement components C3b, C3b" and C3d (CR^, CR^ and
CR^), the Fc portions of IgG and the Fc portions of IgM, and "lectin-
like" receptors which recognise bacterial cell wall sugars. A rosette
assay using sheep erythrocytes coated with various intermediates as
indicator cells was used to visualise all the receptors except "lectin-
like" receptors.. These were detected by the binding of Staph, albus
to macrophages. Complement receptors were demonstrated using purified
human complement components, diluted human AB serum or zymosan depleted
serum (R3) as sources of complement to coat the sheep red cells sensitised
with rabbit anti sheep erythrocyte IgM. Although comparisons between
the different cell types must be treated with come caution since
heterologous systems were used, human monocytes, mouse peritoneal macro¬
phages and guinea pig alveolar macrophages all expressed C3b receptors,
Fc (IgG) receptors and "lectin-like" receptors. Both Fc(IgG) and
"lectin-like" receptors were expressed at both 0°C and 37°C whereas
CR.js were not expressed at 0°C. Mouse peritoneal macrophages had the
highest levels of Fc (IgG) and "lectin-like" receptors and guinea pig
alveolar macrophages expressed slightly lower levels of these receptors
whereas human peripheral blood monocytes (and other leukocytes) showed
a comparatively low degree of Staph, albus binding. On the other hand,
human monocytes appeared to possess more complement receptors (CR^)
with higher affinity than those on mouse peritoneal macrophages, and
guinea/...
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guinea pig alveolar macrophages expressed very low levels of complement
receptors. Human monocytes also expressed CR^ but not CR^ and had
cryptic receptors for the Fc portion of IgM. The presence of these
latter three receptors on mouse peritoneal and guinea pig alveolar
macrophages were not examined. Human neutrophil "lectin-like"
receptors appeared to be qualitatively different from "lectin-like"
receptors on other phagocytes in that they were only inhibitable by
D-galactose and not by D-glucose.
The capacity of various chemoattractants to increase the percentage
of leukocytes binding complement-coated red cells has been termed
complement receptor enhancement. This phenomenon has been described
for human monocytes, neutrophils and eosinophils and for mouse peri¬
toneal macrophages and guinea pig alveolar macrophages. It is thought
to represent a general biological process whereby adhesion of cells
to appropriately opsonised particles is increased.
Casein and f-Met-Leu-Phe, both recognised chemotactic factors,
enhanced the expression of CR^s on human monocytes, mouse peritoneal
macrophages and guinea pig alveolar macrophages, in a dose-dependent
fashion. Concomitantly with this chemoattractant induced increase in
complement receptors, "lectin-like" receptors were inhibited whereas
Fc (IgG) receptors were unaffected by chemotactic factors. A number
of recognised monocyte chemoattractants including lymphokines, C. parvum
extract and other formyl-methionyl peptides, and a.chemokinetic agent,
human serum albumin, increased the percentage of human monocytes which
formed rosettes with complement coated erythrocytes. Comparable results
were obtained irrespective of whether purified complement components or
whole serum was used as a source of complement. Unformylated methionyl
peptides/..„
peptides had no effect on human monocyte complement receptors.
Pharmacological mediators other than chemoattractants had varying
effect on human monocyte complement receptors. Histamine either had
no effect on these receptors or decreased complement receptor expres¬
sion on normal human monocytes. On the other hand complement receptors
on monocytes from atopic patients responded to histamine by enhanced
expression of complement receptors. Prostaglandin F2a' serotonin,
-5 -1
bradykinin and isoprenaline (at 10 moles.1 ) which are known to
increase intracellular cGMP levels, enhanced complement receptor
expression whereas histamine isoprenaline at other concentrations,
which increase cAMP levels in cells, either had no effect or decreased
complement receptor expression. Prostaglandins-and E2 which also
increase cAMP levels and are also chemotactic, increased the percentage
of monocyte complement rosettes. Maximal complement receptor expres¬
sion was generally achieved with 30 minutes incubation in the presence
of chemoattractant but when the chemotactic factor was removed, mono¬
cyte complement enhancement was reversible, returning to normal values
in approximately 120 minutes. Monocyte complement receptor enhancement
and murine macrophage "lectin-like" receptor inhibition did not occur
at 0°C. Monocyte and neutrophil complement receptor enhancement had a
temperature threshold level at around 23°C below which no complement
receptor enhancement was evident.
These data confirm and extend previous findings on leukocyte-
receptor enhancement on human eosinophils and indicate that the pheno¬
menon may have potential as a clinical test for macrophage function
both in health and disease.
The importance of the various surface receptors studies on macro¬
phages in the inflammatory process and the significance of their
modulation by inflammatory agents, is discussed.
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CHAPTER I - INTRODUCTION
2
1.0 HISTORICAL BACKGROUND
The concept of immunology arose from the general observation
that those who survive an infection seldom contact that disease
again. Both Edward Jenner and Louis Pasteur had evolved valid methods
for immunization but the mechanisms involved in protection remained
obscure until the end of the 19th century. In 1890 von Behring and
Kitasato at Koch's Institute in Berlin showed that immunity developed
against tetanus was due to the production of a specific neutralising
substance or antibody in the blood of the immune animal and that such
antitoxin immunity could be transferred to another animal. Subse¬
quently it was shown that antibodies (so-called precipitins) were
developed against a wide variety of foreign material by the animal
into which they were injected. The interest in serotherapy led to
further understanding of the immunological properties of serum. In
1893 Buchner described a heat-labile bactericidal constituent (alexine)
in normal serum. Two years later Bordet showed that there were two
components in immune serum which were bactericidal - one was thermo-
labile and also present in normal serum and the other was thermostable
and specific. Ehrlich (1900) thus considered that the evidence for
the presence of antitoxic and antimicrobial activity in serum was
sufficient to explain the immunity observed in vivo. Metchnikoff
(1905), on the other hand, thought that the serum components merely
stimulated the phagocytes which he had observed in blood and the
destruction of foreign material such as bacteria by these microphages
and macrophages was the main mechanism of protection. The dispute
between the proponents of humoral and cellular immunity was partially
resolved by Sir Almoth Wright (1903) and others who showed that the
presence/...
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presence of the heat labile factor in normal serum and/or the specific
serum factors from immune animals prepared bacteria for phagocytosis.
This cellular immune response together with a purely humoral immune
response involving antibody and complement provided the basis for
observed immunity to infections.
Aschoff (1924) first defined the reticuloendothelial system by
the ability of cells to take up dyes in vivo. Its function was
thought to be involved in the removal of bacteria, other foreign
material and effete tissue elements. More recently van Furth et al.
(1972) have defined the mononuclear phagocyte system according to
various functional criteria. Unt&l relatively recently the scavenging
of foreign material was believed to be the only role macrophages
played in host defence mechanisms. However it has become clear over
the last few years that macrophages play an essential part in the
development and regulation of cellular and humoral immunocompetence
by their involvement in both the afferent and efferent limbs of the






















lymph nodes (free and fixed macrophages;
interdigitating cell?)
spleen (free and fixed macrophage)
bone marrow (fixed macrophage)
serous cavities (pleural and peritoneal
macrophages)
bone (osteoclasts)
nervous tissue (microglial cell)
skin (histiocyte; Langerhans cell?)
synovia (type A cell)
other organs (tissue macrophage)
INFLAMMATION
exudate macrophage
exudate - resident macrophage
epithelioid cell
multinucleated giant cell (Langerhans type
and foreign-body type)




Cells belong to the mononuclear phagocyte system as defined
by van Furth et _al. (1972), (see table).
Various functional criteria are used to distinguish mononuclear
phagocytes from other cells. Cytochemical methods include the
demonstration of non specific esterase (Yam et al., 1971), an enzyme
located diffusely in the cytoplasm of almost all monocytes and
macrophages. Peroxidase is present in granules in monoblasts,
promonocytes, monocytes and exudate macrophages (van Furth et al.,
1970) but is only demonstrable in resident macrophages using electron
microscopy (Daems and van der Rhee, 1980) which detects peroxidatic
activity in rough endoplasmic reticulum, nuclear envelope and the
Golgi apparatus.
Morphology of macrophages depends on: the stage of maturation,
tissue location and methods of elicitation. Generally the size
of the cell varies from 10 - 25u and the shape of the nucleus is
oval or kidney shaped. The nuclear/cytoplasm ratio is relatively
high in promonocytes in the bone marrow. Monocytes in the bone
marrow have an indented nucleus and a lower nuclear/cytoplasm
ratio and peripheral blood monocytes have an essentially similar
morphology with more granules present in the cytoplasm. Tissue
macrophages are generally larger than monocytes and contain more
granules (van Furth et al., 1970; 1980). As macrophages mature the
plasma membrane becomes more ruffled and surface microvilli increase.
Mononuclear phagocytes endocytose avidly. Soluble molecules
are internalised either nonselectively by fluid phase pinocytosis
or selectively by attaching to the macrophage membrane surface via
receptors/...
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receptors. However other cells such as fibroblasts also pinocytose
albeit at a lower rate. Phagocytosis of particulate material is
another major functional property of macrophages (Silverstein et al.,
1977). Ingestion of latex particles is often used to demonstrate
the presence of macrophages (Kohl e_t _al. , 1977) although the demon¬
stration of Fc receptors by the ingestion of opsonised particles is
a more useful criterion (Huber e_t _al. , 1969). Promonocytes are not
as actively phagocytic as monocytes and a lower percentage of cells
have Fc or complement (C3) receptors (56% of human promonocytes
have Fc receptors and 31% have C3 receptors compared to 91% human
monocytes with Fc receptors and 88% with C3 receptors (van Furth ej: al.,
1980)}. Fc and C3 receptors are also present on human skin and
peritoneal macrophages. Similar results were found with mononuclear
phagocytes from mice in which other tissue macrophages can also be
examined. Van Furth et al. (1980) detected Fc receptors on murine
macrophages from liver and lung as well as on skin and peritoneal
macrophages. C3 receptors were present on peritoneal and skin
macrophages but were almost not detectable on alveolar macrophages
(2.2%) and only 33% of liver macrophages were C3 receptor positive.
The use of antisera would probably be the best method for
detecting mononuclear phagocytes. However there are problems with
cross reactivity with other cell types (Springer et al., 1979).
Some recent reports have been published on the use of monoclonal
antibodies which appear to recognize specific membrane determinants
of mononuclear phagocytes and not other cell types (Todd _et al_. ,
1981; Rosenberg _ej: al_. , 1981).
Generally more than one criterion must be examined before a
cell can be assigned confidently to the mononuclear phagocyte
system especially since the demonstration of particular markers
is never 100% positive.
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3.0 ORIGIN AND KINETICS
During ontogeny, haematopoietic stem cells, of mesenchymal origin,
migrate to foetal liver where immature mononuclear phagocytes develop
(Cline and Moore, 1972). Haematopoiesis begins in the bone marrow
from the 3rd week of gestation in the mouse and continues throughout
adult life. The most immature cell of the mononuclear phagocyte system
in the bone marrow is the monoblast and its characteristics have been
described by van der Meer et al. (1980) in bone marrow cultures. Mono¬
blasts differentiate into promonocytes which are the direct precursors
of monocytes. These remain in the bone marrow for a short time before
they are released into the blood stream (van Fur th. _et al., 1972;
van Furth, 1980). The kinetics of monocytopoiesis and turnover have
been studied in several species including man in vivo and in vitro
by measuring the incorporation of tritiated thymidine. Whitelaw
(1972) calculated the half life for circulating human monocytes to
be 71 hours. In vitro incorporation of tritiated thymidine indicated
that monoblasts and promonocytes are actively dividing cells unlike
monocytes and macrophages (van der Meer et al., 1980). It is generally
accepted that all tissue macrophages originate from the bone marrow
(van Furth _et al. , 1972). Although Volkman (1976) suggested from
his experiments with tritiated thymidine incorporation that resident
macrophages in the tissues undergo a slow rate of division and this
is sufficient for self-renewal, the incorporation of label was very
low. Daems and van der Rhee (1980) have suggested that resident
macrophages are not derived from blood monocytes because they are
the only macrophages without peroxidase activity within granules.
However Beelen et al. (1980) has shown the existence of the "exudate-
resident/...
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resident macrophage" which is a transitional cell between monocytes
or exudate macrophages and resident macrophages, and Bainton (19S0)
has shown that monocytes in culture acquire resident macrophage
characteristics.
Monocytopoiesis in inflammation is controlled by colony stimu¬
lating factor (CSF) and a serum factor (factor inducing monocytosis
(FIM)). Macrophages are a potent source of CSF and the production
e
is increased following stimulation with endotoxin (Eaves and Bruce,
1974) or antigen (Metcalf, 1971). Thus macrophages at the site of
inflammation, by producing CSF, have a positive feedback mechanism
which increases the proliferation of monocytes.v&nWaarde et al.
(1977) detected a serum factor (FIM) of mice in the early stages of
inflammation which induced release of monocytes from the bone marrow.
Little is known about exactly how macrophages migrate to the
tissues nor about the ultimate fate of these cells. There appears
to be little recirculation via the blood stream. However they do
migrate to lymph nodes and may die there (McPherson and Steer, 1980).
Although there is some controversy over the steady-state
recruitment of resident macrophages it would appear that macrophages
in inflammatory foci are recently derived from peripheral blood mono¬
cytes.
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4.0 ROLE OF MACROPHAGES IN THE IMMUNE RESPONSE
Studies in vivo and in vitro have shown that macrophages are
necessary for the development of a primary immune response. Experi¬
ments with live macrophages showed that macrophages briefly exposed
to antigen and then injected into histocompatible hosts led to the
development of specific immunity and a much greater response than if
soluble antigen was injected instead (Spitznagel and Allison, 1970).
Since macrophages are mobile cells; Unanue (1972) suggested that by
phagocytosing antigen they can transport it to distant sites and by
modifying the antigen make it more immunogenic for presentation to
T and B cells.
Macrophages or adherent cells are needed in almost all immuno¬
genic reactions in vitro. In the induction of a specific immune
response in cultures of spleen cells (containing a mixture of T and
B lymphocytes) antibody production was greater with antigen-pulsed
macrophages than with soluble antigen alone (Katz and Unanue, 1973).
The majority of humoral responses are T cell dependent and the
generation of T helper (T ) cells in response to stimulation byH
soluble antigens is dependent on the presence of a critical number
of macrophages (Erb and Feldman, 1975a) and the macrophages and
lymphocytes must share some identity at somb portion of the major
histocompatibility complex (MHC) for successful detection of the
antigenic signal borne by the macrophages (Rosenthal and Shevach,
1973). The subsequent T lymphocyte - B lymphocyte interaction also
requires macrophages (Shortman and Parker, 1971; Feldman, 1972).
Both intact macrophages and a soluble factor released from macrophages
(interleukin 1, IL-1) are required to support the differentiation of
human/...
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human B cells into immunoglobulin-secreting cells (Rosenberg and
Lipsky, 1981). Activation of B lymphocytes by T cell-independent
antigens appears to involve antigen presentation to B cells by
macrophages (Boswell _et _al. , 1980).
Macrophage-lymphocyte interaction may occur indirectly by the
secretion of antigen complexed to soluble products or directly by
cell-cell contact. Evidence for the former mechanism exists for
the induction of T cells in the mouse (Erb and Feldman, 1975b).
H
However soluble macrophage products do not elicit T lymphocyte
proliferation in the absence of intact macrophages. Ultrastructural
studies (Lipsky and Rosenthal, 1973) have shown that macrophages
from several different sources are able to interact with T and B
cells and in the presence of antigen the binding is dependent on
sharing MHC gene products and leads to the proliferation of bound
lymphocytes. The histocompatibility restriction of macrophage-T cell
interactions in the presentation of antigen appears to be involved
in the genetic control of the immune response which is regulated by
the immune response (IR) genes linked to the MHC (McDevitt and
Chinitz, 1969). Using two inbred strains of guinea pigs which differed
genetically only at the I region of the MHC and had different immune
responses in vivo, Rosenthal and Shevach (1973a, b) were able to show
that antigen induced proliferation of T cells was dependent on the
presence of antigen pulsed macrophages from the responder strain.
The I region of the MHC also codes for protein molecules
(la antigens) which are expressed oA the surface membranes of mono¬
cytes, macrophages, B cells and activated T cells (Sachs and Cone,
1973; Cullen _et al_, , 1974). These determinants may be receptors
with/...
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with broad specificities which focus or orient antigen to T and B
cells and allow recognition to occur (Feldraan, 1977). For a given
macrophage's repertoire of immune response gene products, their
function may be to specify what portions of an antigen are seen by
the T lymphocytes. The immune response to insulin as an antigen in
guinea pigs is under genetic control (MHC linked). Barcinski and
Rosenthal (1977) have shown that two different strains of guinea pig
recognise distinct antigenic regions of insulin and they suggested
that macrophages select discrete regions of the antigenic molecule
for recognition by the T cell.
Farr_et_al_ (1979a,b) showed that when immune T cells (to Listeria
monocytogenes) are cultured with macrophages and dead bacteria, the
MHC restriction lay in the I-A subregion. Immune T cells established
tenacious contact and bound only to macrophages bearing both antigen
and the appropriate la molecule (Ziegler and Unanue, 1979). Similar
histocompatibility restrictions are also evident in man. The secondary
proliferative response of human T lymphocytes to low concentrations of
PPD is dependent on the presence of macrophages with identical HLA-D
determinants (Bergholtz and Thorsby, 1977).
After this initial essential interaction with T cells, macrophages
secrete a number of growth and differentiation products including IL-1
(previously called lymphocyte activating factor (LAF) (Aarden et al.,
1979)), which induces some T lymphocytes to proliferate and differen¬
tiate, leading to T cell production. Once this occurs B cells mayH
be activated into antibody production, other T cell subsets are called
into action and lymphokines produced which may lead to macrophage
activation (Unanue et al., 1976). Other factors released may decrease
lymphocyte/...
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lymphocyte proliferation since relatively high concentrations of
macrophages in culture systems depress lymphocyte activity (Nelson,
1976). These suppressive factors affect a variety of T and B lympho¬
cyte proliferative (Kirchner, 1978) and non proliferative (Varesio
et al., 1979) responses to antigens and mitogens. Prostaglandins may
be involved and may act by inducing T suppressor activity (Fischer
et al., 1981).
«
Macrophages are also required for cell mediated immunity both
in vivo and in vitro. They are necessary for the generation of cyto¬
toxic T cells in allograft rejection (Wagner _et al., 1972) and have
proved to be the stimulator ceil in contact sensitivity (Thomas, 1977).
Macrophages themselves play an effector role in cell mediated immunity.
Specifically activated T cells secrete lymphokines which activate
macrophages in vitro to become nonspecifically bactericidal, tumori-
cidal and antiviral (Adams, 1976). These lymphokines produced
in vitro include macrophage inhibition factor (MIF) (David, 1966),
MAF (Fowles et al., 1973) and a chemotactic factor for monocytes
(Ward et al., 1969). Presumably these lymphokines are involved in vivo
in attracting macrophages to the site of inflammation, immobilising
and activating them. Recently Sher et al. (1980) have demonstrated
the presence of a soluble mediator which induces exudates rich in
la positive macrophages.
Intensive study into the biochemical nature of activated macro¬
phages has demonstrated that these cells secrete many biologically
active substances not normally secreted. Most of this knowledge
comes from in vitro work and the relative in vivo importance of such
factors/...
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factors has to be inferred (Cohn, 1978; Karnovsky and Lazdins, 1978;
Allison, 1978). The products secreted (see Davies and Bonney (1979)
for a review) include the neutral proteases, plasminogen activator,
elastase and collagenase. However, the increase in enzyme secretion
did not necessarily correlate with cytocidal activity (Karnovsky and
Lazdins, 1978). They may function to degrade tissue around the
inflammatory site and aid macrophage migration. Collagen degradation
products are also chemotactic for macrophages (Chang and Houck, 1970).
The conversion of plasminogen to plasmin by plasminogen activator
may then lead to the activation of certain cascade systems including
the clotting system and complement system. Activation of these systems
in vitro induced rapid spreading by nonstiraulated macrophages (Bianco
et al., 1976) in a manner apparently analogous to that observed with
macrophages which have been activated in vivo (North, 1968). The
complement factor involved in in vitro spreading of macrophages has
been identified as the proteolytic fragment of factor B, Bb, of the
alternate pathway of complement (Bianco et al., 1979). They also
showed that activated factor B inhibited the migration of normal
macrophages. Since macrophages synthesise and secrete the necessary
components for the generation of Bb (Brade and Bentley, 1980) it is
possible that in vivo macrophages are attracted to the site of
inflammation and then immobilised by local production of Bb. Sundsmo
and Gotze (1979) have suggested that Bb may exert its action on macro¬
phages by cleaving C5 which is present on the macrophage membrane.
Complement receptors could thus enhance cell activation since complement-
activating substances are coated with C3b Bb P (C3-C5 convertase of
the alternate pathway of complement) and may be bound via the C3b to
complement/...
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complement receptor bearing macrophages, thereby bringing the con-
vertase into contact with membrane C5 and causing cell activation.
A heat-labile plasma factor induced human monocytes to kill xenogeneic
red blood cell targets (Muchmore et al., 1979). Evidence suggested
that factor B or the late acting complement components were involved.
Activation of the alternate pathway also leads to the production
of C3b which has been shown to induce lysosomal enzyme release from
macrophages (Schorlemmer _et a^., 1976). Some of these enzymes cleaved
C3 and thus amplification of the system is possible.
Mononuclear phagocytes also secrete a-2-macroglobulin a plasma
proteinase inhibitor against a broad spectrum of proteinases (Hovi
et al., 1977) which may act to regulate the effects of protease
activity in inflammatory reactions.
Stimulated macrophages secrete certain arachidonic acid
oxygenation products, prostaglandin (PGE^) being the major product
of most mononuclear phagocytes studied (Bonney et al., 1980). Prosta¬
glandins are probably important in inflammatory lesions (Bray, 1980).
Certain prostaglandins (PGE^ , PGE2' PGA2 an<^ PGB2^ ^ave ^een shown
to be chemotactic and/or to inhibit spreading or adhesion of mouse
peritoneal macrophages in vitro (Cantarow_et_al., 1978) and may be
involved in modulating the immune response. They can suppress many
lymphocyte functions such as lymphocyte proliferation to Con A
(Metzgar et al., 1980) although Kelly et al. (1979) found that
inhibition of the cyclo-oxvgenase pathway reduced lymphocyte trans¬
formation in response to PHA. These contradictory results may reflect
concentration differences. Very low concentrations of prostaglandin E
may enhance mitogenesis whereas high doses may inhibit suggesting
that/...
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that there may be a regulatory mechanism which decides the outcome
of the inflammatory response. Exogenous E-type prostaglandins
inhibited MIF production (Gordon _et al., 1975) as well as production
of mitogenic lymphokines and inflammatory macrophages produce pGE2
in response to lymphokines. Thus macrophage derived PGE2 may provide
an extracellular mediator of T-cell function (Bray et al., 1978) and
by this feedback mechanism inhibit lymphokine-dependent activation
of macrophages (Schultz et al., 1978).
Other arachidonic acid metabolites are also synthesised by
macrophages in response to inflammatory stimuli:.. 5-hydroxyeicosatet-
raenoic acid (5-HETE) and 11-HETE which are chemotactic for both
neutrophils and eosinophils (Goetzl et al., 1980) are elaborated by
phagocytosing rabbit alveolar macrophages via the lipoxygenase path¬
way (Valone et al., 1980). Production of these chemotactic factors
may serve to amplify the cellular component of the inflammatory
reaction. Inhibition of the lipoxygenase pathway (Kelly _et al.,
1979) has been shown to reduce lymphocyte transformation in vitro.
Thus modulation of T-cell function may also be affected by these
products of arachidonic acid metabolism.
Oxidative metabolism is also increased in activated macrophages
and includes increased glucose oxidation, oxygen consumption and
hexose monophosphate shunt activity (Nathan and Root., 1977). Super¬
oxide anions (Johnston _et al., 1978) and hydrogen peroxide (Nathan
et al., 1979a) are secreted and may play an important role in the
killing of tumour cells and parasites (Nathan et al., 1979b and c).
They may also be involved in the destruction of connective tissue
and inflammatory mediators themselves and hydrogen peroxide formation




Interferons are secreted by activated macrophages and these
may be involved in the activation of killer T lymphocytes and natural
killer cells (Djeu et al., 1979) and they also inhibit both prolifer¬
ative and nonproliferative activity of lymphocytes by cell to cell
contact (Schwartz et al., 1978).
Other changes in activated macrophages include increased
adherence, spreading and ruffling of membranes (Blanden, 1968),
increased pinocytic (Edelson _et al., 1975) and phagocytic capabilities
(Bianco et al., 1975). In the latter study thioglycollate-induced
mouse peritoneal macrophages exhibited altered complement receptor
function in that complement coated particles were bound and ingested
by these macrophages whereas normal mouse peritoneal macrophages appear
to bind and not ingest these particles. Recent studies in vitro
(Griffin and Griffin, 1980) have suggested that a T-cell factor is
involved. Macrophage plasma membrane receptors for the Fc fragment
of IgG augment the killing and phagocytosis of infectious agents
during a secondary immune response (Zuckerman and Douglas, 1979) and
their expression is also altered in activated macrophages. A T-cell
factor from immune T cells restimulated with antigen in vitro
increased Fc receptor expression on cultured macrophages (Steinman
et al. , 1980).
Although ideas are changing frequently about the role of macro¬
phages in the immune response, they obviously play an important part
in the induction of the immune response where antigen presentation and
specific interactions with T cells (and possibly B cells) are
regulated by I-region genes, possibly at the level of la expression
on/...
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on macrophages. In cell mediated immunity the principle effector
cells are macrophages which have been activated independently of MHC
genes by lymphokines produced by activated T lymphocytes. Activated
macrophages are involved in chronic, allergic and inflammatory
diseases and are able to nonspecifically kill bacteria, parasites,
tumour cells and viruses. By interacting with other cells including
granulocytes and lymphocytes and with various cascade systems, macro¬




During an inflammatory response, the production of soluble
mediators at the site of injury or invasion by micro-organisms attracts
phagocytes to leave the circulation and migrate to the focus of injury
where the cells either phagocytose foreign material or release various
substances including lysosomal enzymes for the digestion of tissues
and foreign materials, and other inflammatory mediators such as prosta¬
glandins. One mechanism by which leukocytes accummulate at inflammatory
sites may be chemotaxis or directed migration. Although it has not
been possible as yet to show that chemotaxis occurs in vivo, studies
in vitro have shown that cells can respond to chemotactic substances
in their environment in at least two different ways: by chemotaxis
and by chemokinesis or random movement. In vitro methods of assess¬
ment should distinguish between the two modes of movement (Keller _et al.,
1977). Microscopic methods are used including time-lapse photography
where individual cells are followed (Allan and Wilkinson, 1978;
Wilkinson and Allan, 1980) but they are time consuming and laborious.
Measurement of cell movement using Boyden chambers or under agarose
methods do not differentiate between chemotaxis and chemokinesis,
unless a checkerboard assay is carried out (Zigmond and Hirsch, 1973).
5.1 Chemotactic factors
Many chemotactic factors have been described and their structures,
chemical and biological properties and origins vary considerably.
However their in vivo role is not always clear. Probably in any
inflamed tissue there are multiple factors of varying potency and
different factors may be important at different stages of inflammation.
5.2/...
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5.2 Endogenous chemotactic factors
These include the complement derived proteins, C5a and C5a, ;
des arg
blood coagulation products, kallikrein, plasminogen activator and
fibrin split products; factors generated from the proteolytic degra¬
dation of collagen, and soluble substances released from granulocytes,
macrophages and activated T lymphocytes.
5.3 Complement derived factors
These are especially important due to their potency and the variety
of pathways which lead to their formation (Ward et aL, 1965). Decreased
neutrophil chemotaxis in animals and man deficient in key complement
components (Rosenfeld _et _al. , 1974; Cochrane et al., 1970) and animals
artificially depleted of complement (Cochrane et al., 1970) suggest
that complement components are important in vivo. This is also borne
out by the isolation of chemotactically active complement factors
from inflamed tissues (Ward and Zvaifler, 1971; Hill and Ward, 1971).
The complement cleavage factor, C5a, is a potent chemoattractant
for monocytes and macrophages (Snyderman et al., 1971 and 1972) and
other leukocytes (Hugli and Muller-Eberhard, 1978). It had previously
been thought that another complement-derived anaphylotoxin C3a was
also chemotactic for leukocytes but a report by Fernandez e_t al. (1978)
clearly refutes these earlier findings. Contamination of minute
amounts of C5a accounted for observed chemotactic activity observed
with C3a and possibly also C567. C5a is normally converted to an
anaphylotoxin-inactive form (-;5a^es arg by a carboxypeptidase B-like
enzyme present in normal serum but C5a. remains chemotacticdes arg
(Fernandez et al., 1978; Chenoweth and Hugli, 1980)..
C5a is not only generated by the classical and alternate pathways
of complement but also through direct activation by C5 cleaving proteases
which/...
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which have been demonstrated in leukocytes, platelets, myocardium
and human epidermis (Weksler and Coupal, 1973; Levine et al., 1976).
These proteases are called chemotaxigens i.e. they generate chemotactic
activity but are not themselves chemotactic. They may be important in
complement-associated infections where the classical or alternate
pathways cannot be demonstrated.
5.4 Chemotactic factors generated by other cascade systems
Activation of the kinin-generating and the coagulation/fibrinolytic
pathways are frequent accompaniments to inflammation and provide a
potential source of chemoattractants. Many stimuli including endotoxin,
basement membranes and exposed native collagen activate Hageman factor.
This is the first recognised event in the contact phase of the intrinsic
system of blood coagulation and chemotactic factors are produced via
this cascade system (Ward, 1968; Bianco et al., 1976). Prekallikrein
and plasminogen proactivator are converted to their activated forms
kallikrein and plasminogen activator by Hageman factor. Both conversion
products are chemotactic in vitro (Kaplan and Austen 1975). Plasminogen
activator cleaves serum plasminogen, thus generating plasmin, a proteo¬
lytic enzyme which acts on fibrin to produce fibrinolytic peptides
which are also chemotactic for macrophages (Snyderman and Mergenhangen,
1976).
In vitro chemotactic factors have been produced by the enzymatic
degradation of collagen and immunoglobulins (Chung and Houck, 1970;
Aoki et al., 1976). Collagen degradation products may be produced in
inflammatory reactions in vivo by the action of collagenase, which is




5.5 Cellular-derived chemotactic factors
Lymphocytes when incubated with mitogens or antigens produce
and release soluble mediators of inflammation termed lymphokines
(Dumonde et al., 1969). Some of these have been shown to be chemotactic
for neutrophils, monocytes, macrophages and basophils (Ward et al.,
1969).
Human leukocytes from PPD-sensitive humans released a chemotactic
substance of molecular weight, 12,500 daltons when they were incubated
with PPD antigen (Altman et al., 1973). A similar substance was also
produced when lymphocytes were incubated with mitogen. It was termed
lymphocyte-derived chemotactic factor or LDCF (Altman et al., 1974) and
is isoelectrically and antigenically distinct from C5a.
Both activated T and B lymphocytes produce LDCF. T lymphocytes
required the presence of macrophages for its production but B cells
apparently did not (Wahl _et al., 1975). In vivo studies have suggested
that a chemoattractant indistinguishable from the LDCF produced by
antigen-stimulated lymphocytes in vitro was produced in delayed-type
hypersensitivity (DTH) reactions in vivo (Postlethwaite and Snyderman,
1975) concomitantly with the appearance of macrophages at the
inflammatory site.
Tumour cells have also been reported to produce a chemotactic
factor for macrophages (Meltzer et al., 1977) with peak levels produced
during log phase. It was distinguishable from LDCF by its molecular
weight and behaviour on ion-exchange chromatography. Thus chemotactic
factors released by tumours or proliferative cells may provide an
endogenous mechanism for macrophage accumulation.
5.6/...
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5.6 Lipid-associated chemotactic factors
Prostaglandins have been reported to be chemotactic for leukocytes
(Cantarow et al., 1978) although others have not found consistent chemo¬
tactic activity (Goetzl et al., 1980). However products of arachidonic
acid oxidised via the lipoxygenase pathway were chemokinetic and chemo¬
tactic for neutrophils and eosinophils and less so for monocytes (see
Goetzl et al., 1980, for a review of the effects of HETES on leukocyte
functions). Two HETES, 5-HETE and 11-HETE are synthesised and secreted
by rabbit alveolar macrophages in response to the inflammatory stimulus,
zymosan (Valone et al., 1980). Most chemotactic agents are chemotactic
and chemokinetic at similar concentrations and deactivate cells at
very low concentrations whereas HETES were chemokinetic at a lower
dose and deactivated at a similar concentration to that which induced
chemotaxis. They also did not affect oxidative metabolism or induce
lysosomal enzyme release unlike most other chemoattractants studied..
However one of the precursors of HETEs augmented the enzyme releasing
capacities of some of the other chemotactic factors including C5a.
5.7 Exogenous chemotactic factors
5.8 Bacterial chemotactic factors
Production of chemoattractants by a variety of micro-organisms
has been demonstrated. Keller and Sorkin, (1967a) found that culture
filtrates of Staph, albus and E. coli contained chemotactic activity
for neutrophils and Wilkinson et al. (1974) showed that C. parvum
extracts were chemotactic for macrophages. These chemoattractants
were produced by bacteria during log phase of growth (Ward, 1974).
Some organisms possess molecules which may activate the alternate
pathway of complement (Ward et , 1973; McBride et al., 1975), and
they/...
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they also produce chemotaxigens capable of directly cleaving C5 to
produce the anaphylotoxin and chemotactic factor, C5a (Keller and
Sorkin, 1967a).
5.9 Synthetic chemotactic factors
The above bacterial factors could not be attributed to a single
common entity. Schiffman _et al. (1975) found that N-terminal blocked
methionyl di and tripeptides were chemotactic for neutrophils and
macrophages. The initiation of protein synthesis in pro&aryotes uses
a formylated amino acid and this amino acid together with some of the
adjacent amino acids are cleaved from the nascent protein. They
speculated that the chemotactic response to formylated peptides (the
positively charged terminal amino group must be blocked for chemotactic
activity to be evident in the peptide) is a simple recognition system
by which mammalian leukocytes can detect microbial agents since euVfiaryo-
tic cells mainly initiate protein synthesis with nonacylated methionine.
This discovery allowed the synthesis of highly purified structurally
defined substances, previously unavailable for studying the physiology
and biochemistry of chemotactic factor interactions with leukocytes.
Maximum chemotactic activity required that the positively charged
terminal amino group must be neutralised and N-formylation was preferable
to N-acylation (Showell et^ al_. , 1976). Methionine was not obligatory
for the N-terminal position since other amino acids of similar hydro-
phobicity could be substituted. In the second position an amino acid
with a nonpolar side chain was necessary for maximal chemotactic
activity and the most active peptides were those with phenylalanine in
the third position. However Wilkinson (1979) has found that the
structural/...
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structural constraints on N-terminal blocked peptides need not be so
specific for chemotactic activity. The most active peptides were
those which were amphipathic with a considerable hydrophobic moiety.
Thus there are numerous ways in which chemotactic factors can
be generated which provides an efficient mechanism for host defence.
5.10 Regulation
During an inflammatory process, macrophages,, having migrated to
the inflammatory lesions must be retained in these sites where they
become activated and carry out their effector role in inflammation in
a restricted local environment. Control mechanisms may be at the
level of the chemotactic factor by blocking its production or activity
and at the cellular level by rendering the phagocytes unresponsive to
all chemotactic factors. Incubation of cells with high concentrations
of chemoattractants as would be found at the inflammatory foci,
deactivates leukocytes (Ward and Becker, 1968) and thus cells may be
confined in the lesion.
Plasmin and activated factor B, Bb may be produced at inflammatory
sites and Bianco et al. (1976, 1980) have shown that in vitro, both
these factors induced spreading of macrophages and inhibition of
migration.
Cell directed inhibitors of chemotaxis are produced by inflammatory
effector cells including neutrophils (Goetzl, 1975) and lymphocytes
(David, 1966) which produce lymphokines, leukocyte MIF and macrophage
MIF. In addition to the cell-derived factors, the serum proteinase
inhibitors a1 antitrypsin and ct2 macroglobulin inhibited chemotaxis
of leukocytes (Goetzl, 1975).
Several/...
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Several serum proteins may act directly to inactivate chemotactic
factors. C5a is inactivated by at least two serum proteins, anaphylo-
toxin inactivator and chemotactic factor inactivator. The latter
protease(s) also has activity against kallikrein and plasminogen
activator, both of which are also inhibited by a2 macroglobulin, and
kallikrein is also inhibited by C1 esterase inhibitor (Ward et al.,
1977).
■
A greater knowledge of the influencing factors involved in
regulation of chemotaxis may allow better control of inflammatory
disease. For instance monocyte chemotaxis in vitro is decreased in
patients with influenza (Pike et al., 1977) and also in neoplastic
disease (Boetcher and Leonard, 1974; Hausman et al., 1975).
5.11 Mechanism of chemotaxis
Most of the studies on the mechanism of chemotaxis have been carried
out on neutrophils. However macrophages have been investigated as well
and show similar responses as neutrophils and it is assumed that the
majority of results obtained with neutrophils are applicable to
macrophages.
Margination into the blood vessels is necessary before phagocytes
can migrate through the tissues to the site of inflammation and it
has been shown that chemotactic substances caused granulocytes to
aggregate in vitro and when they were injected in vivo neutropenia
resulted (O'Flaherty _et al., 1977). This suggests that chemotactic
agents must first make the phagocytes more sticky so that they can
adhere to blood vessel walls, possibly by decreasing the negative
charge which is present on most biological membranes and therefore
minimising charge repulsion between the phagocyte membrane and the
capillary wall (Gallin _et al,., 197 5).
Chemotactic/...
26
Chemotactic factors probably initiate responses by interacting at
the cell membrane. The response to chemotaxins is very rapid and the
presence of specific receptors for certain chemotactic factors on
leukocyte membranes has now been demonstrated. Evidence for the
existence of formyl methionyl peptide receptors on rabbit and human
neutrophils has been shown by various workers (Aswanikumar _et a_l.,
1977; Williams et al., 1977; Vithauskas et al., 1980)„ Binding was
rapid, saturable, specific and reversible and the specificity of
binding by the peptides correlated with biological activity. Similar
receptors have also been demonstrated on inflammatory and resident
peritoneal guinea pig macrophages (Snyderman and Fudman, 1980) and on
a human monocyte cell line (Pike et al., 1980). Human neutrophils also
have C5a receptors (Chenoweth and Hugli, 1978, 1980) and again the
binding was rapid, specific and saturable. C5a, and C5a„des arg 1-69
(lacking five C-terminal residues which does not have chemotactic activity)
both bind to the C5a receptor suggesting that the receptor recognition
site is in an internal portion of the molecule but the activation site
is represented in the C-terminal end (Chenoweth and Hugli, 1980). The
receptors for f-Met-Leu-Phe and C5a appear to be distinct since C5a did
not inhibit formyl peptide binding to neutrophils (Aswanikumar _et al.,
1977; Williams et al., 1977). Neutrophils also have receptors for a
chemotactic factor generated in neutrophils by urate crystals
(Spilberg and Mehta, 1979). Binding was saturable and specific in
that the chemotactic factors f-Met-Leu-Phe, gly-his-gly and C5a
did not displace the binding of the cell-derived chemotactic factor.
values for all the receptors were similar to the concentration
required to give half maximal response and the number of binding sites
was usually about 10^ per cell. F-Met-Leu-Phe receptors were also
present/...
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present on isolated cell membranes (Vithauskas et al., 1980).
Membrane-modifying agents perfringolysin, a cholesterol binding
agent, and phospholipase C diminished the chemotactic responsiveness
of neutrophils to f-Met-Leu-Phe, suggesting that the receptors may
be intimately associated with hydrophobic domains in the lipid bilayer
and depend on a defined lipid environment for effecting their function
(Wilkinson, 1979).
Thus receptors for high potency chemotactic factors do exist on
leukocyte surfaces. Other chemoattractants such as denatured proteins
may not have specific receptors but may exert their influence by hydro¬
phobic interactions with the membrane (Wilkinson, 1974). Some of these
chemotactic factors such as casein are also amphipathic which appeared
to be one of the major criterion for chemotactically active formyl
peptides (Wilkinson, 1979).
The interaction of formyl peptides and C5a with whole cells was
rapid but dissociation was very slow (Vithauskas et al., 1980; Chenoweth
and Hugli, 1978). Interaction of the formyl peptide and its receptor
led to rapid internalisation possibly by pinocytosis (Vithauskas _et _al_.,
1980; Niedel et al., 1979) and loss of binding site activity. More
receptors were lost from the membrane than the number of molecules
bound suggesting that other mechanisms are also involved apart from
endocytosis, possibly the binding sites become inactivated,. Deacti¬
vation following incubation with formyl peptides was also proportion¬
ally greater than the loss of receptor sites suggesting that a post
receptor event was at least partially responsibly for deactivation




Chemotactic factors increased the permeability of leukocytes to
•J" "f* 2+
the cations Na , K and Ca (Naccache et al., 1977) which are required
externally for optimal responsiveness to chemotactic factors (Showell
and Becker, 1976; Gallin and Rosenthal, 1974). The alteration in Na+
and K+ fluxes may have been due to activation of the Na*K+ ATPase as
chemotactic factors increased the activity of this enzyme in isolated
neutrophil plasma membranes (Becker et al., 1978). Gallin and Gallin
(1977) measured membrane potential changes following activation with
chemotactic factors in macrophages using standard electrochemical
techniques and Gallin _et £l. (1980) measured similar changes in human
monocytes using a membrane potential sensitive cyanine dye. They
found that chemotactic factors induced a K+ dependent membrane hyper-
polarization. Similar experiments with neutrophils showed that the
hyperpolarization triggered by chemoattractants was inhibitable by
oubain, suggesting that there may be a direct effect on the Na*K+
ATPase (Seligman _et £l_. , 1980).
2+
Ca also appeared to contribute to the membrane hyperpolarization
triggered by chemotactic agents. Both an increase in permeability
2+ 2+
to external Ca and release of Ca from intracellular stores may play
a role in chemoattractant induced membrane potential changes (Naccache
_et al_. , 1979a; Gallin _et al. , 1980). Electron microscopic studies have
indicated that f-Met-Leu-Phe caused circumferential loss of plasma
2+
membrane-bound Ca (Hoffstein, 1979) presumeably to the interior of
the cell.
Transmethylation reactions mediated by S-adenosyl-L-methionine
(SAM) appear to be involved in cell movement. Inhibition of this
pathway/...
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pathway blocked carboxy-O-methylation of monocyte proteins concom¬
itantly with inhibition of monocyte chemotaxis (Pike et. al. , 1978).
A rapid stimulation of carboxy-O-methyltransferase activity in rabbit
neutrophils by f-Met-Leu-Phe has been reported (O'Dea et al., 1978)
although Pike et al. (1979) found that chemoattractants had no effect
on the methylation of proteins in guinea pig macrophages which would
seem to contradict their earlier data (Pike et al., 1978). Activation
of the chemotactic factor receptors also stimulated another enzyme,
protein methylesterase which hydrolyses the methyl ester groups on
the methylated proteins (Venkatasubramanian et al., 1980). They suggested
that the increased turnover of protein methylesters may result in
oscillations between charged and uncharged forms of the methyl accepting
protein. This may contribute to alterations of membrane events which
may occur in the earliest stages of chemotaxis.
Chemotaxins inhibited the methylation of phosphatidylethanolamine
(PE) in macrophages (Pike et al., 1979) thereby inhibiting the formation
of phosphatidylcholine (PC). Increased turnover or degradation of
phospholipids was not detected and since PC is the major lipid in the
membrane, the ratio of PE/PC would be increased in newly synthesised
membrane. A continuous supply of new membrane lipid and cholesterol
was required for human monocyte and neutrophil chemotaxis (Pike and
Snyderman, 1980). They suggested that when the chemotactic factor
bound to the cell, phospholipid methylation was inhibited locally which
may lead to changes in the biophysical properties of the membrane such
as fluidity. These asymmetric membrane alterations may be necessary to
establish polarised cellular orientation.
Although Hirata _al. (1979) also found that chemoattractants
inhibited phospholipid methylation, increased degradation of PC and
not/...
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not decreased synthesis accounted for their observation. The dis¬
appearance of methyl groups was associated with release of arachidonic
acid which suggested that phospholipase A^, an enzyme stimulated by
2+
Ca (Gullis and Rowe, 1975), which removes an unsaturated fatty acid
from phospholipids was activated by chemotaxins. Accumulation of
phosphatidyl-N-monomethylethanolamine within the membrane increased
membrane fluidity (Hirata and Axelrcd, 1978). The release of arachidonic
acid is potentially important since it is the precursor of prostaglandins
and lipoxygenase products, HETEs which play a critical role in inflam¬
mation. Phospholipase activation by chemotactic factors may be mediated
2+
by an increase in intracellular Ca <> Inhibition of the lipoxygenase
pathway in neutrophils which is the main pathway for arachidonic acid in
neutrophils (Borgeat and Samuelsson, 1979) prevented increased membrane
2+
permeability to Ca following stimulation with chemoattractants.
2+
Displacement of Ca from intracellular stores was unaffected, suggesting
2+
that the two processes of Ca metabolism can be separated, one preceeding
the other and are related to arachidonic acid metabolism (Naccache _et al_.,
2+
1979b). Ca fluxes may also play a role in the transduction of chemo¬
tactic factor binding to the receptor and inducing methylation of
proteins.
Actin and myosin are probably involved in chemotaxis. Stimulation
of neutrophils with a gradient of chemoattractant led to an increase in
the concentration of actin filaments in the pseudopod put out by the
neutrophil as an initial response to the gradient. The concentration
of actin was maintained in the membraneous portion of the cell facing
the gradient (Oliver e_t al_. , 1978). Microfilaments appear to be involved
in both chemotaxis and chemokinesis since both are inhibited by cyto-
chalasin B (Zigmond and Hirsch, 1972).
Microtubule/...
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Microtubule involvement is not so clear. It has been suggested
that microtubules are not required for spatial detection of or for
locomotion towards a chemotactic factor but are important for accurate
turning by leukocytes and for maintenance of the polarity of the
moving cell (Allan and Wilkinson, 1978).
2+
Ca fluxes may be involved in microtubule and microfilament
assembly (Gallin and Rosenthal, 1974).
Chemoattractants induced a transient increase in intracellular
levels of cAMP (Simchowitz et al., 1980) before other changes were
observed. However agents which are known to increase intracellular
cAMP decreased locomotion (Hill, 1978). Possibly chemotaxin induced
increases in cAMP may be compartmentalised whereas these agents induce
an overall increase in cAMP. Chemotactic factors also induced a small
and transient increase in cGMP and agents which increase intracellular
levels of cGMP enhanced locomotion (Hill, 1978). Probably these agents
modulate rather than initiate chemotaxis possibly by affecting micro-
2+
tubule assembly either directly or through stored Ca (Zurier et al.,
1974). The accumulation of lysophosphatidylcholine mentioned above
may play a crucial role in the regulation of the guanyl cyclase
(Shier et al., 1976).
5.13 Other leukocyte changes induced by chemotactic factors
Metabolism is dramatically altered but these changes are not
necessarily associated with the actual directed migratory response.
Both aerobic glycolysis and HMPS activity increased following incubation
with chemotactic factors even when the cells had been deactivated
and no longer responded chemotactically (Goetzl and Austen, 1974).
However these pathways may provide ATP for membrane-associated transport
systems,/...
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systems, microfilament contractions and possibly microtubule assembly.
Lysosomal enzyme release was triggered by chemoattractants. Although
the concentration of chemotactic factors was higher than that necessary
for migration the structure/activity relationship of some of the
chemotaxins such as the formylated peptides was the same (Showell et al.,
1976). N-formylated peptides also produced chemiluminescence in
leukocytes (Hatch et_ al_. , 1978; Lehmeyer et al. , 1979; Beswick and Kay,
1981). Chemiluminescence is probably a measurement of superoxide and
myeloperoxidase dependent reactions. Structure/activity relationships
suggest that these activities are elicited through interaction of the
peptides with a common receptor.
Directed migration results from the culmination of a complex series
of biochemical events. Initial recognition, at least with some chemo¬
tactic factors is through the reversible interaction with specific
membrane receptors. This may induce perturbations in the membrane,
possibly through conformational changes in the receptor molecule and
rearrangement of membrane lipids. These alterations may affect membrane-
associated enzymes such as the Na*K+ ATPase which increases the sensitivity
of neutrophils to chemoattractants. Local permeability changes for
divalent cations may also be affected. The displacement of intracellular
2+
membrane Ca may increase phospholipase activity and thereby increasfc'.g
the production of arachidonic acid which may be necessary for increased
2+ 2+
permeability to external Ca . Influx of Ca leads to elevated levels
2+
of intracellular Ca and may activate the cell's contractile system.
Alterations in membrane lipids may also affect cyclic nucleotide levels
and these may also be involved in microtubule assembly. Both methy-
lation of phospholipids and proteins are affected by chemotaxins and
may/,..
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may be involved in the control of membrane-associated enzyme and
permeability. They may also induce local changes in membrane fluidity
which may be necessary for pseudopod formation and cellular orientation
in a chemotactic gradient. Activation of metabolic processes may or
may not be necessary for chemotaxis per se and may be more important
when the cell has reached the inflammatory site and can effect its
inflammatory role.
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6.0 MACROPHAGE PLASMA MEMBRANE
The chemical composition of macrophage membranes is similar to
that of other mammalian cells and consists of 46% protein, 41% lipid
and 8% carbohydrate (Nachman et al., 1971a). SDS gel electrohporesis
of solubilised membranes from rabbit alveolar macrophages elicited by
B.C.G. yielded seven to nine major proteins with molecular weights
4 4
between 7 x 10 daltons and 14 x 10 daltons. Pratt and Cook (1979),
in a more recent study on resident rabbit alveolar macrophages, isolated
five major glycoproteins with molecular weights varying between
4 4
2.8 x 10 and 8 x 10 daltons. These discrepancies may reflect
differences between resident and stimulated macrophage membranes. Yin
et al. (1980) reported that there were quantitative and qualitative
differences between plasma membrane polypeptides of resident and
activated macrophages. Kaplan et al. (1979) isolated five major poly¬
peptides and seven to eight minor bands from [~^S] methionine labelled
cells (thioglycollate induced mouse peritoneal macrophages). The major
4 4
proteins had molecular weights between 4.5 x 10 and 31 x 10 .
The major lipids in macrophage plasma membranes consist of phos¬
phatidyl choline, sphingomyelin and phosphatidyl ethanolamine as well
as a more unusual lipid, lyso (bis) phosphatidic acid (Mason et al.,
1972). The fatty acids of macrophage phospholipids contain an
unusually high proportion of arachidonic acid compared to other
leukocytes (Stossel _et _al. , 1974).
6.1 Turnover of macrophage plasma membrane constituents
Nachman _et _al. (1971b) found a seven to eight hour half life of
1 4
[ C]-leucine labelled proteins in the plasma membrane of rabbit
alveolar macrophages. Although these proteins had varying rates of
synthesis/...
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synthesis, all the labelled proteins were rapidly degraded at the same
rate. These cells are known to endocytose at a rapid rate and this
may have accounted for the bulk removal of membrane constituents. A
more rapid endocytic rate with partial recycling and partial degradation
would also fit their data. The turnover of most surface polypeptides
4
of molecular weight greater than 5 x 10 daltons in thioglycollate
induced mouse peritoneal macrophages was very slow (t^ was greater than
eighty hours (Kaplan et al., 1979)). Using the lactoperoxidase
iodination method for studying cell surface proteins Yin et al. (1980)
reported that glycoproteins on mouse peritoneal macrophage membranes
were degraded at different rates, suggesting that the membrane is not
turned over as a single unit as was previously implied by the results
of Nachman (1971b). Again the turnover of most polypeptides was slow
(t, = 21.7h). It had previously been suggested that pinocytosis was
%
the mechanism for the turnover of plasma membrane proteins (Edelson
and Cohn, 1976) in order to explain the decrease in 5" nucleotidase
activity in thioglycollate and endotoxin induced peritoneal macrophages
which show an increased pinocytic rate. However the turnover of
plasma membrane proteins is much slower than the expected pinocytic
rate (Steinman et al., 1976) of two cell surface equivalents per hour
in resident peritoneal macrophages. It is possible that membrane is
selectively excluded from endocytic vesicles or that it is recycled
after endocytosis as suggested by Muller et al. (1980) who radiolabelled
phagolysosomal membranes and showed that the label was rapidly (within
30 minutes) returned to the plasma membrane. Similarly with ligand-
induced pinocytosis, Fc receptors regenerated within 30 minutes after
pinocytosis of a surface load of receptors saturated with small antigen-
antibody/. ..
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antibody complexes (McKeever et al., 1976). Rapid recycling of pino-
cytosis receptors on rat alveolar macrophages for glycoprotein also
occurs (Stahl et al., 1980). So at least some membrane constituents
are not degraded after internalisation but appear to be recycled.
The slow turnover of membrane proteins may also reflect the degradation
rate within the lysosome.
Both Kaplan et al. (1979) and Yin et al. (1980) also found that
there was a more rapid phase of label loss from membrane proteins
apparently due mainly to low molecular weight species. Yin et al. (1980)
recovered this portion of the label in the medium suggesting that it
was shed directly from the cell surface and not endocytosed. Therefore
there may be two different modes of cell surface protein turnover. It
is not clear whether individual proteins are specifically removed by
one route or the other.
Others have studied the kinetics of regeneration of plasma
membrane components after exposure of intact cells to hydrolytic
enxymes. Following trypsin treatment a membrane protein involved in
cholesterol metabolism required seven hours for full recovery of normal
cholesterol exchange rates and required protein synthesis (Werb and
Cohn, 1972). Fc receptors on a macrophage cell line were regenerated
after removal with trypsin (t^ < 12h) and the restoration was blocked
by the protein synthesis inhibitor, cyclohexamide (Unkeless and Eisen,
1975). However it is impossible to conclude from these data whether
these rates reflect a normal membrane protein synthetic rate or an
altered rate due to a damaged cell surface.
Following phagocytosis of latex particles there was a decrease
in plasma membrane constituents in the mouse peritoneal macrophage
(5'/...
37
(5' nucleotidase, phospholipids and cholesterol) (Werb and Cohn,
1972). Fc receptors were also decreased following phagocytosis of latex
particles from rabbit and human alveolar macrophages (Daughaday and
Douglas, 1976) and to a lesser extent by human blood monocytes
(Schmidt and Douglas, 1972). Approximately six hours after phago¬
cytosis these plasma membrane constituents started to return to normal
levels and the regeneration was dependent on protein synthesis. The
amount of new membrane synthesised was proportional to the amount of
membrane interiorized around the latex particles suggesting that
interiorization of membrane constituents and their subsequent degra¬
dation is tightly coupled to the cellular processes involved in
membrane biosynthesis. However internalization is not a completely
random process. The membrane transport systems for amino acids and
nucleotides in neutrophils and macrophages (Tsan and Berlin, 1971) and
complement receptors in macrophages (Daughaday and Douglas, 1976)
appeared to be excluded from membrane internalisation during phagocytosis
of latex. However when neutrophils were treated with colchicine, phago¬
cytosis of latex particles resulted in the internalisation of the
transport carriers. Thus the apparent segregation of transport and
phagocytic sites appears to be under the control of cytoskeletal
elements (Ukena and Berlin, 1972).
Phospholipid synthesis is increased following phagocytosis (Elsbach,
1968). However there is no evidence that phospholipid synthesis is
necessary for phagocytosis except when large numbers of particles are
ingested (Pike and Snyderman, 1980).
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7.0 ENDOCYTOSIS
Utilising their capacity for endocytosis, macrophages fulfill
many important roles in host defence against micro-organisms, parasites
and possibly invasive neoplasms, in scavenging foreign material and
senescent or damaged cells. It provides a mechanism for the acquisition
of nutrients from the external environment, the down regulation of cell
surface receptors and is possibly involved in plasma membrane turnover.
It has important secondary consequences by triggering macrophage
secretory functions.
Endocytosis has been studied in vivo by measuring the plasma clear¬
ance rates of various substances. Liver and spleen macrophages are
the main cells involved in plasma clearance. However these studies
are complicated by the presence of serum opsonins and other host
factors such as hormones. Most of the work on endocytosis has been
carried out in vitro using readily available mononuclear phagocytes
including peripheral blood monocytes, mouse peritoneal macrophages and
also alveolar macrophages and macrophage cell lines.
Endocytosis can be divided into two separate categories: phago¬
cytosis which involves the internalization of particles with diameter
greater than 1u and pinocytosis which involves the uptake of soluble
substances. Pinocytosis, itself, can be subdivided into micropino-
cytosis in which membranous vesicles of diameter less than 0.1y are
interiorized and macropinocytosis in which the vesicles have a diameter
greater than 0.2y., Alternatively endocytosis can be divided into two
different categories: non-receptor mediated endocytosis which is
mainly fluid phase or non-adsorbtive pinocytosis and is more or less
a passive process dependent on the external concentration of the
substances/...
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substances being pinocytosed and the ability of the macrophage
membrane; and receptor-mediated pinocytosis which includes phagocytosis
and adsorptive pinocytosis (Silverstein et al., 1977).
7.1 Pinocytosis
7.2 Non receptor mediated or fluid phase
Macrophages form smooth or uncoated vesicles which invaginate from
the plasma membrane, trapping fluid and solutes, from the extracellular
environment when the membrane fuses to form the vesicles. Using horse
radish peroxidase as a marker for this process it was shown that uptake
was directly proportional to the concentration in the medium and was
temperature dependent (Steinman et al., 1976).
7.3 Receptor mediated or adsorptive pinocytosis
Another population of vesicles formed by macrophages are the so-
called coated vesicles which are involved in the selective uptake of
proteins and particles by adsorptive pinocytosis. One of the most
detailed in vitro studies is that of Goldstein and Brown (1977) on the
uptake of low density lipoprotein (LDL) by human fibroblasts. Cell
surface receptors for LDL are located in coated pits which invaginate
when the ligand is bound and are internalized. These receptors are
specific for LDL and are saturable. Several substances have been shown
quantitatively to exhibit features of adsorptive uptake in vitro by
macrophages including polycation-polyanion complexes (Seljelid, 1973)
lysosomal enzymes (Stahl et al., 1978) and. glycoconjugates (Stahl et al.,




By this process macrophages ingest particulate material which
first attaches to the cell membrane by specific or nonspecific receptors
or binding sites.
7.5 Energy requirements
Phagocytosis and pinocytosis are temperature dependent events and
with phagocytosis there is a minimum threshold level below which particles
are not ingested (Kaplan and M0rland, 1978). ATP is thought to provide
the chemical energy for the process since phagocytosis is accompanied
by increased cyanide-insensitive oxygen consumption, glycolysis and
HMPS, and glycolytic inhibitors such as sodium fluoride and iodo-
acetimide inhibit phagocytosis (reviewed by Karnovsky et al., 1970).. However
many of these alterations are the result of phagocytosis and are not
required for the event to take place (Silverstein et al., 1977).
Michl et al. (1976a, b) have shown that alterations in ATP levels did
not correlate with the phagocytic capabilities of mouse macrophages and
Stossel et al. (1970) found no changes in ATP levels during phagocytosis
of latex particles.
However creatine phosphate consumption was increased during phago¬
cytosis (Silverstein and Loike, 1980) suggesting that the ATP content
of phagocytosing macrophages is maintained at least in part by rephos-
phorylation of ADP by the cells' creatine phosphate content which is
present in three to five times molar excess of ATP.
7.6 Cyclic nucleotides
Most investigators have not observed changes in cAMP levels in
phagocytosing neutrophils (Stossel _et al., 1970). Ignarro and George
(1974)/...
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(1974) found elevated cGMP levels during particle ingestion by neutro-
2+
phils. However omission of Ca from the medium prevented the rise in
2+
cGMP and since phagocytosis normally proceeds in the absence of Ca
it is unlikely that ingestion itself is regulated by these changes.
7.7, Contractile elements
Microfilaments appear to be involved in the endocytic process as
suggested by their presence in phagocytic cells, the association of
actin with the plasma membrane and the ability of cytochalasins to
inhibit phagocytosis (Axline and Reaven, 1974) unlike agents which
depolymerize cytoplasmic microtubules. Microfilaments have a diameter
O
of 50 A, are composed of actin, and are found in abundance beneath the
plasma membrane in the cortical cytoplasm (Reaven and Axline, 1973).
Macrophages are 10% by weight actin and 1% myosin (Hartwig and Stossel,
1975). When the pseudopod first forms the orientation of micro¬
filaments is random. However adjacent to the particle being ingested
microfilaments are arranged in ordered bundles and as the pseudopod
advances round the particle these filaments become more parallel to
the long axis of the pseudopod (Reaven and Axline, 1973). The fila¬
ments also become more densely packed beneath the ingesting particle
(Griffin e;t al., 1976).
Other macrophage proteins interact with actin in vitro to cause
viscosity changes and movement. Actin, myosin, actin-binding protein
2+
(ABP) and a Ca -dependent actin regulator protein (gelsolin) have
been purified from rabbit alveolar macrophages (Hartwig and Stossel,
1975; Yin and Stossel, 1980). Actin and ABP form gel lattices in vitro
2+
and macrophage myosin in the presence of Mg -ATP contracts the actin
filaments isometrically (Stossel and Hartwig, 1976). Immunofluorescence
studies/...
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studies have shown that both myosin and ABP are present in the
peripheral cytoplasm or cortex (Stendahl _et al., 1980). Gelsolin
2+
in the presence of Ca inhibited the formation of the actin-ABP lat¬
tices, suggesting that this protein may be the physiological regulator
of actin gelation (Yin and Stossel, 1980).
7.8 Mechanism of phagocytosis
Electron microscopic studies by various workers have shown that
during phagocytosis of certain particles such as IgG coated sheep red
blood cells, EA , pseudopodia surround the particle until they meet and
G
fuse on the far side of the particle, forming the vacuole (LoBuglio
et al., 1967; Griffin et. al., 1975a, b) . Internalization by this process
appears to involve a segmental response to phagocytic stimuli. Red cells
were bound to macrophages using ligands which did not promote phagocytosis.
The cells were incubated with latex particles or antibody coated bacteria
and it was observed that the latter were ingested but the red cells were
not, suggesting that the putative molecules which link surface receptors
to the underlying cytoskeleton do not diffuse rapidly within the
membrane and only couple to the receptors at the site of phagocytosis.
A zipper mechanism has been proposed to explain the observed surrounding
of the particle by pseudopodia (Griffin et al., 1975b; Shaw and Griffin,
1981). Ingestion only proceeds upon sequential circumferential binding
of macrophage receptors to IgG distributed evenly around the target cell.
When antibody was not distributed evenly as with lymphocytes coated
with anti-immunoglobulin IgG capped at one pole, phagocytosis did not
take place. After macrophages had bound EA at 4°C, they were treatedG
with anti-macrophage IgG and allowed to warm up to 37°C; no ingestion
occured. Initial attachment does not necessarily predestine the
particle/...
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particle for ingestion. The direction and extent of movement of the
macrophage membrane is governed by the distribution of ligands on the
surface of particles and by continued availability of macrophage
surface receptors to interact with the ligands.
However phagocytosis of other particles including complement coated
particles appears to involve a different series of events. Electron
microscopic studies revealed the formation of craters or pits in the
macrophage membrane into which the particle directly sank.. There only
appeared to be regions of close contact at the bottom of the pit which
does not agree with the "zipper hypothesis" of Griffin et al. (1975b)
in which regions of close contact to the walls of the crater would be
expected. This type of phagocytosis was less sensitive to cyto-
chalasin B than the zippering mechanism (Kaplan, 1977) suggesting
that either microfilaments are not involved or that a different set
of microfilaments mediate crater formation. Bundles of filaments at
a deeper level may be relatively resistant to cytochalasin B and may
exert a downward pull in the case of internalization of complement
coated particles.
From these in vivo and in vitro studies Hartwig et al_. (1980) have
proposed a "rigidity-shear" hypothesis to explain how macrophages form
and extend pseudopodia in the zippering mechanism. Two opposing forces
are involved - rigidity which comes from the lattice and shearing from
the myosin moving actin filaments. They assume that the cortical
layer in cells is in an actin-lattice structure which spans the entire
cortex of the cell. The lattice is subject to regional control so that
the cell can alter its structure in distinct regions. ABP is normally
attached to the membrane but when a particle binds to the membrane via
its receptors, ABP is released and cross links the actin filaments in
this/...
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this region which leads to a local increase in rigidity. Myosin,
2+
incorporated into the lattice, in the presence of Mg and ATP contracts
the actin filaments isometrically and increases the tension in the
filaments. Myosin can then pull filaments adjacent to the cross-linked
filaments from a region of lower rigidity into a region of higher
rigidity by an isotonic contraction.
Since some of the actin filaments are attached to the membrane
this pulling pinches the membrane up and toward the particle and new
attachments can occur between the membrane and the particle. Further
ABP dissociates and results in movement of the rigidity gradient into
the advancing pseudopod, propagating its movement. A secondary response
in regions of particle membrane attachment is an increase in cyto-
2+
plasmic Ca which may be released from plasma membrane stores by the
interaction of opsonised zymosan or immune complex precipitates
2+
(Hoffstein, 1979). This increase in free Ca in the presence of
gelsolin leads to the dissolution of the ABP-actin lattice. As an
increase in rigidity advances with the pseudopod, a secondary wave of
solution follows behind it, maintaining a rigidity gradient, where
rigidity is greatest at the tip of the pseudopod.
7.9 Post endocytic events
Endocytic vesicles once formed detach from the plasma membrane and
fuse with pre-existing membrane bound vesicles called lysosomes which
release their hydrolytic enzyme contents into the fused phago-lysosome
(Cohn, 1970) where their ingested substances are digested.
7.10 Metabolic consequences of ingestion
Metabolism in general is increased, particularly cyanide-insensitive
oxygen consumption, H2°2 Proc^uct;'-on anc^ glucose oxidation via the
HMPS/...
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HMPS pathway (Karnovsky e_t al. , 1970). The generation of oxygen
metabolites, superoxide anion and singlet oxygen (Johnston, 1976,
1978) and release of (Nathan and Root, 1977; Nathan et al.,
1979b) appears to be important in bacterial and parasite killing
in macrophages.
Endocytosis stimulates the secretion of neutral proteinases and
these enzymes include collagenase, elastase and plasminogen activator
(Davies and Bonney, 1979). Lysosomal enzyme secretion is also
triggered by phagocytosis and these enzymes include B-glucuronisae
and N-acetyl-S-glucosaminidase. Ingestion of zymosan and opsonised
erythrocyytes leads to prostaglandin E release from macrophages
(Bonney et al., 1980).
5-HETE and 11-HETE, chemotactic factors for neutrophils and
eosinophils are released by rabbit alveolar macrophages after
ingestion of opsonised particles (Valone et al., 1980). Secretion
of these various substances during and following ingestion suggests
that phagocytosis plays a significant role in the host inflammatory
response (Davies and Allison, 1976).
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8.0 THE GENERATION OF CELL BOUND C3b, C3b^ and C3d BY THE CLASSICAL '
AND/OR ALTERNATE PATHWAYS OF. COMPLEMENT
There are cascade systems in the blood of all vertebrates which
are activated by the conversion of proteolytic zymogens to active pro¬
teases. Three of these systems, the complement system, clotting system
and kinin system play an essential part in the defence of the host against
injury and infection. Cascade systems allow rapid responses which are
localised by the high concentration of proteolytic inhibitors in the
blood.
The complement system is the most complex of the cascade systems
and has emerged as an integral part of the immune system. It is activated
by two independent pathways - the classical and the alternate pathways.
The former is activated by immunoglobulins after interaction with antigen
(Porter and Reid, 1979; Muller-Eberhard, 1975, 1980). The alternate
pathway can also be activated by antibody aggregates but through a
different route and may also operate in the absence of specific anti¬
body. It is activated by naturally occuring polysaccharides and
lipopolysaccharides and by certain micro-organisms, viruses, parasites
and mammalian cells depending on the chemical composition on their cell
surfaces (Gotze and Muller-Eberhard, 1976; Muller-Eberhard and Schreiber,
1980) .
The concentration of complement in the blood is between two and
three g/1 with the third component, C3, present in the greatest
quantities of all the components (100mg/1 OOral) . The complement system
comprises of twenty plasma proteins; six constitute the classical path¬
way of activation: C1q, C1r, C1s, C2, C3 and C4, and six the alternate
pathway: C3, B, D, 01H or factor H, C3b inactivator (C3blNA or KAF or
factor I) and properdin. Whereas the latter three proteins are considered
to be regulatory proteins in the complement system, they are essential
for/...
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for the activation of the alternate pathway. Five proteins participate
in the membrane attack pathway: C5, C6, C7, C8 and C9. This pathway
is regulated primarily by S-protein which inhibits the formation of
the membrane attack complex (MAC). The classical pathway regulators
are C1 inhibitor (C1INH), C4 binding protein and C3b1NA. The activa¬
tion peptides of C3, C4 and C5 and their anaphylotoxin activity are
controlled by serum carboxypeptidase B.
Complement has five principle biological functions:
(a) it forms ligand molecules such as C3b which can bind to biological
particles through its metastable binding site and then link these
particles to phagocytic cells via their C3b receptors.
(b) it elaborates inflammatory mediators, C3a, C4a and C5a which have
anaphylotoxin and/or chemotactic activities, Bb which inhibits leuko¬
cyte migration and induces spreading and C3e which has leukocytosis
inducing properties (Ghebrehiwet and Muller-Eberhard, 1979) which may
be important in the granulocytosis response to gram positive bacterial
infections.
(c) it is bacteriolytic by generating a unique membranolytic multi-
molecular complex which is capable of weakening and disassembling lipid
bilayers and of forming transmembrane channels.
(d) it solubilises immune complexes (Miller and Nussenzweig, 1975;
Takahashi et al., 1980). The importance of this function is evidenced
by certain patients with complement deficiencies who have systemic
lupus erythematosus which is related to immune complex deposition
(Einstein _et al_. , 1975). Solubilisation of immune complexes may also
be important in the immune response to soluble antigens. Parish and
Chilcott (1975) postulated that complement receptors might facilitate
T and B lymphocyte interactions by stabilising the union of soluble
antigens/...
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antigens (which would have to be coated with natural antibody and
complement) with antigen specific receptors on complement receptor
positive B cells.
(e) it may play a role in antigen focusing and specific responses
in relation to intercellular co-operation. Depletion of C3 prevents
localisation of antigen in lymphoid follicles and B memory cells are
not generated in the germinal centres (Klaus and Humphrey, 1977).
They suggested that antigen-antibody complexes bound to dendritic cells
via C3b receptors on the dendritic cells and Fc receptors on B cells,
provide the necessary environment for generating memory cells. C3
may act by strengthening the bridge between the dendritic cells and
B lymphocytes. C3 depletion also depresses T-dependent antibody
responses but leaves T-independent responses unimpaired. C3 may promote
bridging between antigen-carrying macrophages and/or T and B lymphocytes
or may enhance the binding of antigen to B cells (Pepys, 1976). How¬
ever other workers have reported that C3 does not play a role in the
in vitro antibody response (Waldman and Lachman, 1975). Koopman et al.,
(1976) has suggested that the transient generation of free C3b either
by proteolytic enzymes or by the C3 convertase may augment the
inflammatory response by stimulating B cells to elaborate chemotactic
and other lymphokines.
C3 is the most versatile of the twenty proteins of complement
and fulfills many different functions in the system.
C3 has a molecular weight of about 180,000 daltons and is composed
of two polypeptide chains linked by disulphide bonds, an a chain of




Activation of the classical pathway after antibody has bound to
antigen which may be on the cell surface or soluble protein or other
molecule. The first component of complement which consists of a
2+
complex of C1q, C1r, C1s and Ca , binds to the C 2 domain of IgGH
(Colomb and Porter, 1975) or the C 4 domain of IgM (Brown and Koshland,H
1977) via the C1q subcomponent (Muller-Eberhard ^t al., 1966a). A
catalytic site'is then exposed in C1s of the C1 complex (Stoud et al.,
1966) which cleaves C4 into C4a and a much larger fragment C4b. The
loss of C4a exposes a hydrophobic site in C4b through which it binds
to cell membranes. C2 binds to C4 and is split into C2a which remains
bound and C2b which dissociates (Nagasawa and Stoud, 1977). C2a
contains an enzymatic site which is responsible for the cleavage of
C3 (Muller-Eberhard et_ al., 1 966b) . C3 is cleaved into C3a, one of the three
anaphylotoxins (Dias da Silva et al., 1967) and the major fragment,
C3b. Concomitant with this cleavage a metastable binding site is
expressed on C3b through which C3b can firmly attach to a large variety
of biological particles and cell membranes by a covalent ester linkage
(Law, Lichtenberg and Levine, 1979; Sim et al., 1981; Tack et al.,
1980). The binding site probably resides in the C3d fragment which
is part of the a chain of C3b since C3c was released by the action of
C3b1NA and other serum proteins while C3d was retained by the cell
(Ruddy and Austen, 1971).
C3b is also generated by the alternate pathway» Activation
consists of initiation and amplification.. It is believed that there
may be a continuous generation of the priming convertase C3Bb at a
slow turnover rate by the interaction between C3, B and D (and properdin).
Deposition of C3b on cell membranes requires the enzymatic cleavage of
fluid phase C3 in order to generate the metastable C3b, capable of
binding to biological particles (Schreiber et al., 1978). It is also
possible/...
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possible that certain chemical groups of the surface of cells may-
cleave this bond, thereby attaching C3 to cell membranes. C3 thus
bound may behave functionally like C3b and serve as the subunit in
the initial C3 convertase. The initial convertase would be surface
bound C3Bb rather than fluid phase C3Bb.
Spontaneous hydrolysis of the thioester bond in C3 initiates
a conformational change which exposes the binding site for factor B
(Vogt et al., 1978). The C3B complex is activated by factor D and
generates the first C3 convertase of the pathway C3Bb. The proteo¬
lytic activity of this enzyme on native C3 subsequently generates
the first molecule of metastable C3b which is then deposited onto
potential target sites.
Surface bound C3b through either the classical or the alternate
pathway is then subjected to two competing processes - amplification
and inactivation. Amplification occurs when additional C3b mole¬
cules are deposited around the original C3b molecule. Factor B
binds to the first C3b molecule and C3bBb is produced by the action
of factor D. A possible amplification loop is generated because
C3bBb is a C3 convertase and each generated molecule of C3b can
repeat this process (Muller-Eberhard and Gotze, 1972) with the sub¬
sequent deposition of many more molecules of C3b. Many of the
functions of cell bound C3b can be abolished by the action of
C3bINA which acts as a proteolytic enzyme (Ruddy and Austen, 1971).
This enzyme requires 81H for its action possibly because 81H
binds to C3b and the resulting conformational change exposes a
site susceptible to cleavage of C3bINA (Pangburn et al., 1977). The
a chain of C3b is cleaved into two fragments without affecting the
B chain (Law et al., 1979; Gaither et al., 1979). All three
polypeptides are held together by disulphide bonds and
therefore/...
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therefore the cleaved molecule C3b* has the same molecular size as
intact C3b. CSb' is covalently bound to the cell surface through the
larger a chain fragment. Conversion of C3b to C3lf is accompanied by-
loss of immune adherence to human erythrocytes, functional haemolytic
activity and the ability to form on the cell surface the factor B,
factor D, properdin dependent amplification C3 convertase. However
C3b* like C3b is recognised by specific surface receptors on phagocytes
(Ross and Rabellino, 1979) and may induce ingestion (Newman et al.,
1980). C3b^ is very susceptible to attack by proteases which cleave
a second bond in the a chain to produce two fragments, C3b and C3d.
The C3d portion remains covalently linked to membrane and the C3c frag¬
ment is released into the medium (Ruddy and Austen, 1971). Further
tryptic digestion of C3c produces C3e which is probably derived from
the a chain and has leukocytosis inducing activity (Ghebrehiwet and
Muller-Eberhard, 1979). In vitro a low concentration of trypsin is
required to cleave C3b' to produce C3c and C3d. However it is not
clear which enzymes are involved in vivo. Plasmin may be used to
substitute for trypsin but high concentrations are required. Elastin
from neutrophils also cleaves C3b>' and this lysosomal enzyme may
represent the in vivo component (Carlo et al., 1979).
A control system apparently exists in that C3b binds to foreign
particles and not to host cells. It appears capable of distinguishing
between activators and non-activators of the alternate pathway (Pangburn
et al., 1980) which is reflected in a differential accessibility of
bound C3b to B1H (Kazatchkine et al., 1979). The competition between
factor B and B1H binding to cell-surface-associated C3b is influenced
by the amount of sialic acid on the cell surface. The presence of
sialic acid increases the affinity of cell bound C3b for 01H but not
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amounts of sialic acid on their surfaces,,
Both the classical and the alternate pathways are potentially
cytolytic. C5 is cleaved by either C5 convertase, C1423b or C3bBbC3b,
into two fragnr^t", C5b and C5a. C5b forms part of the MAC and C5a
which is an anaphylotoxin and chemotactic factor, is released. The
formation of the C56789 complex or MAC appears to be a self-assembly
process (Podack et al., 1980) which exert a direct physical attack on
the target membrane leading to target cell destruction (see Boyle and
Barson, 1980, for a review).
53
9.0 MACROPHAGE COMPLEMENT RECEPTORS
9.1 Function
Complement receptors are involved in the selective elimination
of invasive pathogens by macrophages. Their biological importance
is evidenced by patients with hereditary C3 deficiency or abnormal
C3 metabolism. These patients whose serum opsonising capacity is
diminished (Alper et al., 1976), have an increased susceptibility to
life-threatening recurrent infections which normally can be controlled
by phagocytes in normal serum. However other complement-mediated
functions are also absent in C3-deficient sera and the lack of C3
opsonising capacity cannot account for all the effects observed. Both
complement and Fc receptors are important in bacterial killing by
human monocytes (Leijjy et al. , 1979). Triggering of these receptors
after phagocytosis of opsonised micro-organisms appears to be
necessary for intracellular killing to take place,
C3b induces lysosomal enzyme release from macrophages presumably
by interacting with their C3b receptors (Schorlemmer and Allison,1976).
This may be important in inflammatory reactions where alternate path¬
way activation occurs. The C3b thus generated may act on macrophages
stimulating release of enzymes involved in the inflammatory response.
Some of these enzymes can cleave C3 to form more C3b thus amplifying
the system.
There is some controversy about whether or not C3b alone is
sufficient to stimulate release of superoxide anion (0^ ) or oxidative
metabolism (Newman and Johnston, 1979; Goldstein et al., 1976). How¬
ever synergy between C3b and Fc binding to their respective receptors
caused enhancement of oxidative metabolism and degranulation.
C3b/...
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C3b receptors on macrophages may play a role in antigen presen¬
tation to B lymphocytes by enhancing the approximation of different
cell types involved in co-operation (reviewed by Pepys, 1976). There
may be a functional basis for the fact that SA^C adhere to macrophages
but may not be ingested (Mantovani et al., 1972). In a primary immune
response, immune complexes would remain on the surface of macrophages
and therefore be in a position to stimulate immunocompetent cells.
Antibody-dependent cell cytotoxicity by human monocytes was enhanced
by the presence of complement on IgG coated erythrocytes (Kurlander
et al., 1978) or IgG coated Raji cells (Kessler and LoBuglio, 1980)
although the presence of complement alone on these target cells did
not mediate lysis by monocytes.
Generally a rosetting technique with complement coated red cells
is used to directly visualise complement.receptors (Bianco, 1976) or
^1Cr labelled erythrocytes have been used (Atkinson et al., 1977).
Lymphocyte complement receptors have been investigated using fluores-
ceinated anti C3 antiserum and soluble C3 and C3b or radiolabelled
C3 and C3b (Theofilopoulos et al., 1974). However neither of these two
methods has been used to examine macrophage complement receptors. The
production of anti C3 receptor antibodies (Fearon, 1980; Gerdes and
Stein, 1980, 1981; Dobson et al., 1981) may be used in the future to
detect C3 receptors.
C3 receptors have a widespread tissue distribution and can be
detected on the surfaces of primate erythrocytes (Nelson, 1963), many
nonprimate platelets (Nelson, 1963, neutrophils (Anwar and Kay, 1977a),
macrophages (Mantovani et al., 1972), monocytes (Ehlenberger and
Nussenzweig, 1977), a subpopulation of lymphocytes (primarily Blymphocytes)
(Ross and Polley, 1975) mast cells (Vranien _et jal., 1980) eosinophils
(Anwar/...
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(Anwar and Kay, 1977) and epithelial cells of normal renal glomeruli
(Schreiber and Penny, 1979).
9.2 Specificity
Macrophages do not have receptors for complement components C1 or
C2 (Wellek et al.., 1975). Human monocytes have receptor activity for
C4 (Ross and Polley, 1975) as well as for C3 (Ehlenberger and Nussenzweig,
1977) although the*affinity of the monocyte receptors for C3 is much
greater than it is for C4. Ross and Polley (1975) showed that the C3b
receptor and C4b receptor are the same receptor on human lymphocytes
and different from the receptor for C3d. Probably the same receptor
binds both C3b and C4b on monocytes as well. Macrophages may also have
receptors for soluble C3 and C3b as has been shown for lymphocytes
(Theofilopoulos et al., 1974). Although this has not been shown
formally on intact macrophages, isolated complement receptors from
macrophages bound both soluble C3 and C3b (Schneider et al,, 1981a).
It had previously been thought that C3bINA converted C3b into
C3d but it is now realised that C3b is first degraded to C3b^ and
then to C3d by the action of an unidentified protease. Many studies
which have investigated the presence of C3d receptors, may have been
studying C3b" receptors especially when C3bINA was used. However many
early preparations of C3bINA also probably contained protease activity
and therefore C3d may have resulted. The use of heat inactivated
serum as a source of C3bINA may have led to the production of C3b" or
C3d depending on the concentration of proteases present and the length
of incubation. Therefore interpretation of previous data is difficult.
Ross and Rabellino (1979) have shown that human monocytes (and
immature neutrophils) have two distinct complement receptors, one for
C3b, CR1 , and one for 03^, CR3, and do not have receptors for C3d,
CR2./...
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CR2. Lymphocytes have receptors for all three C3 cleavage products
although apparently the same receptor, CR2, binds both C3b'' and C3d.
However Carlo et al. (1979) found that human monocytes also had all
three receptors. The receptors for C3b and C3d have been shown to be
antigenically distinct on human tonsil cells (Stein et al., 1981) and
CR1 isolated from human erythrocytes which is antigenically similar to
CR1 present on human leukocytes, is distinct from CR2 and CR3 (Dobson
et al., 1981). In vivo deposition of C3b via the classical or
alternate pathways will probably be converted rapidly into C3b"* and
therefore the Clb^" receptor may be more important physiologically.
Phagocytosis via C3b' receptors has been observed by activated macro¬
phages (Newman et al., 1980).
The presence of C5b receptors on macrophages has not been investi¬
gated although it has been suggested that human neutrophils do possess
C5b receptors which are important in phagocytosis (Segerling and
Opferkuch, 1977). C5b receptors on lymphoid cells are apparently
identical to C3 receptors (Landen and Dierich, 1979).
9.3 Number of receptors/cell
At present the use of complement coated erythrocytes does not
allow estimations of the numbers of C3b receptors/cell or the affinity
constants. EAC appears to bind to macrophages with fewer regions of
close contact than EA (Kaplan, 1977) which may be a reflection of
G
fewer receptors. Complement receptors have a greater affinity than Fc
receptors since fewer IgG molecules are required per red cell to
promote ingestion when complement is also present (Ehlenberger and
Nussenzweig, 1977). Using an antibody prepared against solubilised





Complement receptors appeared to be randomly distributed over the
surface of endotoxin-induced macrophages with none present at the
extreme periphery of the cells (Kaplan, 1977). The binding to complement
receptors is temperature dependent. At 4°C very few complement coated
erythrocytes bind to macrophages (Lay and Nussenzweig, 1968). The
number of red cells bound increases with increasing temperature and at
37°C maximum binding is reached. These differences in binding with
temperature changes may be related to the fluidity of the membrane.
2+ 2+
In most systems studied no requirement for Ca or Mg for binding
to complement receptors could be demonstrated. However binding of EAC
2+
to mouse macrophages attached to a glass surface required Mg (Lay and
Nussenzweig, 1968).
Cytochalasins inhibited rosette formation on alveolar macrophages
with a pattern of reactivity: cytochalasin A > E > D > B, and vinblastine
and colchicine also inhibited EAC binding (Atkinson et al., 1977). An intact
cytoskeleton consisting of microfilaments and microtubules may be
required for effective binding between C3-sensitised particles and macro¬
phage C3 receptors. Michl et al. (1979) found that complement receptors,
unlike Fc receptors, did not appear to be mobile in the plane of the
membrane. C3b receptors are clustered in the membranes of human mono¬
cytes and neutrophils and do not diffuse laterally in the plane of the
membrane (Petty et. all. , 1980) .
9.5 Phagocytosis via C3 receptors
The importance of C3b in promoting adherence of sensitised erythro¬
cytes or bacteria to phagocytes is not disputed but there is some
controversy in the literature about whether or not complement receptors
mediate phagocytosis. Huber et al. (1969) reported that human peripheral
blood/...
58
blood monocytes did phagocytose via their complement receptors whereas
Ehlenberger and Nussenzweig (1977) observed that complement coated
erythrocytes were bound but not ingested by human monocytes. Van Furth
et al. (1979) found that although 98% of human monocytes bound, only
16% ingested EAC. Other particles such as complement coated E. coli
were phagocytosed by human monocytes (Horwitz, 1980) and soluble heat
aggregated IgM was ingested in significant amounts in the presence of
complement by mouse and guinea pig macrophages (Van Snick and Masson,
1978; Kijlsta _et_ al_. , 1978). Also, both phagocytosis and killing has
been observed with agammaglobulinaemic human serum (Williams and Quie,
1971). Resident mouse peritoneal macrophages bound but did not ingest
EAC whereas thioglycollate induced macrophages both bound and ingested
EAC (Bianco et al., 1975) and cultured human monocytes were also found
to ingest C3b and C3b' coated red cells (Newman et al., 1980). However
both normal and stimulated mouse peritoneal macrophages will phagocytose
EAC if additional C5 deficient mouse serum was added providing extra
ligands between macrophages and erythrocytes (Bar-Shavit_et al., 1979).
Uncleaved C3 deposited on the macrophage surface via complement receptors
may be cleaved by C142 convertase on the target cell surface which
would provide extra bridging between the cells in a similar manner to
that described by Dierich and Landen (1977). Since complement components
are expressed on the plasma membranes of different cells and macrophages
synthesize certain complement components (Brade and Bentley, 1980) these
additional complement bridges may be important in vivo. The presence
of extra ligands may thus allow the cell to phagocytose using the
zipper mechanism described by Griffin et al. (1975b).
The changes observed with complement receptors on activated macro¬
phages may therefore reflect an increase in numbers or affinity of
complement receptors rather than a change in function.
The/...
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The opsonisation of erythrocytes coated with complement may be
different from opsonisation of bacteria especially because of varying
densities of complement on the surface and the relative size of the
particles coated. Therefore the results of the phagocytosis experiments
should be interpreted according to the functional state of the cell
and the type of particles to be ingested. On bacteria and other particles
which activate the alternate pathway there are surface molecules which
"non specifically" induce phagocytosis and synergism between these
binding sites and complement receptors inducing phagocytosis has been
observed (Czop et al_., 1978).
Complement receptors also play a role in enhancing phagocytosis
mediated by Fc receptors (Ehlenberger and Nussenzweig, 1977). Mono¬
cytes ingested EA more efficiently in the presence of complement with
a limiting amount of antibody. It has been suggested that IgG through
its Fc fragment directly stimulates particle ingestion but is relatively
inefficient at inducing particle ingestion (Mantovani et al., 1972).
Although complement receptors were involved in the binding of these
particles only Fc receptors mediated phagocytosis as shown by Shaw
and Griffin (1981). They allowed erythrocytes coated with IgG and
complement to attach to resident mouse peritoneal macrophages at 4°C
and then blocked the non-engaged Fc receptors with anti-macrophage
serum. When the cells were warmed up to 37°C phagocytosis did not
occur. However using another approach Miehl. ejh al_. (1979) suggested
that complement bound to the Fc fragment of IgG in immune complexes
rendered them ineffective as ligands for macrophage Fc receptors and
the binding occured via complement receptors alone. If this also
occurs on particles coated with IgG and complement, then it is difficult




9.6 Modulation of the expression of complement receptors
As described above, activated or stimulated macrophages phagocytose
EAC unlike unstimulated macrophages which mediate attachment only
(Bianco et al», 1975; Newman et al., 1980). The mechanism of this
change in function may represent an increase in density or affinity
or may be due to the synthesis of a new type of complement receptor.
The observation that thioglycollate induced macrophages showed changes
in complement receptor function suggested that lymphokines may be
involved. Lymphokines produced by in vivo primed T cells incubated
in vitro with macrophages and priming antigen had no effect on resident
macrophage complement receptors (Griffin and Griffin, 1979). However
macrophages which had ingested IgG coated particles triggered the
elaboration of a unique lymphokine from T cells. This lymphokine
altered complement receptor function on resident macrophages, which
had been cultured for 48 hours in the presence of PCS, so that they
ingested EAC as well as binding them (Griffin and Griffin, 1980). The
lymphokine which itself had no effect on Fc receptor expression had a
molecular weight less than 10,000 daltons which is lower than the
molecular weight of MIF/MAF, lymphotoxin or interferon.
New protein synthesis was not required and Griffin and Griffin
suggested that the lymphokine may exert its effect by increasing the
rate of insertion into the membrane or by rearranging existing comple¬
ment receptors in relation to their cytoskeletal elements involved in
phagocytosis. Observations made by Kaplan et al. (1978) and Michl et al.
(1979) tend to suggest the second hypothesis. They showed that although
Fc receptors were motile in the plane of the macrophage membrane, comple¬
ment receptors on resident macrophages did not appear to be so. However
thioglycollate/...
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thioglycollate induced macrophages were able to redistribute their
complement receptors on their plasma membranes suggesting that there
may be alterations in the attachment of complement receptors to the
cytoskeletal elements.
The effects of lymphokines may be important in host defence
mechanisms. Many micro-organisms and possibly tumour cells shed antigens
which become complexed to specific immunoglobulin. When macrophages
ingest these immune complexes, Fc receptor expression is decreased
(Doughaday and Douglas, 1976; Griffin, 1980) and macrophages can no
longer phagocytose the micro-organisms. However ingestion of immune
complexes by macrophages would trigger T cells to produce a lymphokine
which increases complement receptor expression on macrophages which
could then ingest micro-organisms via their complement receptors.
Chemotactic factors also modulate the expression of complement
receptors. Eosinophil specific chemoattractants enhanced complement
receptors on eosinophils without affecting the expression of Fc
receptors (Anwar and Kay, 1977b, 1978). Similarly Goetzl et al.
(1980) has shown that HETEs increased eosinophil and neutrophil
complement receptors without affecting Fc receptors on these cells.
Thus as cells migrate to the site of inflammation and chemotactic
factor production, the alteration in their complement receptor expres¬
sion may prepare them for more efficient ingestion of opsonised
particles.
9.7 Nature of complement receptors
Trypsin sensitivity of complement receptors suggests that they
consist in part of protein (Lay and Nussenzweig, 1968; Doughaday and
14
Douglas, 1976). Biosynthetic labelling with [ C]-glucosamine suggests
that/...
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that the receptor is a glycoprotein (Schneider al., 1981). The
behaviour of C3 receptors isolated from KBr lysates of the membrane
fraction of human tonsil cell homogenates suggested that the receptor
is a lipoprotein complex (Gerdes and Stein, 1981).
Landen et al. (1979) have suggested that a^-antitrypsin may serve
as a C3 receptor on certain cells including Raji cells and B lymphocytes
though not erythrocytes. However Stein et al. (1981) using antisera to
a^—antitrypsin failed to inhibit EAC agglutination with C3 receptor
bearing cells or to stain C3 receptor positive cells.
9.8 Isolation of complement receptors
A 205,000 daltons glycoprotein (gp 205) was solubilised from human
erythrocyte membranes with the non-ionic detergent, Nonidet-P40 and
purified to homogeneity with various chromatographic techniques
including reversible adsorption to Sepharose-C3 (Fearon, 1980). Rabbit
anti gp 205 inhibited rosette formation of erythrocytes, monocytes,
neutrophils and B lymphocytes, with EAC3b but not EAC3b'" or EAC3d.
Immunoprecipitation with anti gp 205 gave a single membrane protein with
an apparent molecular weight of 205,000 on SDS-PAGE from solubilised
membranes of erythrocytes, monocytes, neutrophils and B lymphocytes.
The gp 205 thus appeared to be the C3b receptor of all four cell types.
Since red cells only have CR^, this receptor must be CR^. Dobson
et al. (1981) using essentially the same technique obtained a receptor
with a similar molecular weight (195,000 daltons) with or without prior
reduction of disulphide bonds. Rabbit antibody inhibited EAC14b and
EAC3b rosetting to erythrocytes, peripheral blood and tonsil B lympho¬
cytes, B lymphoblastoid cells, monocytes and neutrophils. However
the antibody had no effect on the binding through CR^ or CR^.
Using/...
63
Using a different species, cell type and method of separation
Schneider et al. (1981) obtained a complement receptor with a molecular
weight of 64,000 daltons. They radio-iodinated rabbit alveolar macro¬
phage membranes and then solubilised the membranes with Nonidet-P40.
The C3b receptor was purified on Sepharose-C3b or Sepharose-C3. A
single peak was obtained which had ligand binding activity in that it
rebound specifically to Sepharose-C3b or Sepharose-C3. Inhibition
experiments suggested that the receptor had a higher affinity for C3b
than for C3.
Immunoprecipitation of KBr lysates of the membrane fraction of
human tonsil homogenates, followed by SDS-PAGE yielded a complement
receptor with a molecular weight of 1 x 10 daltons which behaved like
a lipoprotein complex. The protein moiety consisted of disulphide
bridged polypeptide chains with an apparent molecular weight of
38,000 daltons. CR^ and CR^ receptors had similar molecular structures
but the recognition units for C3b and C3d were located on separate
polypeptide chains (Gerdes and Stein, 1981).
The relationship between these receptors is not known and the
differences may partly reflect the method of separation and partly
species variations. It would seem likely that the receptor is part
of a lipoprotein complex and the various molecular weights obtained
for the glycoprotein moiety may reflect polymerization of individual
subunits (or may be degradation products).
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10.0 MACROPHAGE Fc RECEPTORS
10.1 Function
Macrophage Fc receptors are involved in the selective binding
and ingestion of antigens and bacteria (Reynolds, 1974) and effete
autologous cells (Kay, 1975). These receptors bind to the Fc portion
of immunoglobulins which have been produced against and bind to
foreign antigens. Apart from their involvement in phagocytosis, Fc
receptors are also important in IgG-dependent extracellular lysis with
erythrocytes (Walker, 1977) and tumour cells (Shaw et al., 1978)
as targets and possibly in IgM-dependent cell cytotoxicity.
Inflammatory mediators including prostaglandins, particularly
PGE^ are released after ingestion of antibody/antigen complexes or
antibody-coated red cells, (Bonney et al., 1980) by resident mouse
peritoneal macrophages. Fc fragments of IgG also stimulated release
of PGE^ by human monocytes (Passwell et al., 198,0,) suggesting that
binding of a ligand to Fc receptors, even in the absence of phagocytosis
may play an important role in monocyte activation.
Interaction with Fc receptors after ingestion of opsonised micro¬
organisms by human monocytes, appears to be necessary for intracellular
killing to take place (Lei et al., 1979).
Methods used to visualise Fc receptors include the rosette
technique with antibody-coated erythrocytes (Bianco, 1976) or ^1Cr
labelled erythrocytes can be used to count the receptors directly.
Other methods include fluorescein, radioactive, peroxidase or ferritin
labelling of antibody-antigen complexes or aggregated immunoglobulin
complexes.
Fc receptors are present on many cells apart from macrophages
and monocytes (Mantovani et _al^, 1972; Huber and Fudenberg, 1968)
including/
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including lymphoid cells of the B,T and null cell groups (Basten et al.,
1972; Anderson and Grey, 1974; Stout and Herzenberg, 1975) neutrophils
(Messner and Jelinek, 1970) eosinophils (Anwar and Kay, 1977a),
basophils (Segal _et al., 1981) and platelets (Pfueller et al., 1977).
10.2 Specificity
Most studies have shown that mononuclear phagocytes have Fc
receptors for specific subclasses of IgG„ Fc receptors for IgM and IgE
have been shown but there does not appear to be receptors for IgA.
Human monocytes have receptors for IgG^ and but not for
IgG^ or IgG4« Alexander (1980) found that IgG^ bound with greater
affinity than did IgG^ whereas an earlier report using a different
technique suggested that monocytes had greater affinity for IgG.^
(Abramson et al., 1970). It is not known whether human monocytes
have one receptor or two. However mouse macrophages probably possess
two distinct receptors (Unkeless, 1980), one for monomeric IgG which
is trypsin sensitive (FcRI) and a trypsin insensitive receptor for
aggregated ig^b an<^ probably aggregated IgG^ as well (Diamond and
Scharff, 1980) (FcRII). Phospholipase sensitivity suggests that FcRII
is lipid dependent whereas FcRI is not (Anderson and Grey, 1978).
Varients of macrophage cell lines were established which expressed
either one or the other receptor (Unkeless and Eisen, 1975). Other
workers have found different results and Grey et al. (1977) has suggested
that the discrepancies in the literature may be due to different
techniques used to detect Fc receptors.
There may be functional differences between these receptors
which may be important in vivo since l9G2a ^-s Produced early in the
immune response whereas !gG2b ^"s Present in hyperimmune serum.
Haskill/...
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Haskill and Fett (1976) suggested that antibody-dependent cell cyto¬
toxicity (ADCC) was mediated by IgG since macrophage mediated ADCC
AcL
against a tumour cell line was only blocked by IgG . However Walker
zcl
(1977) obtained contradictory results: IgG„, mediated ADCC and IgG-2b 2a
mediated phagocytosis. Diamond et al. (1978) on the other hand, reported
that macrophages phagocytosed IgG and IgG coated red cells.
ZD
Using a monoclonal antibody, Diamond and Yelton (1981), have
identified a third Fc receptor for IgG2 on mouse peritoneal macrophages
and on some macrophage cell lines. This receptor is trypsin resistant,
mediates phagocytosis and can also mediate ADCC against shee red
blood cells.
Fc receptors possess relatively weak affinity for monomeric IgG
and a high affinity for immune complexes (Phillips-Quagliata et al.,
1971). The summation of individual receptors indentical to the monomeric
receptor may account for the high affinity binding. It has also been
suggested that binding proceeds by a co-operative mechanism (Leslie
and Alexander,-1980).
Binding to the Fc receptor is probably through the C 2 domainH
although this has not been unequivocably demonstrated. Studies with
guinea pigs (Alexander e_t £l. , 1978a), mice (Unkeless and Eisen, 1975)
and man (Alexander ejt £1^. , 1978a) have suggested that the C^2 domain
is involved. However other reports indicated that the C 3 domain mayH
be involved (Dissanayake and Hay, 1975; Okafor et al., 1974) and
Diamond et al. (1979) showed that l9G2b bounc3 to m°use macrophages
via its Cri3 domain and IgG through its C 2 domain.H Z3. H
Binding by resident murine macrophages has also been shown to be
IgM dependent (Lay and Nussenzweig, 1969) and glycogen elicited murine
macrophages also ingest EAM (Mantovani, 1981). IgM anti erythrocyte
antibody/...
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antibody was found to be cytophilic for mouse macrophages (Tizard,
1969). These results suggested that there may be Fc receptors for
IgM but rosetting techniques failed to detect them (Huber jet al.,
1968). However Rhodes (1973) reported that although guinea pig
splenic macrophages did not bind IgM coated red cells they possessed
a Fc receptor for monomeric IgM and not for pentameric IgM. Haegert
(1979a) using a direct plaque forming assay detected IgM Fc receptors
on human monocytes which recognised non-aggregated IgM. Neuraminidase
treatment increased the number of IgM Fc receptors and they became
detectable by a rosette assay (Haegert, 1979b). These receptors were
trypsin resistant like mouse I9G2b an<^ i9G3 receptors and human Fc (IgG)
receptors. These IgM Fc receptors may be involved in both phagocytosis
and IgM dependent cell cytotoxicity.
Fc receptors for IgE have also been described on macrophages
(Capron et al., 1975; Joseph et al., 1977). Prior incubation of macro¬
phages with IgE complexes induced macrophages to become cytotoxic when
bound to S. mansoni shistosomula via the Fc fragment of IgE.
10.3 Number of receptors/cell
The number of Fc receptors on the surface of macrophages lies in
5 6
the region of 10 to 10 per cell depending on the assay used.
Alexander et al. (1979) using radiolabelled trimers of rabbit IgG
4
detected 3x10 binding sites per human monocyte with an affinity
7 -1
constant, Ka equal to 5 x 10 M , whereas Unkeless and Eisen (1975)
5
detected 10 binding sites per mouse peritoneal macrophage for i9G2a
(Ka = 108M 1) and 5 x 10^ binding sites per cell for I9G2b (Ka = ^)
using mouse monomeric myeloma proteins of the respective subclasses.
£
Phillips-Quagliata et al. (1971) found that there were 2 x 10 sites per
rabbit/...
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rabbit alveolar macrophage. These differences may reflect technical
differences or species variations.
10.4 Ultrastructure
Electron microscopic studies indicated that there is an 8nm
distance between a bound immune complex and the macrophage membrane
which is smaller than the length of an immunoglobulin molecule
suggesting that there may be a compact membrane pocket within the
membrane (McKeever et al., 1976).
Fc receptors appeared to be randomly distributed over the entire
macrophage surface but are more concentrated in the perinuclear regions,
cytoplasmic veils and pseudopodia (Kaplan et al., 1975).
The binding to Fc receptors is not temperature dependent unlike
complement receptors (Anwar and Kay, 1977a).
Cytochalasin B not only inhibited phagocytosis of EA but also
v_j
binding (Atkinson and Parker, 1977) suggesting that subplasmalemmal
2+
microfilaments are involved in the binding. The Ca ionophore,
A23187 also blocked the binding of EA (Sanners and Spicer, 1979).
However other workers have found that binding of EA to macrophages
VJ
2+ 2+
is independent of Ca (Lay and Nussenzweig, 1969) and Mg (Davey
and Ascherton, 1967).
10.5 Modulation of Fc receptor expression
A number of studies have shown that activated macrophages possess
more IgG receptors (Zuckerman and Douglas, 1979; Bianco et al., 1975)
than resident or unstimulated macrophages. Although it has been
suggested that the observed increase was due to the greater cell size
of activated macrophages (McKeever _et al_., 1976) lymphokine rich
supernatants/...
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supernatants from mixed leukocyte cultures increased the number of
radiolabelled IgG binding sites per cell on cultured human monocytes
without increasing the cell volume (Guyre et al., 1981). Circulating
human monocytes from patients with chronic granulomatous diseases,
tuberculosis, sarcoidosis and regional enteritis have increased IgG
receptor activity as measured by rosetting and phagocytosis of EA
(Zuckerman and Douglas, 1979). Enhanced Fc receptor expression was
also observed in monocytes from patients with malignancies (Rhodes,
1977). Activation must have occured before the monocytes reached the
tissues suggesting that there may be feedback mechanisms operating
which act on either bone marrow precursors or peripheral blood cells.
In contrast to monocytes, macrophages in chronic granulomas eventually
show decreased Fc receptor activity (Mariano et al., 1976).
Thioglycollate stimulated mouse peritoneal macrophages showed
increased phagocytic capacity for EA„ when cultured in vitro for 48
(j "
hours in the presence of serum. However macrophages from LPS hypo-
sensitive C3H/HeJ mice lost the capacity to bind and phagocytose EA .
A lymphokine rich supernatant from Con A-stimulated spleen cells
(Vogel and Rosenstreich, 1979) and cAMP agonists (Vogel et al., 1981)
corrected this defect. They also showed that the lymphokines (which
they suggested may be MAF) increased cAMP levels in macrophages. The
inability of C3H/HeJ mice to differentiate in vitro with respect to
Fc receptor expression may be due to an inability to respond to a
signal (possibly a lymphokine) which by altering cAMP levels in the
macrophage affects the expression of surface markers. CAMP agonists
also corrected an Fc-mediated phagocytic defect in a macrophage cell
line grown under suboptimal conditions. The effects of cAMP agonists
required/...
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required five to ten hours to become evident suggesting that changes
in cAMP levels were not the immediate signal for phagocytosis but
allowed the cell to enter a permissive state (Muschel _et_ al., 1977).
Insulin which increased cAMP levels also decreased phagocytosis of
EAq in normal macrophages (Muschel et al., 1977). Rhodes, (1975) found
that insulin or a phosphodiesterase inhibitor which increased cAMP
levels in macrophages inhibited the observed increase in Fc receptors
on cultured macrophages.
Prostaglandins PGE„, PGF. , PGF ' and PGA. increased the phago-2 lot 2a 1
cytosis of opsonised particles at physiological concentrations and
decreased phagocytosis at higher concentrations (Razin et al., 1978).
This may be important in vivo since prostaglandins are produced in
inflammatory reactions and may play a role in enhancing the phagocytic
capacity of macrophages.
10.6 Nature of the Fc receptor
Human Fc receptors and mouse I9G2b are trYPs*n resistant (Lay and
Nussenzweig, 1968; Unkeless, 1980). However both IgG and IgGAc1 A D
receptors became trypsin sensitive when detergent solubilised (Anderson
14
and Grey, 1978). Trypsin sensitivity, the evidence that [ C]-gluco-
samine is incorporated into the receptor in vivo (Kulczycki _et al^.,
1980) and neuraminidase or sodium borohydride treatment of isolated Fc
receptors (Mellman and Unkeless, 1980) suggest that Fc receptors are
glycoproteins.
Sucrose density sedimentation of detergent lysates from macrophages
indicated that the soluble Fc receptor was associated with phospholipids
(Anderson and Grey, 1977). Since phospholipases inhibited the expression
of/...
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of Fc receptors (Walker, 1976a) phospholipids may be important in
the functional activity of the receptor. More recent evidence suggests
that only the IgG^ receptor is lipid dependent (Anderson, 1980).
10.7 Isolation of Fc receptors
Various workers using different methods of isolation have obtained
putative Fc receptor molecules with apparent molecular weights varying
between 35,000 and 100,000 daltons. The relation between these
proteins and measurable Fc receptors on cell surfaces is not clear.
Anderson and Grey (1977) detected Fc receptor activity in detergent
lysates but attempts to purify by affinity chromatography were not
successful. More recently Fc receptors have been purified by rabbit
antiglobulin-sepharose affinity chromatography (Kulczycki _et al.,
1980) and appear to have a molecular weight between 35,000 and 55,000
daltons. Separation by affinity chromatography and inhibition studies
indicated that the soluble Fc receptor did not appear to discriminate
between IgG and IgG suggesting that the micro-environment in the
Zci ZD
membrane confers the specificity on the receptor. Mellman and Unkeless
(1980) isolated two polypeptide chains from a mouse macrophage cell
line with molecular weights of about 60,000 daltons and 47,000
daltons which also recognised both i9G2a an<^ IgG2b*
However both Lane et al. (1980) and Anderson (1980) were able to
separate two distinct Fc receptors, one of which recognised i9G2a an<^
the other recognised IgG^.
As with complement receptors, the differences found between size
and specificity of the various Fc receptors isolated, may partly reflect
the methods of separation and partly species variations.
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11.0 NON SPECIFIC RECEPTORS OR RECEPTORS FOR FOREIGN SUBSTANCES ON
MACROPHAGES
Macrophages ingest a wide variety of particles including poly¬
styrene (latex) particles (Doughaday and Douglas, 1976), extracted
yeast cell walls (zymosan) (Czop et_ al_., 1978), senescent red cells
(Kay, 1975), chemically modified erythrocytes (Rabinovitch, 1968;
Capo et al., 1979) syngeneic tumour cells (Piessens, 1978), xenogeneic
cells (Cabilly and Gallily, 1977), bacteria (Weir and Ogmundsdottir,
1980) and parasites (Capo £t ^1_., 1979).
Thus macrophages are able to discriminate between self and
alterations to self as in effete or damaged tissue components or
aberrant self constituents such as tumour cells. They are also capable
of distinguishing between foreign material and self components. The
biological importance of this is probably most obvious in the lung
where alveolar macrophages clear the alveolar respiratory surfaces of
small particles (Heppleston, 1963). The receptors involved may
represent a primitive form of recognition.
The mechanisms that underlie these highly important recognition
capacities of macrophages is in the main unknown. Nonspecific binding
may be dependent on the hydrophobicity of the foreign particle
(Wilkinson, 1976) and membrane biomechanical factors may contribute
to macrophage binding and ingestion of foreign substances. Positively
charged substances such as cationized ferritin bind more avidly than
negatively charged substances which are repulsed by the macrophage's
own negatively charged surface.
Nonspecific binding may, however, in at least some instances,
be mediated by specialised structures on macrophage membranes. Some of
these/...
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these binding sites may be specific receptors which bind defined sub¬
strates and are saturable. Receptors for certain groups of substances
differ from receptors for other substances in their susceptibility to
digestion by hydrolytic enzymes. Monocyte ingestion of zymosan was
more sensitive to trypsin than was phagocytosis of latex particles
(Czop et al., 1978). Receptors for glutaraldehyde treated erythrocytes
(Rabinovitch, 1968) and bacteria (Ogmundsdottir et al., 1978) were
destroyed by trypsin. Michl _et al_. (1976a, b) found that 2-deoxy-
glucose decreased phagocytosis via Fc and complement receptors but did
not affect the phagocytosis of nonopsonised zymosan or latex particles.
The effects of 2-deoxyglucose appeared to be related to its potential
effects on glycosylation and not to ATP levels.
Benoliel et al. (1980) using five different test particles,
EA , glutaraldehyde treated erythrocytes, leishmania, latex beads and
VJ
tumour cells, found that there was no cross inhibition of binding
although ingestion of some particles inhibited the ingestion of certain
others. The pattern of inhibition of binding of these particles by
various inhibitors of cellular functions and potential modulators of
intermolecular forces was also different for each particle. Electron
microscopy indicated that the binding of EA and Leishmania to macro-(j
phage membranes involved large areas where the interacting membranes
were separated by a low density gap of constant width whereas glutar¬
aldehyde- treated erythrocytes and latex interactions with the macrophage
membrane were irregular. These workers suggested that there exists
several groups of functionally linked binding structures on macrophage
membranes which in some cases require active cell participation and
may or may not involve hydrophobic interactions. The role of specific
receptors for these substances (apart from EA ) was not clear.
The/...
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The involvement of serum proteins in nonspecific binding of
target particles ot macrophages is difficult to assess and may involve
Fc or complement receptors in some cases. For instance cytophilic
antibody may be adsorbed onto the macrophage surface (Choi et al.r 1974)
and macrophages themselves synthesise certain complement components
(Brade and Bentley, 1980) and express them on their cell membranes.
Aging erythrocytes accumulate autoantibodies which are very difficult
to remove (Kay, 1975). However for at least some nonspecific receptors
evidence suggests that Fc and complement receptors are not involved
(Czop et al», 1978; Michl et al., 1976a) b).
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12.0 RECEPTORS FOR GLYCOPROTEINS AND POLYSACCHARIDES
Macrophages possess specific receptors for glycoproteins and
glycoconjugates (Stahl et al. , 1978, 1980; Shepherd _et al_. , 1981);
for desialated erythrocytes (Kolb and Kolb-Bachofen, 1978; Nagamura
and Kolb, 1980; Czop et al., 1978); for bacterial cell wall carbohy¬
drates (Ogmunsdottir and Weir, 1976; Ogmunsdottir et al., 1978;
Freimer et al., 1978) and for tumour cells (Weir et al., 1979). These
specific lectin-like receptor activities may explain some of the so-
called non-specific recognition by macrophages. Certain foreign sub¬
stances have terminal sugars expressed on their surfaces e.g. zymosan
consists of polyglucose and polymannose in association with protein
and lipid (Northcote and Home, 1952); specific types of pneumococci
and certain other bacteria contain glucose residues, either terminal
or easily cleaved to the terminal position, in their outer cell wall
(Larm and Lindberg, 1976). N-acetylglucosamine residues comprise the
backbone and terminal positions in cell walls of bacteria including
Staph, aureus (Strominger et £l., 1976).
12.1 Function
These receptors may be important in cleaving micro-organisms
from the lung and other exposed tissues before humoral immunity is
generated. They may be involved in macrophage recognition of altered
self including transformed cells (Weir et al., 1979) and effete auto¬
logous enzymes (Stahl et al., 1978) and effete red cells (Kolb and
Kolb-Bachofen, 1978). Spontaneous cytotoxicity for certain xenogeneic
target cells (red blood cells) by human monocytes was inhibited by
simple carbohydrates (Muchmore and Blaese, 1979) suggesting that
lectin-like receptors on macrophages may be involved in NK activity.
Lectin-/...
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Lectin-like receptors may also function as self-self recognition
units as well as being involved in self-nonself recognition. Antigen-
specific lymphocyte proliferation which is dependent on the presence of
macrophages was inhibited by simple sugars (Muchmore and Blaese, 1979)
suggesting that the sugar specific receptor on human monocytes may
also be involved in T cell recognition.
Clearance of lysosomal enzymes by Kupffer cells or other macro¬
phages also appears to be mediated by a lectin-like receptor (Schlesinger
et al., 1978; Stahl et al., 1978). These receptors may play a role in
enzyme salvage by Kupffer cells since lysosomal enzymes are secreted
continuously. Pinocytosis via these receptors on macrophages may
regulate the lysosomal enzyme concentration in the immediate environ¬
ment and therefore be important in the inflammatory response where lyso¬
somal enzyme secretion is increased. They may also be involved in
the intracellular movement of lysosomal enzymes and in the actual
assembly of the lysosome.
IgM antibody-antigen complexes are pinocytosed by rat liver non-
parenchymal cells via a similar receptor. It appears to recognise
mannose oligosaccharides which become accessible on IgM after it has
complexed with antigen (Day et al., 1980).
12.2 Specificity
Mouse peritoneal macrophages possess "lectin-like" receptors
which recognise unopsonised Gram positive and Gram negative bacteria
(Ogmundsdottir and Weir, 1976; Freimer et al., 1978). The ability
of various monosaccharides to inhibit binding was found to correlate
with their presence in the bacterial cell wall. D-glucose, D-galactose,
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N-acetyl-D-glucosamine and N-acetyl-D-galactosamine all of which are
present in C. parvum cell walls inhibited the binding of C. parvum to
mouse peritoneal macrophages to approximately the same extent. However
fucose and rhamnose which were not detected in the C. parvum cell wall
were also inhibitory. Binding of mutant stwins of S. typhimurium
deficient in certain sugars, were not inhibitable by these particular
monosaccharides. Attachment of tumour cells and mouse embryo fibro¬
blasts in growth phase to mouse peritoneal macrophages was also
inhibited by various monosaccharides (Weir et al., 1979).
Both rat Kupffer cells and alveolar macrophages specifically
recognised glycoproteins or glycoconjugates with terminal mannose,
N-acetyl-glucosamine or fucose on their oligosaccharide chains
(Schlesinger et al., 1978; Stahl et al,, 1978; Shepherd _et al., 1981).
The uptake was specific and saturable. Inhibition studies indicated
the following order of potency for sugar recognition by this system:
L-fucose = D-mannose > N-acetyl-D-glucosamine « D-glucose > D-xylose
» D-galactose = L-arabinose = D-fucose (Shepherd et al., 1981).
These results suggested that orientation about the fourth carbon
(C-4) was critical. C-6 appeared to be less important but still
essential because removal of C-6 (xylose) showed decreased binding.
The orientation about C-2 may also play a role since glucose and
mannose (C-2 epimers) varied in inhibitory potency by an order of
magnitude.
Nauraminidase treated erythrocytes are taken up by Kupffer cells
in vivo (Janik et al., 1978). Both rat Kupffer cells and rat peri¬
toneal macrophages bound desialated red cells via a D-galactose
specific receptor in vitro (Kolb and Kolb-Bachofen, 1978; Nagamura and
Kolb, 1980). Inhibition studies with monosaccharides, oligosaccharides
and/.. o
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and glycoproteins indicated that the receptor recognised N-acetyl-D-
galactosamine, D-galactose, L-fucose and D-fucose. D-glucose was
also inhibitory but only when present on glycoproteins and not as a
monosaccharide. However after phosphorylation at position 6, D-glucose
was as inhibitory as D-galactose (Schlepper-Schaffer et al., 1980).
Desialated orosomucoid was bound with thirty to forty times greater
affinity than the most effective mono- and oligosaccharide in this
system suggesting that the receptor may recognise a specific sequence
of saccharides.
12.3 Number of receptors/cell
With particulate material such as erythrocytes and bacteria it
was not possible to estimate the number of receptors per macrophage.
However rat alveolar macrophages expressed about 75,000 binding sites
per cell for mannose-BSA (Stahl _et al., 1980).
12.4 Ultrastructure
Ultrastructural analysis of the binding between desialated
erythrocytes and Kupffer cells by electron microscopy showed broad
contact zones between the two surfaces (Schlepper-Schaffer et al.,
1980). Extension of pseudopodia around the red cells suggested that
phagocytosis would occur according to the aipper hypothesis of
Griffin et al. (1975b).
Attachment of bacteria, red cells or glycoproteins is not
temperature dependent (Ogmundsdottir and Weir, 1976; Kolb and
Kolb-Bachofen, 1978; Stahl _et al_., 1978).
2+
The presence of external Ca was required for the binding of
•• X
bacteria, desialated erythrocytes and glycoproteins (Ogmundsdottir
and/...
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and Weir, 1976; Kolb and Kolb-Bachofen, 1978; Stahl et ^1., 1978;
2+
Shepherd et. al. , 1981) and Mg was also required for bacterial binding
(Ogmundsdottir and Weir, 1976).
Binding of desialated erythrocytes to rat peritoneal macrophages
or Kupffer cells was not inhibited by cytochalasin B or colchicine
suggesting that neither microfilaments nor microtubules are involved
(Nagamura and Kolb, 1980: Schlepper-Schaffer et al., 1980), The effects
of these agents on the attachment of bacteria or glycoproteins has not
as yet been tested.
12.5 Modulation of the expression of "lectin-like" receptors
Alterations in the expression of "lectin-like" receptors on
mouse peritoneal macrophages which recognise bacterial cell wall sugars
is described in this thesis. Modulation of other "lectin-like"
receptors has not been reported.
12.6 Nature of "lectin-like" receptors
The glycoprotein receptor, and the receptors recognising bacteria
and tumour cells were trypsin sensitive (Stahl et al., 1978;
Ogmundsdottir et al., 1978; Weir et al., 1979). Pronase inhibited the
binding of C. parvum and tumour cells to mouse peritoneal macrophages
(Ogmundsdottir et al., 1978; Weir et al., 1979) and the binding of
desialated erythrocytes to rat Kupffer cells (Schlepper-Schaffer _et al.,
1980). 6-galactosidase, phospholipases C + D and periodate treatment
decreased the binding of C. parvum or tumour cells to mouse peritoneal
macrophages (Ogmundsdottir et al., 1978; Weir, et al., 1979). These
enzyme studies suggest that the receptors are protein in nature and
the sensitivity of the receptors recognising bacteria or tumour cells
indicates/...
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indicates that it is a glycoprotein. The effects of phospholipases
on these latter receptors suggest that phospholipids may be important
in the functional activity of the receptor either directly or to
provide the correct microenvironment.
12.7 Isolation of "lectin-like" receptors
Townsend and Stahl (1981) have isolated a mannose-binding protein
from rat liver by affinity chromatography which has the same binding
characteristics as that observed in vivo with plasma clearance of
lysosomal enzymes and in vitro with rat Kupffer cells and alveolar
macrophages. SDS-PAGE under reducing conditions revealed a single
band with a molecular weight of about 35,000 daltons.
Isolation of the other "lectin-like" receptors has not been
reported as yet.
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CHAPTER II - AIMS OF THE PRESENT STUDY
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Mononuclear phagocytes are involved in inflammation and the clear¬
ance of particulate agents and play an important role in both the
afferent and efferent limbs of the immune response (Unanue, 1972, 1978)
and probably also in the control of neoplasia (James _et al., 1977).
They synthesise and secrete a wide variety of products and are involved
in anabolic and catabolic metabolism.. Cell-cell contact and membrane
stimulation are important features of many macrophage functions such as
phagocytosis, pinocytosis, cell recognition and antigen presentation and
thus many biological activities of macrophages are dependent on their
surface receptors. The aims of the present study were to establish
more precisely the presence and properties of membrane receptors for
IgM, IgG, C3b, C3b"* , C3d, C4, and "lectin-like" receptors on mononuclear
phagocytes, and to develop a greater understanding of environmental
influences which may modulate the expression of these receptors and
therefore the functional capacities of macrophages. Human monocytes,
mouse peritoneal macrophages and guinea pig alveolar macrophages comprise
populations of mononuclear phagocytes from different sources, different
maturation states and have different biochemical characteristics and
physiological roles. The functions of these cells may depend on the
level of expression of their surface receptors and accordingly this
was investigated and comparisons made between different cell types.
Heterogeneity of macrophage populations was first described by Walker
(1976) who showed that macrophages from a single tissue could be
separated into subclasses of cells that are functionally distinct.
Therefore in these studies possible surface receptor heterogeneity
within the populations was also examined.
It had previously been reported that complement receptors on
human peripheral blood eosinophils were enhanced following incubation
with/...
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with various pharmacological mediators to which, they migrate in chemo-
taxis and/or chemokinesis. A number of eosinophilotactic agents,
including the eosinophil chemotactic .factors of anaphylaxis (ECF-A)
(the tetrapeptides, Val-Gly-Ser-Glu and Ala-Gly-Ser-Glu), histamine
and one of its major catabolites imidazoleacetic acid selectively
i
enhanced receptors for complement (C3b and C4b) (CR^) on human eosinophils
in a dose- and time-dependent fashion (Anwar and Kay, 197H, 1978) with
no apparent effect on Fc (IgG) receptors or C3b" receptors (CR^). The
phenomenon of complement receptor enhancement may be an important
feature common to all phagocytic cells. It is proposed that in vivo
chemotactic factors both attract phagocytes to the site of inflammation
and via complement receptor enhancement increase their capacity for
attachment to C3b opsonised particles, thereby increasing phagocytosis
and killing. Enhanced killing of complement coated Schistosomula by
eosinophils pretreated. with ECF-As or by neutrophils preincubated with
a synthetic chemotactic agent, f-Met-Leu-Phe indicates the possible
significance of complement receptor enhancement in vivo (Anwar _et _al. ,
1980). It seemed important to investigate chemoattractant induced
complement receptor enhancement by other phagocytes and accordingly
various mononuclear phagocytes were examined. Three different macro¬
phage populations were studied - human monocytes, mouse peritoneal
macrophages and guinea pig alveolar macrophages - because they exhibit
regional differences in their biochemistry and function. They can
modify their own and other cells' mechanism of complement receptor
enhancement and its possible consequences in vivo,, the effects of various
chemoattractants and other pharmacological mediators on surface receptors
of functionally distinct macrophages were examined.
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All chemicals were analytical grade, obtained from BDH Chemicals
Ltd., Poole, Dorset, unless otherwise stated.
1.1 Dulbecco's phosphate buffered saline (modified) D.PBS
This was prepared by dissolving 8.0g NaCl, 0.2g KC1, 1.08g Na^HPO^,
0.2g KH^PO^, 0.089g CaCl^H^O and 0.203g MgCl^SH^O up to 1 litre with
distilled water.
1.2 Phosphate buffer (Sorensen's)
A. M/15 sodium phosphate
9.465g Na^HPO^ was dissolved in distilled water and made up to
1 litre.
B. M/15 potassium acid phosphate
9.08g KH^PO^ was dissolved in distilled water and made up to
1 litre.
Various amounts of the above 2 mixtures were mixed to give the
required pH.
1.3 Phosphate buffered saline (PBS)
PBS was prepared by mixing 8.5g NaCl, 1.07g Na2HPO^ and 0.39g
NaH2PO^ and adjusting the volume to 1 litre with distilled water.
1.4 Hepes buffer
Hepes buffer was prepared by dissolving 23.83g Hepes buffer
(Flow Laboratories, Irvine, Scotland, U.K.) in approximately 90ml
distilled water. Sufficient 5N NaOH (about 5ml) was added to adjust
the pH to 7.6 - 7.7 and the final solution adjusted to 100ml with




This was prepared by mixing 10ml of 10 times concentrated medium
199 (Flow Laboratories, Irvine, Scotland, U.K.) with 3ml of 1M Hepes
buffer and adjusting the volume to 100ml with distilled water.
1.6 Eagle's Minimum Essential Medium (MEM)
Eagle's MEM was prepared by mixing 10ml of 10 times concentrated
Eagle's MEM (Flow Laboratories, Irvine, Scotland, U.K.), 3ml 1M Hepes
buffer, 1ml of 0.2M glutamine and 0.1ml of penicillin and streptomycin
-1
(200,000 U.ml ) and adjusting the volume to 1 litre with distilled
water.
1.7 Formol-saline
10% formal-saline was prepared by making 10ml formalin up to
100ml with PBS. This stock solution was diluted to 1 % with medium 199
as necessary.
1.8 0.Q01M Acetate buffer
A. 0.001M Sodium acetate
0.136g NaCH^COOH.3H20 was dissolved in 1 litre of distilled water.
B. 0.001M Acetic acid
57pl of 17.5M stock solution of acetic acid were diluted to 1 litre
with distilled water.
Approximately 1 litre of A and 3 litres of 3 were mixed to give
0.001M acetate buffer, pH 5.0.
1.9 Five times Veronal (5 X Veronal)
This was prepared by mixing 42.5g NaCl, 1.875g sodium barbitone





10g gelatin was dissolved in 100ml hot distilled water and 10ml
volumes dispensed into universals and autoclaved.
1.11 0.03M CaCl2
4.41g CaCl^I^O was dissolved in 1 litre of distilled water.
1.12 0.1M -MgCl
20.33g MgCl^SH^O was dissolved in 1 litre of distilled water.
1.13 Gelatin-Veronal buffer (GVB++)
This was prepared by mixing 200ml 5X Veronal, 10ml 10% gelatin,
5ml 0.03M CaCl2 and 5ml 0.1M MgCl2 and adjusting the volume to 1 litre
with distilled water.
1.14 Gelatin Veronal buffer (GVB )
This was prepared according to the above buffer recipe without
the addition of 0.03M CaCl2 and 0.1M MgCl2°
1.15 5% Dextrose (D5W++)
50g dextrose, 5ml 0.03M CaCl2 and 5ml 0„1M MgCl2 were dissolved
in 1 litre of distilled water.
1.16 Dextrose-gelatin-Veronal buffer (DGVB"1"*")
Equal volumes of GVB++ and D5W++ were mixed together.
1.17 Isotonic EDTA
89.33g disodium EDTA was made up to 1 litre with warm distilled
water. 780ml 0.3M NaOH was added to adjust the pH to 7.4. The final
molarity of EDTA is 0.086M.
1.18/...
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1.18 0.01M EDTA GVB~~
100ml of 0.086M EDTA was adjusted to 860ml with GVB
1.19 Lysis buffer
This was prepared by dissolving 8.2g NH^Cl, 1.0g KHCO^ and 0.037g
Na^EDTA in 1 litre of distilled water.
1.20 Alsevers
21g dextrose, 8g trisodium citrate. 21^0, 4.2g NaCl and 0.4g
anhydrous citric acid were dissolved in 1 litre of distilled water.
This solution was aliquoted and autoclaved.
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2.0 STAINS
2.1 White cell diluting fluid
A stock solution was prepared by adding 0.1g gentian violet to
100ml of 1% acetic acid. To use the stock was diluted 1:10 with 1%
acetic acid and 1 part cell suspension was added to 9 parts stain.
2.2 Trypan blue
1% aqueous trypan blue was added 1:1 with the cell suspension.
2.3 Eosinophil stain
A. 0.1% methylene blue
0.1g methylene blue was added to 100ml propan-1-2-diol.
B. 0.1% phloxine
0.1g phloxine was added to 100ml propan-1-2-diol
1ml of each of the above 2 stains was mixed with 2ml distilled
water and 1 part cell suspension added to 9 parts stain.
2.4 Non specific esterase stain
This method is modified from that of Yam, Li and Crosby (1971).
Cells of the mononuclear phagocyte series are stained diffusely brown.
A. Hexazotised pararosaniline
Solution A 1g pararosaniline (Sigma Chemical Company, St. Louis,
Missouri, U.S.A.) was dissolved in 25ml 2N HC1 by heating gently.
The solution was cooled, filtered and stored at 4°Co
Solution B 4g sodium nitrate was dissolved in 100ml distilled
water.
Immediately before use, equal parts of A and B were mixed.
B./...
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B. a napthyl acetate substrate
45mg a napthyl acetate (Sigma Chemical Company, St. Louis,
Missouri, U.S.A.) was mixed with 2.5ml N, N dimethylformamide, 45ml
Sorensen's phosphate buffer, pH 7.2, and 1.8ml freshly hexazotised
pararosaniline. This solution was filtered before use.
Cell smears were incubated in the above mixture for 45 minutes
at room temperature or for 20 minutes at 37°C.
«
2.5 May Grunwald/Giemsa stain
May Grunwald stain was diluted 1:1 with PBS.
Giemsa stain was diluted 1:10 with PBS.
Cell smears were stained for 2 minutes in each stain in the above
order, followed by 5 minutes destaining in PBS.
2.6 Eosinophil stain
A. Chromotrope
1g of chromotrope was dissolved in 1 % phenol.
B. Tartrazine
0.1g tartrazine was dissolved in 1% acetic acid.
Cell smears were incubated in the chromotrope stain for 15-20





1.0 HUMAN MONOCYTES AND NEUTROPHILS
Monocytes and neutrophils were separated according to the method
of Boyum (1968). Blood from healthy donors was drawn into plastic
tubes containing 10 U of heparin.ml \ and then diluted 1:4 with
normal saline. The diluted blood was layered onto Ficoll-Hypaque
cushions (Pharmacia, Uppsala, Sweden) (s.g. 1.078) and centrifuged
for 30 minutes at 400g. After the interface cells (monocytes and
lymphocytes) were collected, the pellet containing granulocytes and
red blood cells were resuspended in 0.82% ammonium chloride to lyse
the erythrocytes as described by Boyle (1968). The separated cells
were finally washed twice in D.PBS and resuspended in medium 199.
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2.0 Human eosinophils
Blood was obtained from atopic eczema patients or healthy donors
with eosinophilia. Leucocyte rich plasma was prepared by mixing 1 part
6% Dextran T70 (Pharmacia, Uppsala, Sweden) and 4 parts heparinised
blood and incubating for 30 minutes at 37°C. The plasma was layered
over cushions of sodium metrizoate (Nyegaard and Company, As, Oslo,
Norway) (s.g. 1.140) and centrifuged for 30 minutes at 400g. The
pellet containing neutrophils, eosinophils and red blood cells was
treated as for neutrophils above.
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3.0 ANIMALS
Dunkin-Hartley guinea pigs (250 - 400g) and CF1 mice (age 6-10
weeks) were from the Bacteriology Department breeding colony.
4.0 MOUSE PERITONEAL MACROPHAGES
These were obtained by peritoneal lavage with D.PBS and heparin
(10 U.ml"1).
5.0 GUINEA PIG ALVEOLAR MACROPHAGES
These were collected by tracheo-bronchial lavage (Myrvik, Lenke
and Farris, 1971) using D.PBS and heparin (10 U.ml ^) from animals
anaesthetised with intra-peritoneal sodium phawbarbital.
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6.0 LYMPHOCYTE SUPERNATANTS
A cell suspension containing up to 90% lymphocytes was obtained
from defibrinated blood as described by Boyum (1976). The separated
cells were resuspended to a concentration of 3 x 10^ lymphocytes ml ^
in medium 199. Under sterile conditions and with added penicillin and
streptomycin, 9yl of phytohaemagglutinin (PHA-P, Wellcome Reagents Ltd.,
Beckenham, Kent) were added to 3ml of the mononuclear cell suspension.
The cells were incubated for 3 days at 37°C in a humidified atmosphere
containing 5% CO.-,. After incubation the supernatants were harvested
by centrifugation, aliquoted and stored at -70°C until use. The
unstimulated lymphocyte supernatants were prepared in an identical




PREPARATION OF INDICATOR CELLS
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1.0 PREPARATION OF RABBIT ANTISHEEP ANTIBODY
1.1 Preparation of sheep stroma
250ml of whole sheep's blood was diluted 1:1 with Alsevers and
washed once with normal saline. The cells were slowly added to ice
-4
cold 4.4 x 10 M acetic acid, mixing continuously for a few minutes.
The stroma was allowed to settle overnight at 4°C. After removal of
most of the supernatant fluid, the sediment was centrifuged at 800g
for 20 minutes at 4°C. The resultant pellet was washed repeatedly in
cold 0.001M acetate buffer, pH 5.0 until most of the haemoglobin was
removed. The packed stroma was washed 3 times with 0.15M NaCl,
resuspended in 45ml 0.15M NaCl and boiled for 1 hour. When cool
the stroma was ultrasonicated to a smooth suspension and stored at
-70°C.
1 .2 Rabbit antisheep stroma
To raise antiserum to the stroma, adult rabbits were injected
intravenously in a series of 11 injections spread over 12 days. The
amount injected was gradually increased from 0.1 to 2ml. The rabbits
were test bled on the 4th day after the last injection and bled out
if the titre was high enough. The resultant antiserum was heated
at 56°C for 1 hour to destroy complement, and stored at -20°C.
1.3 Fractionation of IgM and IgG antibodies from whole serum
A. Ammonium sulphate precipitation
This was carried out according to Heide and Schwick (1978). 20ml
of whole heat inactivated serum was precipitated with 16.4ml of a
saturated ammonium sulphate solution (45% ammonium sulphate) which
























Sephadex G-200 fractionation of rabbit anti sheep erythrocyte
sera.
100
stirring continuously. The treated serum was centrifuged at 10f000g
for 20 minutes at 4°C and the precipitate dissolved in 5ml distilled
water. This was dialysed against 5 litres of distilled water for
12 to 18 hours at 4°C and then against 5 litres of PBS for 6 to 12
hours. The dialysed solution was stored at -20°C.
B. Fractionation with Sephadex G-200
This was carried out according to Shevach et al.(1972).. 2.5ml
of the above ammonium sulphate fractionated serum was applied to a
Sephadex G-200 column (bed volume = 750ml) at 4°C and eluted with
PBS using a flow rate of 14ml.hr ^. 5ml fractions were collected.
The optical density at 280nm for each fraction was measured (Fig. 1).
The ascending half of the first peak (IgM fraction) was pooled, and
the upper three-quarters of the second peak (IgG fraction) was pooled.
Each pool was dialysed against 5 litres of distilled water for 18
hours at 4°C, freeze-dried and resuspended to one-tenth their original
volume.
The IgM and IgG pools were further purified according to Fahey
and Terry (1978).
C. Further purification of IgM. Fractionation with Protein A-
Sepharose CL-4B
0.5g of Protein A (Staph, aureus) covalently bound to Sepharose
CL-4B (Pharmacia, Uppsala, Sweden) were swollen for 3 hours in 4ml
PBS at 4°C, poured into sterile 10 cc syringe containing a thin layer
of glass wool. The gel was allowed to settle to a packed bed volume
of approximately 1.7ml before washing with 25ml PBS.
The entire IgM sample from the above Sephadex G-200 fractionation
was applied and eluted with PBS, 1ml fractions being collected. All
fractions with OD greater than zero were pooled, dialysed against2oU
distilled/...
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distilled water, freeze-dried and reconstituted in PBS to 1mg protein,
ml ^.
D. Further purification of IgG. Fractionation with DEAE-52
Approximately 3.5ml of pre-swollen DEAE-52 (Whatman Biochemicals
Ltd., Maidstone, Kent, U.K.) were mixed with 0.01M Tris: 0.02M NaCl
(pH 7.5) and poured into a 60ml syringe containing a thin layer of
glass wool.
The entire IgG sample from the above Sephadex G-200 fractionation
was applied to the DEAE-52 column and eluted with 50ml Tris NaCl buffer.
1ml fractions were collected and the OD_on readings for each wereA oU
recorded. All fractions with an OD reading greater than zero were
ZoU
treated as above.
Samples of IgM, IgG and whole serum were tested in an immunodif¬
fusion assay (carried out by the South-East Scotland Regional Blood
Transfusion Service, Royal Infirmary, Edinburgh) and the IgM and IgG
fractions determined to be uncontaminated by other immunoglobulins.
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2.0 DETERMINATION OF IgM AND IgG TITRES BY AGGLUTINATION OF SHEEP
RED CELLS
Sheep red cells were washed twice in normal saline and resuspended
8 ""1 ++
to 1 x 10 cells.ml in DGVB . 50vil of red cells and 50yl of
doubling dilutions of antibody were incubated together in V-shaped
well microtitre plates for 1 hour at 37°Co From the settling pattern
of the sheep cells the agglutination titre could be ascertained.
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3.0 PREPARATION OF ANTIBODY COATED SHEEP RED CELLS
3.1 Preparation of rabbit antisheep IgM coated erythrocytes (EA )
Sheep blood was drawn asceptically into sterile Alsevers solution
and stored at 4°C. The red cells were washed twice in cold saline and
once in 0.01M EDTAGVB . The cell concentration was adjusted to
9 -1
1 x 10 cells.ml and IgM antisheep red blood cells was added,
the amount depending on the titre calculated above. The mixture
was incubated for 30 minutes at 37°C, followed by 30 minutes at
4°C with frequent shaking. The cells were washed once in 0.01M
EDTAGVB and twice in DGVB++ and stored at 4°C. The cells were
kept for not longer than 5 days and were washed daily with DGVB++.
3.2 Preparation of rabbit antisheep IgG coated erythrocytes (EA^a^)
IT clb
The method for preparing EA was exactly the same as that
G
rab
for EAm except that IgG was used to sensitise the red cells
instead of IgM.
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4.0 PREPARATION OF COMPLEMENT COATED SHEEP RED CELLS
4.1 Preparation of yeast
This method was modified from U. Hadding (1967).
250g of fresh baker's yeast was suspended in 1 litre of PBS and
autoclaved for 30 minutes at 120°C, washed with PBS until the super¬
natant was clear and resuspended in 250ml PBS containing 0.1M
mercaptoethancSl. The mixture was incubated at 37°C for 2 hours
with frequent stirring and washed once with saline to remove most
of the mercaptoethanol. The yeast was stirred at room temperature
for 2 hours in 250ml of normal saline containing 20% w/v 0.2M
phosphate buffer (pH 7.2) and 20mM iodoacetimide,, The pH was
checked periodically. After washing 3 times with PBS, the yeast was
resuspended in 1 litre of the same buffer and re-autoclaved for 30
minutes at 120°C and washed until the supernatant was clear. Finally
the yeast was suspended in 500ml of GVB++ containing 0.01% azide and
stored at 4°C.
4.2 Titration of yeast
After washing twice with DGVB++, various dilutions of yeast were
incubated with an equal volume of serum for 30 minutes at 37°C. The
suspension was centrifuged at 400g for 10 minutes and the supernatants
collected.
0.1ml of the various supernatants was added to an equal volume
of EA^3*3 (108 cells, ml ^) and incubated for 30 minutes at 37°C. The
dilution which was just below that which gave detectable lysis was
1/5 and this was the dilution used (see next section)„
4.3/...
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4.3 Preparation of EAC
Two different methods of preparing EAC were used.
A. Human AB serum as a source complement
Fresh human AB serum was obtained from a suitable donor and
checked for the presence of Foissmann's antibody by incubating neat
serum with sheep red cells. If lysis occurred the serum was adsorbed
with sheep red cells at 4°C with frequent shaking for several hours.
The serum was centrifuged to remove the red cells and then aliquoted
and stored at -70°C for not longer than 6 months. For each experiment
a fresh ampoule was used and not refrozen.
Equal volumes of EAf,3^ at a concentration of 1 x 108 cells, ml \
and human AB serum diluted with DGVB++ to a suitable concentration,
were mixed and incubated for 30 minutes at 37°C. The cells were
washed and resuspended in the same buffer to give a final concen-
8 — 1
tration of 1 x 10 cells.ml
B. Zymosan depleted serum as a source of complement
With human, neutrophils and eosinophils and mouse peritoneal and
guinea pig alveolar macrophages the concentration of serum required
to give an optimal number of rosettes would have lysed the red cells.
So; for experiments involving these cells^a different method of
preparing EAC was used.
Equal volumes of yeast prepared as described above in part 4
and AB serum were mixed and incubated for 30 minutes at 37°C. The
yeast was centrifuged and the remaining supernatant, termed R3, was
used as the source of complement. The alternate pathway of complement
was activated and the terminal components of complement - C5 to C9
were used up. Although a considerable proportion of C3 is also
turned/...
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turned over, it is still possible to coat the sheep cells with more
C3 than if the highest possible concentration of serum was used.
Equal volumes of R3 diluted with DGVB++ and EA^3*"* at a concen-
8 —1
tration of 1 x 10 cells, ml were mixed and incubated for 30 minutes
at 37°C. The cells were washed and resuspended in DGVB++ to give a
8 -1
final concentration of 1 x 10 cells, ml
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5.0 PREPARATION OF EAC USING PURIFIED HUMAN COMPLEMENT COMPONENTS
Purified human complement components were obtained from Cordis
Laboratories, Miami, U.S.A.
5.1 Preparation of EA14
it 2 ID
EA,„ was mixed with 400 effective molecules of human C1 per red
M
cell, incubated for 15 minutes at 37°C and washed twice with DGVB++.
EA14 was prepared by the addition of 5,000 molecules of 04 and
incubated for 30 minutes at 37°C, washed twice and resuspended in
++ 8 -1
DGVB at a concentration of 1 x 10 cells, ml
5.2 Preparation of EA1423b
EA1 was prepared as described above. 400 effective molecules
of C4 were added and the mixture incubated at 37°C for 30 minutes.
After 2 washes with DGVB+', a further 400 molecules per cell of C1
were added to EA14 and incubated for 15 minutes at 37°C. The cells
were washed twice and incubated with 50 effective molecules of C2
per cell for 10 minutes at 30°C. Without washing varying amounts of
C3 per cell were added to EAC142 and incubated at 37°C for 30
minutes. After washing twice with DGVB++, the EAC1423b was diluted
8 —1
to 10 cells, ml
5.3 Preparation of EAC1423b"
Two methods of preparing EAC1423b" were used.
A. C3b inactivator
EAC1423b cells were prepared as described above in part 5.2,
usually with 500 molecules of C3 per cell. The cells were incubated
with purified C3b inactivated (KAF) (Cordis Laboratories, Miami, U.S.A.)
at/...
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at a concentration which reduced immune adherence (see below) by 95%,
, , ++
for 1 hour at 37°C. The cells were washed twice with DGVB and
8 —1
resuspended to 1 x 10 cells, ml
B. EDTA-chelated AB serum
EAC1423b were incubated with neat AB serum chelated with 10mM
EDTA for 15 minutes at 37°C, washed twice and resuspended to a concen-
8 -"1
tration of 1 x 10 cells.ml
e
5.4 Preparation of EA1423d
EA1423d was prepared by incubating EAC1423b" (made by either of
g
the above two methods) with 0.25mg trypsin per 10 cells for 2.5 minutes
at 37°C. The reaction was stopped by flooding the cells with ice-
, 4* • I*
cold DGVB and the cells washed twice with DGVB and resuspended to
8 -1
a concentration of 1 x 10 cells.ml
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6.0 IMMUNE ADHERENCE
Human red cells have receptors for C3b and not for C3b"* or C3d.
In order to demonstrate the presence of C3b an immune adherence
assay was set up in V-shaped microtitre plates. In each well 50yl
8 — i
of human 0 red cells (10 cells, ml ) and 50ul of test sheep red cells
8 ~"1
(10 cells.ml ) were mixed and incubated at 37°C for 2 hours. From
the settling pattern it was possible to determine which complement
coated sheep red cells had C3b deposited on their surfaces. If the
cells were spread out over the bottom of the well immune adherence
had occurred whereas if the cells had pelleted the test cells did not
have C3b on their cell membranes. Using this assay it was possible to
demonstrate that as expected EA1423b cells were immune adherence positive
as were EAC prepared using AB serum as a source of complement. EA1423b^
and EA1423d were immune adherence negative.
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7.0 PREPARATION OF BACTERIA
7.1 Preparation of Staphylococcus albus (Staph, albus)
Staph, albus maintained by aerobic subculture on horse blood agar
was obtained from the Bacteriology Department teaching collection.
A suspension of bacteria was prepared by growing an innoculum
aerobically in 10-15ml of horse digest broth plus 3% glucose for
24 hours at 37°C and then transferred into 100ml of the same medium
and incubated for a further 19 hours at 37°C in a shaking incubator.
The cultures were harvested in log phase and centrifuged for 20 minutes
at 2,000g at 4°C, washed once in normal saline and killed by 24 hour
exposure to 0.5% formalin at 4°C. The killed bacteria were washed
3 times in saline, resuspended in about 10ml saline and stored at
4 °C.
7
Since an optical density at 540nm corresponds to 2 x 10 Staph.





1.0 DETECTION OF Fc AND COMPLEMENT RECEPTORS ON CELLS IN SUSPENSION
A portion (0.1ml) of sheep red cells coated with immunoglobulin
8 —1
and/or complement (10 cells.ml ) was added to 0.1ml of leukocytes
6 _ i g
(2 x 10 cells.ml or in the case of monocytes or macrophages 1 x 10
monocytes or macrophages.ml 1). The mixtures were centrifuged at 100g
for 10 minutes at 4°C and the pellets incubated at 37°C for 20 minutes
i» a K a K
for EA or EAC and for 30 minutes at 0°C for EA_ . The pellet was
M G
gently resuspended in medium 199 containing 1% formal saline and smears
prepared on clean glass slides in duplicate. These were dried quickly
in air, fixed in methanol and monocytes, macrophages and neutrophils
were stained with May Grunwald/Giemsa and eosinophils stained with
Chromotrope and tartrazine. In some experiments the monocytes were
fixed in 2.5% glutaraldehyde and stained using a-napthyl acetate
histochemistry. Leukocytes with 3 or more adherent red cells were
termed rosettes. In each slide 200 leukocytes were counted and the
percentage rosetted cells calculated.
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2.0 DETECTION OF Fc AND COMPLEMENT RECEPTORS ON CELLS IN MONOLAYERS
2.1 Preparation of monolayers
Eosinophils and neutrophils were suspended in Eagle's MEM to
give a final total cell count of 2 x 10^ cells.ml Monocytes and
5
macrophages were suspended to give a final concentration 2 x 10
-1
monocytes or macrophages, ml . One ml of the above cell preparations
was layered onto 13mm diameter (No 1) glass coverslips in 16mm diameter
tissue culture plates (Costar, Cambridge, Mass., U.SoA.) and incubated
for 1 hour at 37°C. Non adherent cells were removed by washing with
D.PBS.
2.2 Fc and complement rosette formation
0.5ml of EA^3*3 or EAC (10^ cells.ml was added to each monolayer,
centrifuged for 5 minutes at 100g and incubated for 40 minutes at 37°C.
Non adherent red cells were removed by very gentle washing with D.PBS.
Coverslips were air dried, fixed in methanol and stained with
May Grunwald/Giemsa. Positive binding was scored as those leukocytes
with two or more red cells attached. In each coverslip 200 leukocytes
were counted and the results expressed as the percentage of cells
binding organisms.
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3.0 DETECTION OF "LECTIN-LIKE" RECEPTOKS ON CELL MONOLAYERS
3.1 Staph, albus binding to cell monolayers
Monolayers were prepared as described above in part 2.1. The
coverslips were overlaid with 1ml Staph, albus in D.PBS and incubated
for 2 hours at 4°C. Non attached organisms were removed by repeated
washing with D.PBS.
3.2 Effect of sugars on Staph, albus binding
5.58g of glucose or galactose were dissolved in cold distilled
water to give an isotonic solution of 310mM, filtered and stored at
4°C. They were diluted as necessary with D.PBS.
Cell monolayers were incubated with 0.5ml of solutions of glucose
and galactose for 20 minutes at 4°C. The cells were then washed and
the Staph, albus binding assay performed as described previously.
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SECTION V -
EFFECT OF CHEMOATTRACTANTS, PHARMACOLOGICAL MEDIATORS




F-Met-Leu-Phe was a gift from Dr. Derek Hudson (Royal Postgraduate
Medical School, London), f-Met-Leu-Phe, Met-Leu-Phe and Met-Met-Phe
were gifts from Miles Laboratories (Stoke Poges, England). F-Met-Phe
was obtained from Sigma Chemical Company (St. Louis, Missouri, U.S.A.).
Other materials were obtained as follows„ Histamine acid phosphate
and casein (BDH Chemicals Ltd., Poole, Dorset, U.K.); C. parvum 10390
supernatant was a gift from Dr. W. McBride (Department of Bacteriology,
University of Edinburgh Medical School, Edinburgh, U.K.); human serum
albumin (Sigma Chemical Company, St. Louis, Missouri, U.S.A.);
prostaglandins E^, E^ and F ^ were a gift from Dr. J.- Pike (Upjohn
Company, Kalamazoo, U.S.A.); bradykinin triacetate, 5-hydroxytryptamine
creatine sulphate complex and isoprenaline (Sigma Chemical Company,
St. Louis, Missouri, U.S.A.); neuraminidase from Vibrio cholerae,
E.C. 3.2.1.18., 500 U ml 1 (BDH Chemicals Ltd., Poole, Dorset, U.K.).
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2.0 PREPARATION OF REAGENTS
2.1 F-Met peptides
The f-Met peptides were dissolved in dimethyl sulphoxide (DMSO)
-2 -1
at a concentration of 10 moles,1 and further diluted in medium
-5
199 to the required concentrations. At the highest dose used (10
-1 -2 -1
moles.1 ) the concentration of DMSO was about 10 moles.1 and at
this concentration had no effect on cell viability as determined by
trypan blue dye exclusion and locomotion in vitro through micropore
filters (Kay, Glass and Salter, 1979).
2.2 Casein
Casein was dissolved in distilled water and the pH raised to
11 with 1N NaOH. The pH was then adjusted to 7.4 with 1N HC1. 9
parts of the casein solution were then added to 1 part of 10 times
concentrated medium 199 with Hepes buffer, pH 7.4.
2.3 C. parvum 10390 supernatant
The C. parvum supernatant was prepared from formaldehyde-killed
C. parvum organisms which had been washed twice in 0.9% NaCl, lyo-
philised and reconstituted in distilled water. The reconstituted
material had a concentration of 7mg.ml ^ dry weight which represented
1n113 x 10 organisms.
2.4 Prostaglandins
The prostaglandins E^, E2 and F ^ were dissolved in alcohol at a
-2 -1
concentration of 10 moles.1 and further diluted in medium 199. At
-4 -1
the highest dose used (10 moles.1 ) the concentration of alcohol
had no effect on cell viability.
All other compounds were dissolved in medium 199.
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3.0 EFFECTS OF CHEMOATTRACTANTS AND OTHER MEDIATORS ON LEUKOCYTE
RECEPTORS
Equal volumes of leukocytes (2 x 10^ cells.ml and various
concentrations of the compounds under study or medium alone as a
control were mixed and incubated in a shaking water bath usually for
30 minutes at 37°C. The cells were then washed twice in medium 199
and the numbers adjusted to their original concentration in the same
medium. The cells were then rosetted as described previously.
In some experiments cell monolayers were incubated with 0.5ml
of solutions of the chemoattractants for 30 minutes at 37°C. After
gentle washing the rosetting assays were performed as described
previously.
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4.0 NEURAMINIDASE TREATMENT OF HUMAN PERIPHERAL BLOOD MONOCYTES
5 x 106 total mononuclear cells were incubated with 5 U of
neuraminidase per 1 x 106 total cells in the presence of 2% bovine
serum albumin (BSA) for 30 minutes at 37°C. Control cells were
incubated in the same way without the presence of neuraminidase.
Each set of cells were washed twice with 0.2% BSA and resuspended to
their original volume of 1 ml. Rosette assays were performed at
this stage. The remaining mononuclear cells were then incubated
with fluid phase IgM (0.004ml of 1/40 titre per 106 total cells)
in 0.2% BSA for 30 minutes at 4°C, washed twice with 0.2% BSA and
rosette assays performed as before.
STATISTICS
Measurements from duplicate incubations from at least
three separate experiments were pooled, the mean and standard
errors calculated and the observations compared using the
student's t—test. Such pooling was considered to be statisti¬
cally valid since in the present study the variation within each
experiment was similar to the variations between individual
experiments.
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CHAPTER IV - RESULTS
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SECTION 1 -
DETECTION OF RECEPTORS FOR IMMUNOGLOBULIN AND COMPLEMENT,
AND LECTIN-LIKE RECEPTORS ON HUMAN MONOCYTES,




Membrane receptors for the Fc fragment of immunoglobulin and
complement components have been demonstrated on a number of phagocytic
cells. Although most studies have been on lymphocytes, other cells
such as mononuclear phagocytes, granulocytes, mast cells and basophils
have also been shown to possess these receptors. The presence of
complement and Fc receptors on lymphocytes is believed to be involved
in antigen presentation and on phagocytic cells they function as
recognition sites in mediating the binding of particles ranging in
size from antigen-antibody complexes to whole cells coated with
antibody and complement. Apart from being involved in phagocytosis
of these particles, Fc and complement receptors are also important
in other functions of leukocytes including antibody-dependent cell
cytotoxicity.
In the last few years lectin-like receptors have been described
on mouse macrophage membranes that recognize bacterial cell wall
sugars leading to macrophage bacterial adherence. These receptors
are likely to be of importance in relation to the pathogenesis of
bacterial .infection.
The present studies were concerned with defining and comparing
the presence of complement, Fc and lectin-like receptors on a
variety of mononuclear phagocytes from different species and
environments - human peripheral blood monocytes, mouse peritoneal
macrophages and guinea-pig alveolar macrophages. These preliminary
experiments were also necessary for determining the optimal conditions
for demonstrating the presence of these receptors before studies on




Visualisation of Fc and complement receptors was carried out
using the rosette technique with sheep red cells coated with immuno¬
globulin and/or complement. Attachment of Staph.albus to phagocytic
cells in a bacterial adherence assay was used to demonstrate the
presence of lectin-like receptors.
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SECTION II -
DETECTION OF RECEPTORS FOR IMMUNOGLOBULINS ON HUMAN
MONOCYTES, MOUSE PERITONEAL MACROPHAGES AND
GUINEA PIG ALVEOLAR MACROPHAGES
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1:.0 DETECTION OF RECEPTORS FOR IgG ON MONONUCLEAR PHAGOCYTES
1.1 Determination of optimal experimental conditions: Time
course and temperature
Binding of rabbit anti-sheep IgG coated sheep red cells (EA^2*3)
to human monocytes was both time and temperature dependent (Figs. 2
and 3 and Table 1). At 37°C the percent rosetted cells remained
constant (about 35%) for 20.minutes and then decreased to 28% by
60 minutes (Fig. 2). The number of monocytes which had phagocytosed
red cells increased from 15% at 5 minutes to 35% at 60 minutes.
Maximum binding of EA^2*3 to monocytes at 4°C was observed by 30
minutes (Fig. 3) and thereafter remained constant. Table 1 shows
that Fc receptor expression is temperature dependent; at 30 minutes
with 1/20 dilution of antibody, 25% of the monocytes formed rosettes
at 0°C whereas at 23°C and 37°C a slight increase in the number of
rosetted cells was observed (34% and 32.5% respectively).
IT clfo
In order to investigate effects on binding of EA to mononuclear
G
phagocytes all subsequent experiments were carried out at 4°C for
30 minutes.
1.2 Effect of increasing the IgG concentration on human monocyte,
mouse peritoneal macrophage and guinea pig alveolar macrophage
rab
rosette formation with EA^,G —
Dose response curves for human monocytes, mouse peritoneal
macrophages and guinea pig macrophages were carried out, varying the
amount of IgG antibody coating the sheep red cells (Fig. 4). The
percentage of rosette formation by mononuclear phagocytes was
-i
directly dependent on the IgG concentration. At /10 dilution of




macrophages bound EA whereas both human monocytes and mouseG
peritoneal macrophages appeared to express fewer Fc receptors (47%
and 49% respectively). However at lower concentrations of antibody
mouse macrophages had the highest level of binding and human
monocytes the lowest level of binding.
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Fig. 2
The time course of the binding
JT cib
of EA by human monocytes at 37°C,G
Each point represents the mean - 1 S
(• •) or phagocytosis (o o)
using 1/20 dilution of antibody.
E.M. of three experiments.
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Fig. 3
The time course of the binding of EA by human monocytes
at 0°C using 1/20 dilution of antibody. Each point represents the
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The effect of temperature on the binding of EA
G
human monocytes. The results represent the mean of 3
experiments - 1 S.E.M.
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DILUTION OF ANTIBODY x 103
Fig. 4
The effect of increasing the amount of sensitising antibody
IT3b
(IgG) on the binding of EA by guinea pig alveolar macrophages
(• •), mouse peritoneal macrophages (o o) and human monocytes
(■ 1) . Each point represents the mean - 1 S.E.M. of three experiments.
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2.0 DETECTION OF RECEPTORS FOR IgM ON HUMAN MONOCYTES
Sheep red cells sensitised with a subagglutinating titre of
rabbit anti-sheep IgM (EA^3*3) were tested for their capacity to
form rosettes with human monocytes. The experiments were performed
at 37°C for 20 minutes and no rosette formation was observed
(Fig. 5). However treatment of the monocytes with neuraminidase
3T clb
led to the formation of rosettes with EA^ . These newly expressed
receptors for EA^ab could be blocked by further incubating the
monocytes with fluid phase IgM. In contrast Fc and complement
receptors were relatively unaffected by neuraminidase action on
monocyte membranes; a slight increase in Fc receptors and a slight
decrease in complement receptors was observed (results not shown).
Fc receptors for IgM on human monocytes are therefore, not
normally expressed and there is no possibility that rosettes formed
with sheep red cells sensitised with IgM and coated with complement




CONTROL IgM N N + IgM
Fig. 5
The effect of neuraminidase on EA1',3'3 rosette formation by human
M
monocytes. (control) untreated, (N) neuraminidase, (IgM) fluid phase
IgM, (N + IgM) neuraminidase and fluid phase IgM. Each column represents
the mean - 1 S.E.M. of three experiments.
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3.0 SUMMARY
Human peripheral blood monocytes, mouse peritoneal macrophages
and guinea pig alveolar macrophages formed rosettes with EA
The number of rosetting cells was directly related to the amount
of sensitising antibody and was time and temperature dependent. A
comparison of the expression of Fc receptors on the three types of
cells was made.
Human monocytes only formed rosettes with sheep red cells
sensitised with IgM after treatment with neuraminidase.
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SECTION III -
DETECTION OF RECEPTORS FOR VARIOUS HUMAN COMPLEMENT
COMPONENTS ON HUMAN MONOCYTES, MOUSE PERITONEAL
MACROPHAGES AND GUINEA PIG ALVEOLAR MACROPHAGES
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1.0 DETERMINATION OF OPTIMAL EXPERIMENTAL CONDITIONS FOR
DETECTING C3 RECEPTORS ON HUMAN MONOCYTES
1.1 Time course and temperature
Various different methods for visualising complement receptors
were used but all involved sheep red cells sensitised with rabbit
IT clfc)
anti-sheep IgM (EAjyj ) • Most of the experiments which were carried
IT 3.b
out to detect complement receptors on human monocytes used EA
incubated with human AB serum which activates the classical pathway
and coats the red cells with the third component of complement.
Binding of these red cells (EAC) to human monocytes was time and
temperature dependent (Fig. 6 and Table II). In contrast to Fc
receptor expression, virtually no binding of EAC was found at 4°C.
The number of monocytes rosetting at 23°C was about half that observed
at 37°C (19% and 37% respectively). Fig. 6 shows that there was a
time dependent increase in rosette formation at 37°C for the first
20 minutes and thereafter the percentage of rosettes remained
relatively constant. Little or no phagocytosis of EAC was observed
for the first 20 minutes but with longer incubation times, up to
25% of the monocytes had phagocytosed one or more sheep red cells.
In order to observe complement receptors in this type of assay
the optimal conditions were 20 minutes at 37°C.
1.2 Effect of increasing the concentration of AB serum on human
monocyte C3 receptors
A dose response curve was obtained by varying the dilution of
AB serum used to coat the IgM sensitised erythrocytes (Fig. 7).






Human peripheral blood monocyte rosette formation with EAC
(prepared with AB serum as a source of complement). (Non-specific
esterase, X 1000 magnification).
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Fi9- 6
The time course of EAC rosette formation by human monocytes
at 37°C, using 1/700 dilution of AB serum. Each point represents




0 3.5 - 2
23 19 - 1.5
37 37-3
TABLE II
The effect of temperature on the binding of EAC
human monocytes. The results represent the mean of 3
experiments - 1 S.E.M.
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1
DILUTION OF AB SERUM x 103
Fig. 7
The effect of increasing the concentration of AB serum on the
binding of EAC by human monocytes. Each point represents the mean
- 1 S.E.M. of three experiments.
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bound 3 or more red cells. Lysis of the red cells meant that lower
dilutions than ^/200 could not be used. The percent rosettes
observed was directly proportional to the dilution of AB serum.
1.3 Dependence of human monocyte complement receptor expression
on the concentration of purified human C3b
Some experiments with human monocytes were carried out using
purified human complement components to coat rather than using
£ 3b
AB serum. EA^ coated with purified human C1 (EAC1) did not form
rosettes with human monocytes at 37°C. When purified C4 was added
to EAC1 to form the intermediate EAC14 no rosette formation was
observed even when the amount of C4 was increased from 400 molecules
C4/cell (the optimal number of C4 molecules required for the ultimate
deposition of C3) to 6,000 molecules C4/cell. When C2 was added to
EAC14 (400 molecules C4/cell) no rosettes were detected. Rosette
formation with human monocytes occurred once C3 was added to EAC142
to produce EAC1423b. By varying the number of molecules of C3 added
to EAC142 it can be seen in Figure 8 that there is a direct relation¬
ship between the percent rosetting monocytes and the amount of C3
present on the red cells. At the highest concentration of C3 used
(2,000 molecules/cell) 63% of the monocytes formed rosettes.
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Fig. 8
The effect of increasing the number of C3 molecules on the
binding of EAC1423b by human monocytes. Each point represents the
mean - 1 S.E.M. of three experiments.
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2.0 ROSETTE FORMATION BETWEEN HUMAN MONOCYTES AND EAC315"
Red cells coated with C3b" were prepared by either treating
EAC1423b cells with purified human C3b inactivator (KAF) or with
human AB serum chelated with 10mM EDTA (see materials and methods).
These cells were no longer immune adherence positive in contrast
to untreated EAC1423b or AB serum coated red cells (EAC).
Human monocytes formed rosettes with EAC1423fcf cells prepared
by either of the above 2 methods (Fig. 9). When EAC1423B' cells
were prepared from EAC1423b using 1,000 molecules C3/cell, the
r
percent monocyte rosettes was increased from 37% to 46% in the
case of EDTA serum treated EAC1423b and 49% with KAF treated EAC1423b.
The increase in monocyte rosettes using 500 molecules C3/cell was
not so marked (33% to 38% using EDTA serum treated EAC1423b).
However using either 500 or 1,000 molecules C3/cell, monocyte
rosettes with C3^o coated red cells had more erythrocytes per cell























The effects of C3b inactivator and trypsin on the rosetting of
complement-coated sheep red cells (EAC1423b:1000 molecules C3 per red
cell) by human monocytes. EAC1423b were incubated with purified C3b
inavtivator with or without trypsin (T+KAF and KAF respectively) or
were incubated with EDTA-chelated human AB serum (as a crude source of
C3b inactivator) with or without trypsin (T+EDTA-serum and EDTA-serum
respectively). The percentage rosetting by such treated EAC1423b by
human monocytes was compared with untreated controls (C). The results
are expressed as the mean of two experiments.
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3.0 ROSETTE FORMATION BETWEEN HUMAN MONOCYTES AND EAC3d
EAC1423d cells were prepared by trypsinising EAC1423b" cells
(either KAF or EDTA serum treated EAC1423b)» Human monocytes did
not form rosettes with these cells (Fig. 9).
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4.0 DETECTION OF COMPLEMENT RECEPTORS ON MOUSE PERITONEAL
MACROPHAGES AND GUINEA PIG ALVEOLAR MACROPHAGES
Mouse peritoneal macrophages and guinea pig alveolar macrophages
did not form rosettes with EA^at> coated with AB serum even at V200
dilution of serum. However by using zymosan depleted serum (R3) (see
materials and methods) which removes the terminal complement components
C5 to C9, it was possible to increase the amount of C3 deposited on
the red cells without causing lysis. As can be seen in Fig. 10 both
mouse and guinea pig macrophages formed rosettes using this method
albeit that considerably higher concentrations of R3 were required
than for human monocytes (Vl50 dilution gave 25 - 2% human monocyte
rosettes). Guinea pig alveolar macrophages expressed considerably
fewer C3 receptors than mouse peritoneal macrophages using this
method. Only 17% of the guinea pig cells formed rosettes at V2
dilution of R3 whereas 55% of mouse peritoneal macrophages formed
rosettes at VlO dilution of R3.
Some experiments were carried out using mouse peritoneal
macrophage monolayers rather than using cell suspensions. In order
to obtain between 20 to 30% rosettes a slightly lower dilution of
R3 was used - V35 instead of V^O.
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Fig. 10
The effect of increasing the concentration of zymosan-depleted
AB serum (R3) on the binding of EAC by mouse peritoneal macrophages
(o o) and guinea pig alveolar macrophages (• •). Each point
represents the mean - 1 S.E.M. of three experiments.
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Plate II
Mouse peritoneal macrophage monolayer rosette formation with
EAC(R3) (May Grunwald/Giemsa, X lOOQ magnification).
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5.0 DETECTION OF COMPLEMENT RECEPTORS ON HUMAN NEUTROPHILS AND.
EOSINOPHILS
In a few experiments modulation of complement receptors on human
peripheral blood monocytes, neutrophils and eosinophils was studied.
Both neutrophils and eosinophils express fewer complement receptors than
monocytes and therefore require more complement on the indicator red
cells before rosette formation can take place. R3 was used to coat
EA^ab in these experiments since 1/200 dilution of AB serum was
insufficient to promote binding. For 23 - 3% human neutrophils to
bind 3 or more red cells a 1/25 dilution of R3 was required and
for eosinophils a VlO dilution was required to give 26 - 3% rosettes.
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6.0 SUMMARY
The capacity of sheep red cells (E) coated with various purified
human complement components or human AB serum to form rosettes has
been studied with human peripheral blood monocytes, neutrophils and
eosinophils, mouse peritoneal macrophages and guinea pig alveolar
macrophages.
Untreated sheep red cells (E), E sensitised with IgM, EAC1 ,
EAC14, EAC142 and EAC1423d did not form rosettes with human monocytes.
EAC1423b, EAC1423b" and EAC on the other hand, formed rosettes with
human monocytes. The number of rosetting cells was directly related
to the amount of complement coating the red cells and was time and
temperature dependent.
Human peripheral blood neutrophils and eosinophils, mouse
peritoneal macrophages and guinea pig alveolar macrophages appeared
to express fewer receptors for human complement than human monocytes
and required a higher concentration of complement deposited on the
erythrocytes before they formed rosettes.
Together with the results from Section II it was concluded that
human monocytes bear membrane receptors for human complement
components C3b and C3b", for Fc portion of IgG and have hidden Fc
receptors for IgM. Guinea pig alveolar macrophages and mouse




DETECTION OF "LECTIN-LIKE" RECEPTORS ON HUMAN
MONOCYTES, NEUTROPHILS AND EOSINOPHILS, MOUSE
PERITONEAL MACROPHAGES AND GUINEA PIG ALVEOLAR MACROPHAGES
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1.0 DETERMINATION OF OPTIMAL CONDITIONS FOR BINDING OF STAPH. ALBUS
TO MOUSE PERITONEAL AND GUINEA PIG ALVEOLAR MACROPHAGES
Optimal conditions for Staph, albus binding to C3H mouse
peritoneal macrophages had already been determined by H. Ogmundsdottir
(Ph.D. thesis, 1979) when she showed that binding of bacteria to
mouse peritoneal macrophage monolayers took place at 4°C and
required 2 hours incubation for maximal binding.
Assuming that this would be true for other cell types dose
response curves were carried out under these conditions as shown in
Fig. 11. The number of macrophages binding organisms was directly
related to the concentration of bacteria used although at concentrations
8 — i
greater than 10 bacteria ml no further increase in binding was
observed. Mouse peritoneal macrophages showed a higher level of
binding than did guinea pig alveolar macrophages (63 - 4% and
+ 9-1
36 - 5% respectively at 10 Staph, albus ml ).
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Plate III
Staph, albas binding to mouse peritoneal macrophage monolayer
(May Grunwald/Giemsa, X^000 magnification).
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Fig. 11
The effect of increasing concentrations of Staph, albus on the
binding by mouse peritoneal and guinea pig alveolar macrophages and
human peripheral blood leukocytes. Each point represents the mean
- 1 S.E.M. of four experiments for mouse peritoneal and guinea pig
alveolar macrophages and the mean of two experiments for human
leukocytes.
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2.0 DETERMINATION OF OPTIMAL CONDITIONS FOR BINDING OF STAPH.ALBUS
TO HUMAN PERIPHERAL BLOOD MONOCYTES, NEUTROPHILS AND EOSINOPHILS
Staph, albus binding to human leukocyte monolayers was performed
as described above at 4°C for 2 hours. As shown in Fig. 11 the
number of leukocytes binding organisms was directly proportional to
the concentration of Staph, albus. Human peripheral blood leukocytes
showed a considerably lower degree of binding than that observed with
9
mouse and guinea pig macrophages. A concentration of 2 x 10
organisms.ml ^ was required before 22% monocytes or 17% neutrophils
9
bound 2 or more organisms and eosinophils required 6 x 10 bacteria.
-1 .10
ml before 23% cells showed positive binding. Above 10 organisms.
ml ^ the presence of bacteria in the background made it difficult to
estimate binding and therefore detection of leukocytes binding
bacteria at these concentrations was not possible.
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3.0 INHIBITION OF STAPH. ALBUS BINDING TO MOUSE PERITONEAL MACRO¬
PHAGES AND GUINEA PIG ALVEOLAR MACROPHAGES BY D-GLUCOSE AND
D-GALACTOSE
Inhibition of binding of Staph, albus to C3H mouse peritoneal
macrophages by D-glucose and D-galactose had previously been described
by Freimer et al. (1978). Similar inhibition studies were carried
out with CF1 mouse peritoneal macrophages and guinea pig alveolar
macrophages.
Staph, albus were used at a concentration which gave 20 to 30%
binding.
Monolayers were pre-exposed to a range of concentrations of
D-glucose and D-galactose (5-20 mM) prior to overlaying the Staph, albus
as described in the materials and methods. D-galactose and D-glucose
reduced the binding of Staph, albus to both guinea pig alveolar and
mouse peritoneal macrophages at 10 and 20 mM concentrations (Fig. 12).
Inhibition was directly related to sugar concentration except that
10 mM galactose inhibited bacterial binding to guinea pig alveolar
macrophages to a greater extent than did 20 mM galactose (38 - 5%
and 24 - 19% respectively). With both cell types 20 mM glucose was
more inhibitory than 20 mM galactose and binding to mouse macrophages
was reduced to a greater extent by 10 mM glucose than by 10 mM






































The effect of D-glucose and D-galactose on Staph.albus binding
to mouse peritoneal and guinea pig alveolar macrophages. The percentage
inhibition of binding is calculated as the difference between control
and test divided by the control X 100. Each column represents the
mean - 1 S.E.M. of six experiments for mouse macrophages and four
experiments for guinea pig macrophages.
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4.0 INHIBITION OF STAPH. ALBUS BINDING TO HUMAN PERIPHERAL BLOOD
MONOCYTES, NEUTROPHILS AND EOSINOPHILS
The effects of D-glucose and D-galactose on the binding of
Staph, albus to human leukocyte monolayers was investigated as
described above for mouse and guinea pig macrophages... Staph.albus
9 -1
was used at a concentration of 2 x 10 organisms.ml for monocytes
and neutrophils which gave mean control values of 22% and 17%
9 -1
respectively; for eosinophils a concentration of 6 x 10 bacteria*ml
was used which gave a mean control value of 23%. As shown in Fig. 13
D-galactose reduced the binding of Staph, albus to all 3 leukocyte
types at 10 and 20 mM concentrations, with 10 mM galactose being
slightly more inhibitory especially with regard to the monocytes
- 10 mM galactose inhibited binding by 43.5 - 2% compared to 20mM
galactose which caused 26 - 7% inhibition. (p-= M.S^)
In contrast to D-galactose, D-glucose inhibited binding of
Staph, albus to monocytes and eosinophils but not to neutrophils at
any of the concentrations tested. Binding to monocytes and eosinophils






























5 10 20 5 10 20 5 10 20
CONCENTRATION (m moles, l"1)
Fig. 13
The effect of D-glucose and D-galactose on Staph, albus binding
to human peripheral blood leukocytes. The percentage inhibition of
binding is calculated as in Fig. 12. Each column represents the mean
- 1 S.E.M. of five experiments.
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5.0 SUMMARY
Staph, albus bound in a dose dependent fashion to CF1 mouse
peritoneal macrophages, guinea pig alveolar macrophages, and human
peripheral blood monocytes, neutrophils and eosinophils. Mouse
macrophages showed the highest degree of binding and guinea pig
macrophages had a slightly lower level of binding. However even at
the highest possible concentrations under the assay conditions
human peripheral blood leukocytes did not express more than 23%
positive binding compared to the highest values observed for mouse
and guinea pig macrophages (63% and 43% respectively).
D-glucose and D-galactose inhibited Staph, albus binding to all
the cell types investigated except for human neutrophils which were
only inhibited by D-galactose.
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SECTION V -
EFFECTS OF CHEMOATTRACTANTS AND OTHER PHARMACOLOGICAL
MEDIATORS ON MONONUCLEAR PHAGOCYTE RECEPTORS
161
1 .0 INTRODUCTION
Co-workers had previously reported that complement receptors on
human eosinophils were enhanced by a number of eosinophil chemotactic
factors (including the ECF-A tetrapeptides, histamine and imidazole-
acetic acid) in a dose and time dependent fashion (Anwar and Kay,
1977b and 1978). The phenomenon of complement receptor enhancement
may be an important feature common to all phagocytic cells. There¬
fore it seemed important to determine whether other human peripheral
blood leukocytes such as monocytes and other phagocytic cells from
different species and environments such as mouse peritoneal macro¬
phages and guinea pig alveolar macrophages underwent similar changes.
In the earlier sections of this thesis the monocyte cell membrane
was shown to bear receptors for C3b and C3b^, the Fc portion of IgG
and IgM and to have lectin-like receptors. Accordingly these receptors
were investigated to determine whether their expression could be
altered and thus gain further insight into phagocytic membrane changes
in response to their environment and the possible consequences of
such changes. Studies were undertaken to examine the effects of
substances known to promote their migration in_ vitro including the
chemotactic factors casein, formyl methionyl peptides and lymphokines
from PHA-stimulated human lymphocytes, on the expression of receptors
on mononuclear phagocytes. The exact mechanism by which cells respond
to chemoattractants which cause random or directed migration is not
clear although participation of "recognition units" on the cell
membrane has been suggested particularly with regard to the formyl
methionyl peptides (Aswanikumar et al., 1977; Williams et al., 1977;
Snyderman and Fudman, 1980) and C5a (Chenoweth and Hugli, 1978).
The/...
162
The relationship between Fc, complement and lectin-like receptors
and those proposed for chemotactic factors is unknown at present.
Membrane responses to pharmacological mediators (including
prostaglandins, bradykinin, serotonin and histamine) which have
been shown to play important roles in host defence mechanisms and
in inflammatory diseases, were also examined.
163
2.0 EFFECTS OF CHEMOATTRACTANTS ON HUMAN MONOCYTE COMPLEMENT AND
Fc RECEPTORS
2.1 Effect of increasing concentrations of casein
In these experiments the monocyte suspensions were incubated
for 30 minutes at 37°C with increasing concentrations of casein at
1, 2 and 3 mg. ml ^and the cells were then added to indicator sheep
red cells to test their rosette forming capacity (see materials and
methods).
Casein enhanced the percentage of monocyte C3b rosettes in a
dose dependent fashion (Fig. 14) irrespective of whether EAC or
EAC1423b were used as indicator cells. In contrast there was a small
IT clfo
but insignificant increase in the percentage of EA (Fc) rosettes.G
With the highest dose of casein the mean values for the enhancement
of Fc receptors was 13% whereas with EAC and EAC1423b the increase
was 92% and 100% respectively. Increasing the concentration of casein
-1
to 4, 5 or 6 mg»ml had no effect on the expression of Fc receptors
(results not shown).
2.2 Time course of monocyte.complement receptor enhancement
Enhancement of complement receptors by casein at a concentration
-1
of 3 mg ml was dependent on the time of incubation. Maximal effects
were observed at about 30 minutes after which there was no further
increase (Fig. 15). Similar results were obtained irrespective of
whether EAC or EAC1423b were used as indicator red cells. A small
but insignificant increase in Fc receptors was also observed in this
time course study and was maximal after approximately 60 minutes.




The effect of casein on monocyte C3b and IgG rosettes
121 EAC1423b, Q EAC, S EA^. Each column represents the mean
- 1 S.E.M. of three experiments.
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The time course of the percentage enhancement of monocyte
rosettes by casein using sensitised erythrocytes coated with complement
or igG. (• • ) EAC, (o o)EACl423b, (ft—ft) EA^ Each point represents
the mean - 1 S.E.M. of three experiments. The inidcator red cells were
EAC at 1/700 dilution of AB serum, EAC1423b with 400 molecules C3 per
red cell and EA^ab at 1/20 dilution of IgG.
EA1V/TC1423
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value. Extending the length of incubation with casein up to 180
minutes, 240 minutes or overnight had no further effect on Fc
receptors.
As the dose response and time-course studies were essentially
similar using EAC or EAC1423b, EAC were used as indicator cells in
further experiments on the modulation of C3b receptors on human
monocytes.
The effect of increasing doses of casein on the rate and degree
of monocyte complement receptor enhancement is shown in Fig. 16. The
degree of enhancement and the rate at which enhancement occured was
dependent on the concentration of casein. Increasing the concentration
-1 -1
of casein from 1 mg. ml to 2 mg.ml increased the rate of monocyte
rosette enhancement three-fold. Further increase in the concentration
-1
of casein up to 3 mg.ml had no apparent effect on the rate of
complement receptor enhancement.
2.3 Effect of formyl methionyl peptides on monocyte complement
receptor expression
A number of formyl methionyl peptides were also tested for their
effects on monocyte complement receptors (Fig. 17). With f-Met-Leu-Phe
—7 —8 —1
activity was observed at 10 and 10 mol.l with little enhancement
-9 -1
at 10 mol.l . F-Met-Met-Phe and f-Met-Phe were less active than
—5 —6 ""1
f-Met-Leu-Phe but both gave enhancement at 10 and 10 mol.l but
-7 -1
not 10 mol.l . The unformylated peptides Met-Leu-Phe and
Met-Met-Phe were virtually inactive.
2.4 Time course of complement receptor enhancement by f-Met-Leu-Phe





The time course of monocyte complement receptor enhancement by
-1 -1
increasing doses of casein. (•———•) 3mg.ml casein, (o o) 2mg.ml
1 "^1
casein, (a fl) Img.ml casein. Each point represents the mean - 1
S.E.M. of three experiments. The indicator red cells were EAC (prepared




The effect of formyl-methionyl peptides on the expression of
monocyte complement receptors. (• •) F-Met-Leu-Phe, (o o) Met-
Leu-Phe, (| |) F-Met-Met-Phe, (D B) Met-Met-Phe, ( £ F-Met-
Phe. Each point represents the mean - 1 S.E.M. of three experiments.
The indicator red cells were EAC as in Fig. 16.
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was also dependent on the time of incubation. Fig. 18 compares the
effects of f-Met-Leu-Phe on human peripheral blood monocytes, neutro¬
phils and eosinophils. The time course for monocytes is similar to
that shown with casein (Fig. 15) with maximal effects observed by
30 minutes, after which there was no further increase. The degree
and rate of complement receptor enhancement was greatest with neutro¬
phils and least with eosinophils.
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Fig. 18
The time course of complement receptor enhancement by F-Met-Leu-
-7-1
Phe at 10 moles.1 for human monocytes (• • ) and eosinophils
—8 — 1
( ■ B) and 10 moles. 1 for human neutrophils (o o) . Each
point represents the mean - 1 S.E.M. of four experiments. The indicator
cells were EAC(R3) at 1/150 dilution for monocytes, 1/10 dilution for
eosinophils and 1/25 dilution for neutrophils, of R3.
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3.0 EFFECT OF OTHER CHEMOATTRACTANTS ON HUMAN MONOCYTE COMPLEMENT
RECEPTORS
Other recognised monocyte chemoattractants were tested for their
capacity to enhance monocyte complement receptors. Supernatants from
lymphocytes stimulated with PHA (see materials and methods) increased
the numbers of monocyte rosettes in a dose-dependent fashion (Fig. 19).
In contrast, unstimulated lymphocyte supernatants had significantly
less effect when tested at comparable dilutions. At ^/8 dilutions
the stimulated lymphocyte supernatant enhanced monocyte rosettes by
84 - 5% compared to the unstimulated supernatant which only enhanced
rosettes by 39 - 7% at the same dilution. (_f<.o-o5)
A chemoattractant elaborated from C.. parvum 10390 also increased
the expression of complement receptors on human monocytes in a dose-
dependent fashion (Fig. 19). At a V4 dilution of this factor there
was a 95 - 10% increase in monocyte complement
172
Fig. 19
The effect of stimulated (• •) and unstimulated (o o)
lymphocyte supernatants, and C. parvum 10390 supernatant on the
expression of monocyte complement receptors.. Each point represents
the mean - 1 S.E.M. of three experiments. The indicator red cells
were EAC as in Fig. 16.
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4.0 EFFECT OF A CHEMOKINETIC AGENT, HUMAN SERUM ALBUMIN, ON MONOCYTE
COMPLEMENT RECEPTOR EXPRESSION
Human serum albumin which is known to be chemokinetic but not
chemotactic was tested for complement receptor enhancement by human
monocytes (Fig. 20). At doses which are chemokinetic (0.5 to 3.0
mg.ml ^), there was a dose-dependent increase in complement receptor
expression except at the highest dose used which gave less enhance-
-1
ment than the second highest dose (2 mg.ml ).
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Fig. 20
The effect of human serum albumin on the expression of monocyte
complement receptors. Each point represents the mean - 1 S.E.M. of
/
five experiments. The indicator red cells were as in Fig. 16.
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5.0 EFFECT OF CHEMOAT.TRACTANTS ON MOUSE PERITONEAL AND GUINEA PIG
ALVEOLAR MACROPHAGES
Complement receptors on mouse peritoneal and guinea pig alveolar
macrophages were increased following incubation with the chemo-
attractants f-Met-Leu-Phe and casein (Figs. 21, 22 and 23) for 30
minutes at 37 °C. F-Met-Leu-Phe enhanced the percentage of mouse
-9
macrophage C3b rosettes in a dose dependent fashion from 10 moles.1
-11 -1
to 10 moles. 1 (Fig. 21). Higher doses of f-Met-Leu-Phe had less
-9 -1
enhancing effects. Peak activity, at 10 moles.1 f-Met-Leu-Phe,
gave a mean value for enhancement of 81 ^ 10%. Complement receptors
on mouse macrophages were also increased following incubation with
casein at a concentration of 2 and 3 mg.ml ^ (Fig. 22). In contrast
it ci Id
f-Met-Leu-Phe had no effect on EA (Fc) rosettes (Fig. 21).G
The effects of f-Met-Leu-Phe and casein were also studied on
mouse peritoneal macrophage monolayers;.. As shown in Table III the
results are essentially similar to those found using mouse macrophage
suspensions. F-Met-Leu-Phe increased macrophage complement receptors
-9 -1 +
to the greatest extent at a concentration of 10 moles.1 (74 - 22%)
Casein also enhanced the receptors at a concentration of 2 and 3 mg.ml
At the highest concentration a greater degree of enhancement was
observed with the mouse monolayers compared to the mouse macrophage
suspensions (73 - 9 and 48.5 - 10 respectively). (j-
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Fig. 21
The effect of F-Met-Leu-Phe on the expression of mouse peritoneal
macrophage complement receptors (• • ) and Fc (IgG) receptors
(o o). Each point represents the mean - 1 S.E.M. of three experi¬
ments. The indicator red cells were EAC(R3) at V^O dilution of R3 and
EA^ab at 1/50 dilution of IgG.G
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Fig. 22
The effect of casein on the expression of mouse peritoneal
macrophage complement receptors. Each point represents the mean -




The effect of F-Met-Leu-Phe on the expression of guinea pig
alveolar complement receptors (• • ) and Fc (IgG) receptors
(o—o) . Each point represents the mean - 1 S.E.M. of three
1
experiments. Indicator red cells were EAC(R3) at /2 dilution of
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The effect of f-Met-Leu-Phe and casein on complement
receptor expression on mouse peritoneal macrophage mono¬




The chemoattractants casein and f-Met-Leu-Phe markedly enhanced
the expression of complement receptors on human monocytes, mouse
peritoneal and guinea pig alveolar macrophages in a dose-dependent
fashion. Increases in monocyte complement receptors by both chemo-
tactic factors were also shown to be time dependent. The time course
of enhancement of monocyte complement receptor enhancement was
compared to that found with human neutrophils and eosinophils. Other
known chemotactic agents were also tested for their capacity to
increase complement rosettes on monocytes„ Both lymphokines produced
by human lymphocytes and a chemotactic factor elaborated by C. parvum
were found to enhance the expression of complement receptors.
A chemotactic agent, human serum albumin, also increased
complement receptors on human monocytes. In contrast to the increases
observed with complement receptors, Fc receptors on human monocytes,
mouse peritoneal and guinea pig alveolar macrophages were unaffected
by casein or f-Met-Leu-Phe.
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SECTION VI -
EFFECTS OF CHEMOATTRACTANTS ON THE EXPRESSION OF
OTHER TYPES OF RECEPTORS ON MONONUCLEAR PHAGOCYTES
182
1.0 EFFECT OF f-Met-Leu-Phe ON HUMAN MONOCYTE RECEPTORS FOR THE
Fc PORTION OF IgM
As described in Section 1, Part 3.0 human monocytes do not
normally express Fc receptors for IgM but apparently a small percen¬
tage of the monocytes (14 - 1%) have cryptic receptors which are
revealed after neuraminidase treatment. Experiments were carried
out to investigate the possibility that incubation with chemoattrac-
tants might similarily reveal these receptors. As shown in Table IV
-7 -1
10 moles.1 f-Met-Leu-Phe did not alter the expression of Fc
receptors for IgM on untreated human monocytes. The effects of
f-Met-Leu-Phe were also examined on monocytes after treatment with




Control 3 - 1
f-Met-Leu-Phe,
10 ^ moles.1 ^ 2 - 1
Neuraminidase 14 - 1
Neuraminidase
+ f-Met-Leu-Phe, 12.5 - 3
*rs-1 -,"110 moles.1,
TABLE IV
The effect of neuraminidase and f-Met-Leu-Phe on mono-
cyte rosette formation with EA^ . The results represent
the mean of 3 experiments - 1 S.E.M.
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2.0 EFFECT OF f-Met-Leu-Phe ON HUMAN MONOCYTE RECEPTORS FOR C3b"
As described in Section III, Part 2.0 human monocytes from
rosettes with EAC1423b"*, prepared by either incubation of EAC1423b
cells with purified human KAF or with EDTA-chelated serum. The
latter indicator cells were used to investigate the effects of
f-Met-Leu-Phe on C3b^ receptors. The results in Table V show that
-7 -1
at the highest concentration tested (10 moles.1 ) f-Met-Leu-Phe
had a slightly inhibitory effect on the expression of C3b^ receptors
+ —8 —9 —i
on human monocytes (-11 - 1%). At 10 and 10 moles.1 f-Met-Leu-Phe
no alterations in C3b^ receptors were observed.
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The effect of f-Met-Leu-Phe on monocyte rosette formation
with EAC1423b>". The results represent the mean of the 3 experiments
- 1 S.E.M.
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3.0 EFFECTS OF f-Met-Leu-Phe AND CASEIN ON STAPH. ALBUS BINDING TO
MOUSE PERITONEAL MACROPHAGES
The effect of increasing doses of f-Met-Leu-Phe on Staph, albus
binding to mouse peritoneal macrophages is shown in Fig. 24 and Table VI.
A dose dependent inhibition of Staph, albus binding was observed when
the cells were pre-exposed to varying dilutions of f-Met-Leu-Phe at
37°C for 30 minutes. At the highest concentrations tested 10 7 and
—8 — 1
10 moles. 1 , less inhibition was observed. Bacterial binding was
also reduced by casein in a dose dependent fashion (Fig. 25) . However
pre-exposure of the macrophage monolayers to f-Met-Leu-Phe or casein
at 4°C (Table VI) had no effect on Staph, albus binding.
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Fig. 24
The effect of F-Met-Leu-Phe on the binding of Staph, albus by
mouse peritoneal macrophages. The percentage inhibition of binding
is calculated as in Fig. 12. Each point represents the mean - 1 S.E.M.
of four experiments.
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CONCENTRATION OF INHIBITION OF STAPH.. ALBUS
CHEMOATTRACTANT BINDING (%) AT 4 °C


























The effect of prior incubation of Staph, albus binding to
mouse peritoneal macrophages. The results represent the mean of
3 experiments - 1 S.E.M.
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Fig. 25
The effect of casein on the binding of Staph, albus by mouse
peritoneal macrophages. The percentage inhibition of binding is




Neither Fc receptors for IgM or CSb^ receptors on human monocytes
were affected by the chemoattractant f-Met-Leu-Phe. Both f-Met-Leu-Phe
and casein inhibited the expression of "lectin-like" receptors on
mouse peritoneal macrophages in a dose dependent fashion.
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SECTION VII -
EFFECTS OF MEDIATORS ON MONOCYTE COMPLEMENT RECEPTORS
192
1.0 EFFECTS OF PROSTAGLANDINS, 5-HYDROXYTRYPTAMINE, BRADYKININ
AND ISOPRENALINE
In this series of experiments the monocytes were incubated with
various substances for 1 hour at 37°C. Prostaglandins E^, E^ and F^a
were tested for their effects on monocyte C3b receptors (Fig. 26).
Prostaglandin E^ (PGE^) showed significant enhancement at 10 ^, 10
and 10 4 moles.1 1 with peak activity at 10 ^ moles.1 1 (48 - 7%) . < o .oos^
Prostaglandin E^ (PGE^) significantly increased monocyte complement
-7 -1 -4
receptor expression at concentrations from 10 moles.1 to 10
-1 -7 -1
moles.1 and the greatest activity was observed at 10 moles.1
(f<, o o s)
(62 - 1-5%) C" Significant enhancement of rosettes by prostaglandin
F (PGF ) was only observed at 10 4 moles. 1 ^2a 2a
5-Hydroxytryptamine (or seratonin) (5-HT) increased monocyte
complement receptors in a dose-dependent fashion (Fig. 27). At
-5 -4 -1
10 and 10 moles.1 enhancement was significantly different from
-4 -1
control values. A concentration of 10 moles.1 gave an increase
of 61 - 6%. (/< ° 'Oi)
Bradykinin was tested for its effect on complement receptor
—6 -1
expression (Fig. 27). A peak in activity was observed at 10 moles.1
+ _5 _4
(42 - 10%) with lower enhancement observed at 10 and 10 moles.1
The effects of isoprenaline were tested over a range of concen-
-7 -4 -1
trations from 10 to 10 moles.1 (Fig. 27). No significant
effects on EAC rosettes by human monocytes were observed.
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Fig. 26
The effect of prostaglandins PGF2a' PGE-| an<^ PGE2 on tiie exPres~
sion of human monocyte complement receptors. Each point represents
the mean - 1 S.E.M. 10 4 to 10 6 moles.1 1 - five experiments. 10 7
-9 -1
to 10 moles.1 - four experiments. Indicator red cells were EAC





















































The effect of various pharmacological mediators on human mono¬
cyte complement receptor expression. Each point represents the mean




2.0 EFFECTS OF HISTAMINE ON COMPLEMENT RECEPTORS ON MONOCYTES OF
ATOPIC AND NON-ATOPIC INDIVIDUALS
2.1 Introduction
A study on the expression of histamine receptors on human peripheral
blood monocytes from atopic and non-atopic individuals was carried out
by an Honours Student, Lesley M. Smart, following the description of
c
these receptors on guinea pig alveolar macrophages and other phagocytes
(Diaz et al., 1979). Individuals were patch tested to determine
whether they were atopic or non-atopic using common allergens such as
house dust mite, grass pollen, cat hair and egg. Monocytes were also
obtained from atopic individuals attending the Skin Clinic, Royal
Infirmary, Edinburgh. Concurrently with this study the effect of
histamine on monocyte complement receptor expression was studied.
Although preliminary studies had shown that the response to histamine
was generally small there was a marked enhancement of complement
receptors by this agent in a few individuals. The reason for such
variations between apparently healthy individuals was unclear but
the possibility that it might be related to their atopic state was
explored.
2.2 Effect of increasing concentrations of histamine
The effect of histamine on atopic and non-atopic individuals is
shown in Fig. 28. Nine atopic and seven non-atopic individuals were
assessed for modulation of monocyte complement receptor expression
-7 -4 -1
by histamine with a range of concentrations from 10 to 10 moles.1







The effect of histamine on human monocyte complement receptor
expression from atopic and non-atopic subjects. Each point represents
the result from one individual. Indicator red cells were EAC as in
Fig. 16.
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atopic group. The effects of histamine did not show obvious dose-
dependency with any individual. It was observed that histamine at
every concentration tested decreased the expression of complement
receptors on the monocytes of the majority of non-atopic individuals.
Enhancement of complement receptors by a value of greater than 20%
was only observed at 4 points. Three out of the four were the
results obtained from one individual. The 4th point (42% enhancement
-7 -1
at 10 moles.1 histamine) was obtained from a second individual
—6 —7 ~~ i
who also showed positive enhancement at 10 and 10 moles.1
(12% and 8% respectively).
The results obtained with the atopic individuals were very
different. At all concentrations of histamine tested the expression
of complement receptors on monocytes was enhanced albeit to varying
degrees with a few notable exceptions. The number of EAC rosettes
was reduced at 10 ^, 10 ^ and 10 ^ moles.1 ^ histamine by 26%, 2% and
18% respectively in the case of one individual. Another person
-6 -4
showed fewer EAC rosettes than the control value at 10 and 10
-1 -4 -1
moles.1 (15% and 5% respectively). A concentration of 10 moles.1
histamine had no effect on the expression of complement receptors
on monocytes of 2 other individuals, one of whom also showed a lack
—6 _ i
of response at 10 moles.1 . The vast majority of points were
found to lie between 10 and 65% enhancement.
A similar series of experiments were also carried out with human
neutrophils (results not shown). Again there was a wide variation in
the results and the effects of histamine were not dose dependent.
However no obvious differences between the response of neutrophils
from non-atopic and atopic individuals was observed.
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3.0 SUMMARY
The effects of prostaglandins, seratonin, bradykinin and histamine
on human monocyte complement receptor enhancement were examined. PGE^
and PGE„ increased EAC rosette formation as did PGF„ but the latter2 2a
only showed activity at the highest dose tested. Monocyte rosettes
were also increased by 5-Hydroxytryptamine and bradykinin. In
contrast isoprenaline had no apparent effect at any of the doses
tested. Histamine had different effects on different individuals.
Monocytes from atopic people tended to have increased complement
receptor expression after incubation with histamine whereas monocytes








Possible explanations for the mechanisms of complement receptor
enhancement has been discussed in previous reports (Anwar and Kay,
1977b,1978) and included "membrane unfolding", "receptor externa-
lisation" and "subunit association".
In the previous sections it has been shown that chemotactic
factors enhance the expression of complement receptors on a variety
of phagocytes including human peripheral blood monocytes, mouse
peritoneal macrophages and guinea pig alveolar macrophages. Other
receptors including Fc receptors for IgG and IgM, and C3b"' receptors
were unaffected and lectin-like receptors were reduced by chemo-
attractants. Having established the optimal conditions for monocyte
complement receptor enhancement with casein and f-Met-Leu-Phe,
these chemotactic agents were used to explore the phenomenon further
in order to gain more insight into the mechanism of increased
receptor expression. The following studies investigated the
effects of temperature and also examined the possibility that
complement receptor enhancement might be a reversible phenomenon.
Some comparisons were made with human neutrophils.
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2.0 EFFECTS OF WASHING CELLS AFTER INCUBATION WITH CHEMOTACTIC
FACTORS
Monocyte complement receptor enhancement appeared to be
reversible (Fig. 29). Following 30 minute incubation with 3 mg.ml ^
casein at 37°C, the cells were washed and resuspended in medium 199.
After about 30 minutes there was a gradual decrease in monocyte
rosette enhancement and by 120 minutes there was no discernible
difference from the control value. Similar results were obtained
-7 -1
with f-Met-Leu-Phe (10 moles.1 ) (Fig. 30),although for the
first 30 minutes after removal of the chemoattractant there was an
apparent rise in complement receptor expression before the number
of rosettes declined to control values at 120 minutes.
Complement receptor enhancement by human peripheral blood
neutrophils was also found to be reversible following incubation
—8 ~~ i
with f-Met-Leu-Phe (10 moles.1 ) (Fig. 31). Neutrophil rosette
enhancement decreased more rapidly than that observed with monocytes
and by 30 minutes had returned to control levels.
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(Monocytes were preincubated with 3 mg/ml of casein for 30 min at 37°C,
centrifuged, the supernatant removed and the cells resuspended in
medium 199 to the original volume and incubated at 37°C for
various time intervals as shown)
Fig. 29
Reversibility of monocyte complement receptor enhancement with
3mg.ml ^ casein. Each point represents the mean - 1 S.E.M. of three




Reversibility of monocyte complement receptor enhancement with
-7 -1
10 moles.1 F-Met-Leu-Phe. Each point represents the mean of two
experiments. The indicator red cells were EAC as in Fig. 16.
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Fig. 31
Reversibility of neutrophil complement receptor enhancement
—8 —1
with 10 moles.1 F-Met-Leu-Phe. Each point represents the mean
1
of two experiments. The indicator cells were EAC(R3) at /25 dilution
of R3.
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3.0 TEMPERATURE DEPENDENCE OF COMPLEMENT RECEPTOR ENHANCEMENT BY
CHEMOTACTIC FACTORS
In these experiments the leukocytes were incubated with the
chemotactic factors at varying temperatures for 30 minutes.
Monocyte complement receptor enhancement was temperature
dependent as shown in Fig. 32. At 0°C there was no increase in the
percentage of rosettes formed with any of the concentrations of
casein used. However at 23, 30 and 37°C, enhancement was observed
and increased proportionally with the rise in temperature. Similar
results were obtained with f-Met-Leu-Phe (Fig. 33). At 0 and 23°C
little enhancement was observed with any of the concentrations of
f-Met-Leu-Phe used. However at 30 and 37°C enhancement occured with
—7 —8 —1
10 and 10 moles.1 , a greater increase being observed at 37°C.
Neutrophil complement receptor enhancement was also temperature
dependent (Fig. 34). There was no increase in the number of rosettes
formed with any of the concentrations of f-Met-Leu-Phe at 0 and 23°C.
At higher temperatures (30 and 37°C) enhancement was observed and
increased proportionally with the rise in temperature.
In order to investigate the possibility that lowering the
temperature was decreasing the rate of enhancement rather than the
degree, time course studies at varying temperatures were carried
out as shown in Fig. 35. At 37°C monocyte complement receptor
-7 -1
enhancement by f-Met-Leu-Phe (10 moles.1 ) remained virtually
constant over the 120 minute incubation period. At 30°C there was
a gradual rise from 45% at 30 minutes to 67% at 120 minutes.
Increasing the incubation time with f-Met-Leu-Phe at 0 and 23°C had
no effect on the degree of enhancement observed.
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The effect of temperature on monocyte complement receptor
enhancement. (•———•) 3mg.ml casein, (o——o) 2mg.ml casein,
(I j ) img.ml-1 casein, (fl fl ) medium 199. Each point represents
the mean - 1 S.E.M. of three experiments. The indicator cells were
EAC as in Fig. 16.
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Fig. 33
The effect of temperature on monocyte complement receptor
—7 ~"1 -8 ~1
expression. (• •) 10 moles.1 , (o o) 10 moles. 1 and
-9 -1
( g g) 10 moles.1 F-Met-Leu-Phe. Each point represents the
mean - 1 S.E.M. of three experiments. Indicator red cells were
EAC(R3) at V150 dilution of R3.
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Fig. 34
The effect of temperature on neutrophil complement receptor
—8 —1 ""9 — 1
enhancement. (• • ) 10 moles. 1 , (o o) 10 moles. 1 and
—10 —1
(I g) 10 moles.1 F-Met-Leu-Phe. Each point represents the
mean - 1 S.E.M. of three experiments. Indicator red cells were EAC(R3)
as in Fig. 31.
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Fig. 35
The time course of monocyte complement receptor enhancement
at 37°C (• •) , 30°C (o o) , 23°C ( g g ) and 0°C ( D Q ) .
Each point represents the mean of two experiments. Indicator red
cells were EAC(R3) as in Fig. 33.
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4.0 SUMMARY
Washing the monocytes after enhancement with f-Met-Leu-Phe or
casein and allowing the cells to recover in medium led to a gradual
return in complement receptor expression to basal levels. Similar
results were obtained with human neutrophils.
Enhancement of complement receptors on human monocytes and
neutrophils was temperature dependent and occurs mainly in the
temperature range of 30 to 37°C. The lower level of enhancement
observed at 30°C was partly due to a decrease in the rate at which
enhancement occured.
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CHAPTER V - DISCUSSION
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1.0 RECEPTORS FOR IMMUNOGLOBULIN, COMPLEMENT AND BACTERIA ON HUMAN
MONOCYTES, MOUSE PERITONEAL MACROPHAGES AND GUINEA PIG ALVEOLAR
MACROPHAGES
1.1 Techniques
Using the rosette technique, receptors for immunoglobulin and
complement were demonstrated on various mononuclear phagocytes and
using a binding assay "lectin-like" receptors were aiso detected on
these cells. The use of these methods for the investigation of various
cell membrane markers is well established. For most of the experiments
using the rosette technique, the cells were in suspension and smeared
onto glass slides before fixation and staining. The ratio of indicator
sheep red blood cells to leukocytes was important because they are
present in the background and if too many were present it became
impossible to distinguish individual rosettes. This problem did not
arise when adherent cell monolayers were used since non-attached red
cells were simply washed away. In the latter studies leukocytes with
2 or more attached indicator red cells were counted as positive rosettes
whereas with the smears 3 or more red cells attached were scored as
positive. The disadvantages of using monolayers were (a) it lengthened
the time of the experiment and therefore increased the possibility of
lowering the viability of the cells; (b) change in membrane activity
was likely and in fact with the same ratio of red cells to leukocytes,
less complement was required to coat the red cells for detection of
complement receptors on monolayers, than on the same cells in suspension
to obtain the same percentage of rosetting cells; (c) it was possible
that selection of a more adherent cell population might occur.
"Lectin-like" receptors were detected on human peripheral blood
leukocytes, mouse peritoneal and guinea pig alveolar macrophages by
overlaying/...
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overlaying bacteria (Staph, albus) on monolayers of these cells, and
after incubation at 4°C the non-attached organisms were washed away.
Monolayers of cells were used despite the disadvantages discussed above
because after interacting the phagocytes and bacteria in suspension,
it proved very difficult to remove sufficient non-attached organisms
to obtain a clear background. Even with the monolayers, preparations
at a bacterial concentration greater than 101^ organisms, ml 1 the
presence of bacteria in the background made it difficult to estimate
binding. Glass coverslips in wells of tissue culture plates were used
in these assays instead of flying coverslips in W.R. tubes as employed
previously (H. Ogmundsdottir, Ph.D. thesis, 1979). This improved
method made experimental manipulations considerably easier and faster.
Because the abseoce of serum was very important in these investigations
of binding of unopsonised bacteria to phagocytes, the cells were
initially adhered to the coverslip with no serum present. This meant
that with the human monocyte and mouse peritoneal macrophage preparations,
contaminating lymphocytes also adhered (W. McBride, personnal communica¬
tion). The majority of these lymphocytes, presumably mainly B cells,
were removed by washing the monolayers after 1 hour incubation at 37°C
with medium also at 37°C, since it was noted that washing with medium
at 4°C did not remove the lymphocytes. It is perhaps surprising that
both eosinophils and neutrophils should also adhere so readily to
glass since it is generally considered to be a functional property of
macrophages and is used as a separation method. However eosinophils
and neutrophils share many functions in common with mononuclear phago¬
cytosis. Both of these functions probably involve adherence phenomena,
in chemotaxis to the substratum (tissue cells in vivo) and in phago¬
cytosis to the ingesting particle.
Care/...
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Care was taken to grow the bacteria, Staph, alfaus, under virtually
identical conditions each time a fresh batch was prepared. However
variations did occur in the degree of binding obtained and occasionally
little or no binding to leukocytes was observed. The only obvious
differences between batches was that different preparations of horse
digest broth for culturing the bacteria was unavoidably used. This
suggests that the environment in which the bacteria grow may affect the
surface properties of the organisms and these considerations may be
important in terms of pathogenesis, if the invading organisms grow in
a particular environment which does not facilitate the synthesis of
binding ligands for the phagocyte receptors, then the organism may be
able to grow unchecked.
Rosette smears and coverslips were usually stained with May
Grunwald/Giemsa. The use of this stain for monolayers instead of the
Gram method as used by H. Ogmundsdottir (Ph.D. thesis, 1979) allowed
the observer to recognise more readily the morphoiogy of the cells.
For some of the rosette experiments the monocytes were stained with
non-specific esterase (Yam et al., 1971) so that monocytes could be
more easily distinguished from lymphocytes. However in order to
prevent lysis of the indicator sheep cells glutaraldehyde fixation was
used instead of the recommended formaldehyde/acetone buffer and the
intensity of the stain was reduced (methanol destroys esterase activity).
In the experiments where the cells were incubated at 37°C before
rosetting, staining with non-specific esterase was often very weak
presumably because the enzyme involved is water soluble and may be
leached from the cell. Low density staining meant that the slides
were difficult to count and this problem together with the relative
ease of the May Grunwald/Giemsa stain prompted the author to use the
latter/...
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latter stain wherever possible. Although it was more difficult to
distinguish monocytes from lymphocytes using this stain, comparison of
the two methods by 4 independent observers revealed no statistically
significant differences in differentiating monocytes from lymphocytes.
Because of the obvious morphology of neutrophils there was no
difficulty in counting neutrophil rosettes in smears or on coverslips.
Previous work by Anwar and Kay (1977a, b, 1978) had investigated the
presence of Fc and complement receptors on eosinophils and had used
May Grunwald/Giemsa to stain these cells. However counting eosinophil
smears under the X 25 objective was very difficult and the X 100
objective had to be used which made counting very slow and laborious.
The use of chromotrope which specifically stains eosinophils red and
tartrazine as a counter-stain for the indicator red cells enabled
the author to easily distinguish eosinophils from other granulocytes.
1.2 Fc (IgG) receptors
IT 3b
Sheep red cells sensitised with rabbit IgG (EA ) formed rosettesCj
with human monocytes, mouse peritoneal macrophages and guinea pig
alveolar macrophages in a dose-dependent fashion with increasing doses
of antibody (Fig. 4). Since this is a heterologous system, comparisons
between the different cell types must be treated with caution. These
results are in agreement with Huber et al. (1969) for human monocytes,
Mantovani et al. (1972) for mouse peritoneal macrophages and Rhodes
(1975b) for guinea pig alveolar macrophages in that all 3 cell types
possess Fc (IgG) receptors. Rabbit IgG binds to both classes of Fc





Optimal experimental conditions were determined for the detection
of Fc (IgG) receptors on human monocytes. Althouglrmoremonocytes
expressed Fc receptors at 37°C than at 4°C (Figs. 2 and 3), even by
5 minutes, varying degrees of phagocytosis had occured and thereafter
the percentage of positive cells decreased. It is possible that
instability of EA -monocyte rosettes at 37°G may be as a result ofG
shedding of the receptor into the medium as has been demonstrated for
Fc receptors on lymphocyte membranes at 37°C (Sandor et alM 1979) or
it could arise from micropinocytosis of small pieces of the attached
red cells, the remainder of the red cells breaking away as has been
suggested by Brown and Nelson (1973). However as observed here, the
r ab
percentage of cells phagocytosmg EA increased as rosettmgG
decreased, suggesting that this was the main cause of the diminished
binding. If the medium in which the monocytes were incubated at 37°C
contained shed Fc receptor material it might be expected to inhibit
Fc rosette formation by other Fc receptor bearing cells. The present
studies did not examine this possibility. The expression of Fc receptors
at 4°C is in contrast to the results of Passwell et al. (1978) who
found that the binding of EA^Um to human monocyte Fc receptors required
metabolic energy whereas cytophilic antibody binding did not. These
workers prepared monocyte monolayers and the indicator cells and
sensitising antibody used were ORh+ human erythrocytes and human anti-D
2~i" 2+ .
antibody. Binding of EA in this system required Ca and Mg ionsG
whereas other workers have found that neither cation was necessary
(Lay and Nussenzweig, 1969; Davey and Ascherton, 1967). Although
Passwell ej: £l_. (1978) found that colchicine inhibited rosette for¬
mation with EA Atkinson and Parker (1977) showed that it had no effect
G
on rabbit alveolar macrophages. It is possible that cells which have
adhered/.. ■.
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adhered to glass may have different binding capacities. The appearance
of prominent microtubules within the cytoplasm of adherent monocytes
is presumably associated with enhanced spreading abilities and the
topography of the membrane may be altered as a result, as evidenced
by the irregular ruffled plasma membrane of these cells. Functionally
anti-D antibody behaves as an incomplete antibody since the distribution
of D antigen on Rh+ human erythrocytes is such that it prevents
effective haemagglutination. Conversely anti sheep red cell antibody
readily agglutinates sheep erythrocytes suggesting that the density of
antigen and therefore antibody is considerably greater in this system
than with the anti D-Rh+ human erythrocyte system. The formation of
macrophage-EA rosettes occurs only when there is ligand-receptor inter-
actions between many macrophage Fc receptors and the erythrocyte bound
antibody. This union is dependent upon the density of bound antibody
on the red cells and also, probably, on the ease with which the macro¬
phage Fc receptors can move in the plane of the membrane. In the
sheep erythrocyte system there is rosetting at 4°C because although
Fc receptor mobility is low, there is a high density of erythrocyte-
bound antibody. At 4°C, in the human Rh+ system, both erythrocyte-
bound antibody density and the Fc receptor mobility are low and thus
rosetting cannot occur.
At the highest possible concentration of antibody 100% positive
Fc rosetting cells were never obtained. There is a limit to the amount
of antibody which can be deposited on the indicator sheep cells, since
it must be subagglutinating. This problem could be overcome by using
ox erythrocytes and antiox antisera (Hallberg et al., 1973) because ox
erythrocytes are able to bind more molecules of antibody per cell than
sheep erythrocytes, or. by using certain monoclonal anti sheep red cell
antibodies/...
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antibodies (Kerbel, 1980) which were . completely incapable of directly
haemagglutinating these cells. Other more sensitive assays including
immunofluorescence or radiolabelled antibody could be employed. However
sheep red cells are readily available and the rosette assay is relatively
easy to perform and inexpensive. It is possible that the antibody may
have a lower affinity for Fc receptors than those used in other systems.
In the present studies the presence of cytophilic antibody on the
mononuclear phagocytes tested, was not investigated. By blocking Fc
receptors such antibody may prevent binding of EA^3*3 to the monocytes
or macrophages. When mononuclear leukocytes were isolated directly from
whole human blood using Ficoll-Hypaque they had cytophilic antibody on
their surfaces (Alexander et al., 1978b) and this decreased the binding
of immune complexes compared to cells which had been washed prior to
separation. It is not clear why Ficoll-Hypaque should cause cytophilic
antibody to bind tightly to Fc receptors when it usually binds with low
affinity. The author isolated human monocytes with Ficoll-Hypaque at
4°C unlike Alexander et. al_. (1978b) who performed their separations at
22°C. It is possible that cytophilic antibody does not bind to the
same degree at 4°C under these conditions. Also, particulate complexes
IT clO
(EA ) were used rather than soluble immune complexes to detect Fc
G
receptors. The former might be expected to bind with greater affinity
than the smaller immune complexes (Phillips-Quagliata et al., 1971).
Ogmundsdottir and Weir (1976) found no evidence for cytophilic anti¬
body on mouse peritoneal macrophages. So although the presence of
some cytophilic antibody on human monocytes may account for the limited
number of Fc rosettes it is unlikely to account for these findings on
mouse peritoneal macrophages. It is not known whether guinea pig
alveolar/...
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alveolar macrophages possess such antibody,on their surfaces but it
seems unlikely since they were washed prior to use and were not
separated on Ficoll-Hypaque.
There may be a population of human monocytes, mouse peritoneal
macrophages or guinea pig alveolar macrophages which express Fc
receptors poorly, either immature cells or possibly as yet unidentified
subsets. However van Furth et al. (1980) found that 92% human mono¬
cytes and 100% mouse peritoneal macrophages expressed Fc receptors and
Rhodes (1975b) reported that 80% guinea pig alveolar macrophages
expressed Fc receptors. It is possible that if the mononuclear phago-
ITcib
cytes had been incubated with EA_ coated with the highest concen-
VJ
tration of antibody, at 37°C rather than 4°C, slightly more cells would
have rosetted, as indicated by the temperature dependence studies
(Table I). However with all 3 cell types, there does appear to be
heterogeneity of expression of Fc receptors which is in agreement with
Norris et al. (1979) for human monocytes, Rhodes (1975b) for guinea pig
alveolar macrophages and Pelus et al. (1981) for mouse peritoneal
macrophages. Heterogeneity may be a reflection of different popula¬
tions of cells or may be related to stages of cellular differentiation
(maturation). Although in the present work there are insufficient
points on the dose response curves (Fig. 4) to indicate the existence
of sigmoidicity, in view of the work by Rhodes (1975) it seems likely
that the curve is of sigmoid form. Such sijmidal curves are often
indicative of co-operative effects and therefore may be a consequence
of co-operative interactions between Fc receptors as suggested by
Tizard (1971) and Leslie and Alexander (1980). High avidity cells
among the resident macrophage population may have been stimulated by
naturally/...
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naturally occuring irritants or pathogens and therefore show increased
expression of Fc receptors (Zuckerman and Douglas, 1979). The observed
heterogeneity of Fc receptors may reflect functional differences within
macrophage populations. For instance Norris _et al_. (1979) found that
the monocyte population which was larger in size and Fc receptor positive
also showed high ADCC activity whereas the small monocytes which were
mainly Fc receptor negative were inactive against sensitised red blood
cell targets.
1.3 Fc (IgM) receptors
Sheep red cells sensitised with IgM were also tested for their
capacity to bind to human monocytes at 37°C (Fig. 5) and at 0°C (results
not shown). Under the experimental conditions described in this thesis
there was no significant rosette formation by human monocytes and it
it 3. ID
was therefore decided to use these EA^ cells in the preparation of
complement coated intermediates to investigate the presence of comple¬
ment receptors on various phagocytes.
The presence of Fc receptors for IgM on human monocytes has been
described by Haegert (1979a) using a direct plaque forming assay. He
found that neuraminidase treatment increased the expression of these
receptors and they became detectable by a rosette assay (Haegert,
1979b). In the present work the author, using an essentially similar
technique was able to detect fewer cryptic Fc (IgM) receptors on human
monocytes (14 - 1% compared to 33 - 11%). The IgM used may have a
lower affinity for Fc (IgM) receptors than the IgM used by Haegert.
Another possibility is that phagocytosis of latex particles as
employed by Haegert may have altered the expression of cryptic IgM
receptors. Ingestion of latex particles is known to decrease certain
plasma/...
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plasma membrane constituents including Fc (IgG) receptors (Werb and
Cohn, 1972; Doughaday and Douglas, 1976) and conceivably may increase
the expression of Fc (IgM) receptors. Although neuraminidase treat¬
ment may have simply increased the stickiness of the monocyte membrane
and thus led to enhanced binding of EA^a^, neither nor EAC
rosette formation were affected by neuraminidase treatment.
It has been suggested by Haegert (1979b) that these receptors may
be involved in IgM dependent ADCC. Because the monocytes had phago-
JT clb
cytosed latex particles, ingestion of EA^ would not have been possible.
Under the experimental conditions described in this thesis (20 minutes
at 37°C) no phagocytosis was observed. Lay and Nussenzweig (1969)
have described binding of EA^ouse by mouse peritoneal macrophages but
very little phagocytosis was observed in contrast to that found with
EA™ouse. However glycogen elicited murine macrophages do phagocytoseG
E^mouse (Mantovani, 1981). It may be significant that rosetting and
phagocytosis did occur in this system when homologous IgM antibody was
used.
Since fluid phase IgM inhibited rosette formation after neuramini¬
dase treatment, these cryptic receptors must also recognise cytophilic
IgM. Rhodes (1973) found that guinea pig splenic macrophages possess
an Fc receptor for monomeric IgM. Thus normal monocytes and macro¬
phages may have receptors for IgM which could passively arm these
cells and bind antigen, thereby initiating phagocytosis or cell
mediated cytotoxicity. Neuraminidase treatment of human peripheral
blood neutrophils led to deminished cell viability and the formation
of large clumps of cells and therefore the presence of cryptic Fc (IgM)
receptors on these cells could not be investigated (normal neutrophils
did not bind EAm ). The present studies did not examine the presence
of these receptors on other macrophages or other peripheral blood
leukocytes./...
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leukocytes. The small percentage of monocytes which possessed Fc (IgM)
receptors may be a subpopulation of cells and further investigation
into their expression of other receptors such as Fc (IgG) would be
useful.
1.4 Complement receptors
Experiments using the rosette technique were performed to detect
the presence of membrane receptors for various complement components
on human monocytes, mouse peritoneal macrophages and guinea pig alveolar
macrophages. IgM coated sheep red blood cells (EA^3*3) were used in
preparing all the complement coated intermediates. The IgM was purified
from whole rabbit immune serum as outlined in the Material and Methods
by initial ammonium sulphate precipitation, Sephadex G-200 chromato¬
graphy and further purification of the ascending IgM peak by Sepharose-
4b-Protein A in order to remove any possible remaining contaminating
IgG. This ensured that there was no possibility that any IgG was present
and was confirmed by immunodiffusion. Thus Fc receptors could not be
detected using these red cell intermediates.
Diluted AB serum was used for most of the experiments as a source
of complement. However zymosan depleted serum (R3) which removes the
terminal complement components and therefore allows more C3 to be
deposited on the red blood cells, was used for the detection of comple¬
ment receptors on certain leukocytes instead of diluted AB serum.
EAC formed by either method was immune adherence positive (see
Materials and Methods, Part 6.0) indicating that C3b on the surface of
the sheep red cells was present. However Newman et al. (1980) using
R3 as a source of complement has shown that C3b" was also present,
presumably/...
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presumably because both C3b1NA and 81H were present in the serum.
Harrison and Lachmann (1980) using fresh human serum as a source of
C3blNA and 81H showed that fluid phase C3b was degraded by Clb".
Prolonged incubation (between 3 and 24 hours) with purified C3b!NA
and 81H cleaved C3b^ into C3c and C3d by a contaminating DFP-sensitive
protease. However prolonged incubation with fresh human serum did not
lead to C3d production although aged human serum does contain C3c.
Similarly Law _et al_. (1979a) using C3b and 81H contaminated with serum
proteases observed the conversion of EAC3b into EAC3b" and EAC3d (if
DFP was not present). Using V10 dilution of human AB serum chelated
with 0.1M EDTA, EAC3b cells were converted into EAC3b'" but not EAC3d.
Thus although proteases are present in serum which are capable of
degrading EAC3b^ to EAC3d they are not normally present in sufficiently
high concentrations. Similar degradation mechanisms for the conversion
of EAC3b to EAC3b" must also exist in both human AB serum and R3.
However with monocytes in particular very dilute serum was used (^/700
dilution of AB serum or V150 dilution of R3) and this may be sufficient
to dilute out the effects of C3blNA/81H.. With lower dilution of AB
serum or R3 these components may become more important. The extent of
degradation could be assessed with anti-C3c and anti-C3d and this may
allow the proportions of C3b, C3b^ and C3d on the surface of the red
cells to be calculated. Since AB serum or R3 treated red cells were
immune adherence positive these indicator cells are probably mainly
detecting C3b receptors. Although C3b' and C3d may also be present, the
surface of the red cells should be more akin to the in vivo state than
the in vitro situation,using purified components added sequentially,
especially since the alternate pathway is also activated in the serum
system/...
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system and the amplification loop would lead to more dense clusters
of C3b on the surface of the red cells (Muller-Eberhard and Gotze,
1972) .
Human monocytes formed rosettes with erythrocytes sensitised
with IgM and AB serum in a dose-dependent fashion using increasing
concentrations of AB serum (Fig. 7). At the lowest possible dilution
complement receptors were only detected on human monocytes and not on
guinea pig alveolar macrophages or mouse peritoneal macrophages. This
is in agreement with Dierich £t al.(1974) who suggested that mouse
macrophage complement receptors did not recognise C3b presumably
because of species differences in the structure of either the C3b
components or the C3b receptors or both. However by using R3, comple¬
ment receptors could be demonstrated on both mouse peritoneal macro¬
phages and guinea pig alveolar macrophages. At ^/25 dilution, 64%
human monocytes formed rosettes with EAC(R3) whereas at dilution
55% mouse peritoneal macrophages and only 17% guinea pig alveolar
macrophages were complement receptor positive by this method. Comparison
between these 3 cell types is difficult because there may be species
1
variations as suggested above and in fact using mouse serum ( /2 dilution),
60% mouse peritoneal macrophages were complement receptor positive
and using guinea pig serum (V"l200 dilution) 37% guinea pig alveolar
macrophages formed rosettes with EAC (guinea pig). Human neutrophils
and eosinophils also express fewer complement receptors than human mono¬
cytes (Anwar and Kay, 1977a). There results are in agreement with
Ehlenberger and Nussenzweig (1977) for human monocytes and Mantovani
et al. (1972) for mouse peritoneal macrophages. Although complement
receptors have been detected on alveolar macrophages from various
species/...
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species including human (Reynolds et al., 1975) and rabbit (Atkinson
et al., 1977), they have not been reported on guinea pig alveolar
macrophages to the author's knowledge.
Optimal conditions were determined for the detection of comple¬
ment receptors on human monocytes. Unlike Fc receptors, complement
receptors were not expressed at 4°C, less than half the cells which
could be shown to be complement receptor positive at 37°C, showed EAC
8
binding at 23°C. This may be a reflection of the dependence of
complement receptors on the fluidity of the membrane as suggested by
Lay and Nussenzweig (1968). In contrast Fc receptor expression does
not appear to be affected by membrane fluidity changes. Fc receptors
have been shown to be able to move in the plane of the plasma membrane
unlike complement receptors (Michl et al,, 1979). Cytochalasin B
decreased binding to Fc receptors (Atkinson and Parker, 1977) but has
less effect on EAC binding to complement receptors although other
cytochalasins had a greater inhibitory influence (Atkinson et^^l_., 1977).
Petty £t al. (1981) found that complement receptors appeared to be
arranged in clusters in the membranes of human peripheral blood mono¬
cytes and neutrophils and unlike other membrane components were
relatively immobile. These observations suggested that Fc and complement
receptors are coupled to the underlying cytoskeleton differently.
It has been reported in the literature that only activated macro¬
phages (Bianco et al., 1975) and cultured human monocytes (which are
presumed to differentiate into macrophages and become activated)
(Newman et al., 1980) phagocytose complement coated erythrocytes. The
low percentage of human monocytes which were observed eventually phago¬
cytose EAC at 37°C may represent systemically activated monocytes.
Such/...
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Such activated cells have been suggested to occur in patients with
cancer (Rhodes, 1977). C3b receptors on human monocytes were also
detected using purified human complement components instead of AB
serum. With either method at the highest concentration of complement
on the red cells, not all monocytes formed rosettes. Similarly mouse
peritoneal and guinea pig alveolar macrophages also did not appear to
be 100% positive. This may be a reflection of the amount of C3
deposited on the red cells and more sensitive assays such as immuno¬
fluorescence or radiolabelled complement components may be able to
detect more complement receptor positive cells. As with Fc receptors,
this may represent a population of cells which express complement
receptors poorly or not at all. However van Furth _et al. (1980)
reported that 88% human monocytes and 100% mouse peritoneal macrophages
expressed complement receptors. The cells involved may be immature
cells or unidentified subsets. Whether the populations of phagocytes
which express Fc receptors poorly overlap with the populations which
express complement receptors poorly is not known.
As with Fc receptors there was a direct relationship between the
amount of C3 deposited on the red cells and the number of monocytes/
macrophages forming rosettes (Figs. 7, 8 and 9). Again this may
reflect heterogeneity of cells within the mononuclear phagocyte popula-
taions with respect to complement receptor numbers or affinity or
both. As far as the author knowns no reports in the literature have
described heterogeneity of complement receptor expression on phago¬
cyte subpopulations unlike those for Fc receptors. These differences
in complement receptor expression may be important with regard to
functional differences within a given population of cells.
Human/...
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Human monocytes have been reported to express C4 receptors (Ross
and Polley, 1975) although 18,000 molecules of C4 were required to
obtain 70% monocyte rosettes compared to 2,000 molecules of C3.
However although 6,000 molecules of C4 per cell were used to detect
C4b receptors on human monocytes (an amount expected to give about
20% monocyte rosettes from Ross and Polley (1975)), no rosettes were
formed. Possibly more C4 molecules per cell were required in this
system but time and expense limited further investigation. In the
present studies no experiments were undertaken to investigate the
relationship between C3b and C4b receptors on human monocytes. Ross
and Polley (1975) showed that the same receptor on human lymphocytes
recognised both complement components since fluid phase G3, C3b and
C4 inhibited both EAC14b and EAC1423b binding to lymphocytes.
It should be noted that the amount of C4 used to prepare it
EAC1423 intermediates was limited (400 effective molecules per red
cell) so the rosettes observed with these intermediates were thought
to be entirely C3 dependent and it is highly unlikely that C4 even
contributed to a limited extent in the formation of rosettes (especially
considering that no rosettes were observed when the concentration of
C4 was increased 15 fold). Receptors for C1 or C2 were not detected
on human monocytes thus confirming the results of Gigli and Nelson
(1968).
Recently Ross and Rabellino (1979) have reported the presence of
C3b^ receptors on human monocytes and immature neutrophils and in the
present study, the presence of C3b' receptors on human monocytes was
confirmed. C3b' coated erythrocytes were prepared by using either
1
purified KAF (or C3bINA or Factor I) or with /10 dilution of AB serum
chelated with EDTA (which inhibits both the classical and alternate
pathway/...
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pathways by removing Mg ions) as a source of KAF according to the
method of Law et al. (1979a). Observations by the author suggests that
human monocytes may have higher affinity for C3b' coated cells compared
to C3b coated cells since monocytes rosettes had more erythrocytes
bound per cell and they appeared to be more tightly bound as judged by
microscopic examination.
Phagocytosis of C3b^ coated particles by cultured human monocytes
has been reported (Newman et al., 1980) and since cell bound C3b in
serum is probably rapidly cleaved to CSb'' by C3bINA (Law et al. , 1979a;
Carlo et al., 1979) C3b^ receptors on human monocytes may have more
physiological relevance under these situations. Mature neutrophils
do not appear to have C3b^ receptors probably because of the appearance
of elastase on their surfaces as they mature, which converts C3b'* on
the target particles to C3d for which neutrophils do not have receptors.
However they do possess C4b receptors (Ross and Polley, 1975; Anwar
and Kay, 1977a) and these may be funtionally important in vivo since
C4b which can be cleaved by C3bINA (Ruddy and Auste, 1971; Cooper,
1975) may be partially protected from C3bINA action by the formation
of either a short lived complex with C2 (Cooper, 1975) or with the low
molecular weight C4b binding protein (Nagasawa and Stroud, 1978). Thus
the C4b sites may be preserved for a sufficient length of time to allow
binding of antigen-antibody complexes to the immune adherence (C3b and
C4b) receptor bearing phagocyte. The presence of C5b receptors on
human neutrophils (Segerling and Opferkuch, 1977) may be important
in vivo for similar reasons. However as discussed in the Introduction,
Part 8.0, natural activators of the alternate pathway of complement
such as bacteria and yeast, have a high affinity for factor B and a
low/...
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low affinity for 81H (Pangburn _et al. , 1980; Kazatchkine et al.,
1979) unlike erythrocyte target cells which are more likely to partici¬
pate in the lytic pathway of complement. It seems probable that with
both yeast and bacteria, C3b can act as an effective opsonin despite
the presence of C3b1NA. Therefore both C3b and 03^ receptors on
human monocytes (or other phagocytes) are important in different
situations - alternate pathway activators being removed via C3b receptors
and nonactivators which have been coated with complement via the
classical pathway, being removed by C3b" receptors.
C3b^ is very susceptible to cleavage by proteolytic enzymes and
EAC1423d was prepared by treating EAC1423b>' with a low concentration
of trypsin. Human monocytes did not form rosettes with these indicator
cells, confirming the results of Ross and Rabellino (1979). However
Carlo et al. (1979) found that EAC3d attached to human monocytes.
1.5 Lectin-like receptors
Optimal conditions were determined for the binding of unopsoriised
bacteria, Staph, albus, to human peripheral blood leukocytes, mouse
peritoneal macrophages and guinea pig alveolar macrophages. Even at
the highest possible concentration of organisms human leukocytes did
not show more than 25% binding (Fig. 11). This may be a reflection of
the assay system in that there was a limit to the number of bacteria
which could be overlaid or it may be that only a small subpopulation
of these cells express "lectin-like" receptors. Similar results were
also found with mouse peritoneal blood monocytes (Dougherty, Stewart,
8 —1
Glass and Weir, unpublished observations). At 10 bacteria.ml , the
degree of binding for peritoneal macrophages from CF1 mice and guinea
pig alveolar macrophages plateaued (Fig. 11) and although both these
cell/...
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cell types showed a much higher level of binding than did peripheral
blood leukocytes, 100% binding was never observed. Similarly mouse
peritoneal macrophages from other species did not express "lectin-
like" receptors on all their cells (Glass et al., 1981b).
There may be subpopulations which do not express these receptors or
express low affinity receptors. Work in progress in this laboratory
has shown that mouse peritoneal macrophages which have been elicited
by an intraperitoneal injection of C. parvum (0.25mg/mouse) 4 days
previously had significantly lower expression of "lectin-like"
receptors as measured by Staph, albus binding. This suggests that the
altered expression may represent the influx of monocytes from the
blood which apparently have lower levels of receptors. The macrophages
present in the peritoneal exudate population which are actually
activated may or may not have altered receptor expression compared to
resident peritoneal macrophages. Further work to investigate these
possibilities (by separating out the putative subpopulations) is
currently being undertaken. These results are in general agreement
with those found by Ogmundsdottir et al. (1976) and Freimer et al.
(1978) who found that "lectin-like" receptors were present on C3H
mouse peritoneal macrophages. Lectin-like receptors were demonstrated
by the binding of various bacteria including Staph.albus at 4°C for
2 hours which the author assumed would be the optimal conditions for
the other phagocytes tested for the presence of these receptors.
However it is possible that binding at 37°C may have indicated that
more cells expressed these receptors especially since H. Ogmundsdottir
(Ph.D. thesis, 1979) showed that they were temperature dependent in
that more bacteria bound per cell at higher temperatures. Also,
different/...
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different phagocytes may preferentially recognise strains of bacteria
other than Staph, albus. In the present studies no experiments were
undertaken to investigate these possibilities.
Staph, albus binding to C3H mouse peritoneal macrophages was
inhibited by certain monosaccharides (Freimer et al., 1978) and similar
experiments were carried out with various other phagocytes (Figs. 12
and 13). D-glucose and D-galactose which are present in the cell wall
of Staph, albus, reduced the attachment of this micro-organism to all
phagocytes tested except neutrophils at 10 and 20 mM concentrations.
No obvious differences in the inhibition patterns were observed. Higher
concentrations than 20 mM had variable effects which were probably due
to nonspecific alterations of the leukocyte membranes rather than
specific effects on the lectin-like receptors. Van Oss (1978) suggested
that the inhibitory effect of glucose on the phagocytic activity of
neutrophils was due to the influence of this monosaccharide on cell
shape. He observed that concentrations greater than 11 mM led to the
withdrawal of pseudopods and the cells became spherical. Glucose
may have increased the negative charge on the surface of the neutrophil
membranes and therefore increased repulsive forces. It should be
noted that both the glucose and galactose solutions were iso-osmolar and
20 mM is only 4 times the normal level in body fluids. At the highest
concentration of sugars used, 100% inhibition was never observed, and
was usually between 20 and 50%. Binding of bacteria may take place
by other sugar components when one of them is blocked although experi¬
ments in which more than one sugar was added at the same time to the
macrophage monolayers were inconclusive (J. Stewart, personnal commun¬
ication) . The bacteria may also be binding to the phagocyte surface
by mechanisms independent of the recognition of these sugars. Non¬
specific/. . .
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specific binding involving hydrophobic and other membrane biomechanical
forces may contribute to the adherence observed (Wilkinson, 1976). In
some bacteria such as E. coli, S. typhimurium and C. parvum lectins are
present in the bacterial cell wall itself. These are specific for
mannose and appear to bind to that sugar on tissue cells (Ofek _et al.,
1977; Bagg et al., 1981). It is also probable that oligosaccharides
would be more inhibitory in the present system because more interactions
between ligand and receptor could be generated. Such considerations
are bourne out by the findings of Schlepper-Schaffer et al. (1980).
They found that desialated orosomucoid was 30 to 40 times more inhibitory
than monosaccharides in reducing the binding of neuraminidase treated
erythrocytes to rat peritoneal macrophages.
Attachment of Staph, albus to human neutrophils (and guinea pig
peritoneal neutrophils (Glass et al., 1981b)) was not inhibitable by
D-glucose at any of the concentrations tested suggesting that the "lectin-
like" receptors on neutrophils may be different from these on other
cell types. It is likely that the neutrophil receptors have a different
role from those on macrophages and as suggested above they may prefer-
erentially recognise bacteria other than Staph, albus. Neutrophil
"lectin-like" receptors may be important in the early stages of the
inflammatory response in the removal of non-opsonised bacteria whereas
macrophage "lectin-like" receptors are likely to be involved in the
presentation of antigen leading to an immune response. Co-workers and
the author have found that binding of Staph, albus to mouse peritoneal
macrophages can be blocked by pretreatment of the monolayers with
conventional and monoclonal antisera directed against la antigens of
the H-2 system (Stewart at al., submitted for publication). The role
la antigens in the co-operative cell interactions in the immune response
(see/...
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(see Introduction, Part 4.0) is in support of the antigen presenting
role of the "lectin-like" receptors on macrophages and their association
with la antigens.
The in vivo importance of bacterial recognition by "lectin-like"
receptors is also suggested by studies on diabetic mice (Weir et al.,
1981). Increased blood glucose levels appear by partially blocking the
"lectin-like" receptors on leukocytes to make the animals more suscep¬
tible to infection by a glucose terminated mutant of.S. typhimurium
associated with a reduced ability of mouse peritoneal macrophages to
bind this organism (Freimer et al., 1978).
Although peripheral blood neutrophils expressed a comparatively
low level of "lectin-like" receptor expression it is possible that
neutrophils in an inflammatory response may express more receptors or
receptors, with higher affinity for non-opsonised bacteria. The
differences between neutrophil and macrophage receptors with respect
to sugar specificity may also be because they recognise different
species of bacteria. This is borne out by the results of D. Kinane
(unpublished observations) who found that unopsonised N. gonorrhoea
adhered to 70% human peripheral blood neutrophils and only to 30%
8
human monocytes at the same concentration of organisms (10 N. gono-
-1
rrhoea.ml ). This is probably not surprising in view of the fact
that neutrophils are the major phagocytic cells involved in the
inflammatory response to obligate extracellular bacteria as typified
by pyogenic streptococci and staphylococci. Mononuclear phagocytes on
the other hand are of great importance in the defence against both
obligate and facultative intracellular parasites such as Mycobacterium
leprae and Toxoplasma gondii.
Eosinophil/...
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Eosinophil "lectin-like" receptors appeared to have the lowest
affinity for Staph, albus of all the cell types tested. Eosinophils
also express fewer Fc and complement receptors than neutrophils or
mononuclear phagocytes (Anwar and Kay, 1977a). This may explain their
relatively poor phagocytic response which is slower than neutrophils
in terms of the rates of ingestion (reviewed by Kay, 1974) and therefore
it is unlikely that eosinophils play a major role as phagocytic cells.
At present evidence suggests that eosinophils are important in immediate-
type hypersensitivity reactions and they may be the principle cytotoxic
killer cells in helminthic disease (reviewed by Kay, 1979). These
processes presumably involve recognition mechanisms enabling contact
between eosinophils and target cells such as Schistosoma mansoni which
may depend not only on immunoglobulin and complement (Anwar and Kay,
1979) but also on "lectin-like" receptors recognising putative sugar-
specific residues on the helminth surface. Antibodies directed against
Schistosoma mansoni cross reacted with glycoprotein antigens (with an
approximate 2:1 ratio of carbohydrateiprotein) of Fasciola hepatica
suggesting that similar glycoproteins are also expressed on the surface
of S, mansoni (Hillyer and Sagramoso de Ateca, 1979). This hypo¬
thetical recognition system could be important in innate resistance to
helminth infections which all mammalian species exhibit to some extent.
Ellner and Mahmoud (1979) have shown that human monocytes have the
capacity to kill S. mansoni, in vitro independently of antibody and
complement.
The relationship between the "lectin-like" receptors described in
this thesis and similar receptors reported by other workers (Stahl et: al. ,
1978; Kolb and Kolb-Bachofen, 1978; Muchmore and Blaese, 1979) is not




studies and also probable differences in function (see Introduction,
Part 12). For instance desialated sheep red blood cells bind to a
trypsin sensitive receptor on human monocytes which may recognise
D-galactose expressed on the surface of the desialated erythrocytes
although Czop et al, (1978) did not actually show that this was the
mechanism of attachment. These desialated red cells also bind to
rat peritoneal macrophages and Kupffer cells by a pronase-sensitive
galactose-specific "lectin-like" receptor (Kolb and Kolb-Bachofen,
1978; Nagamura and Kolb, 1980). Staphs albus and desialated erythro¬
cytes may be recognised by the same receptor but some initial experi¬
ments by the author and co-workers were equivocable. Certain cell
types appear to express receptors for Staph, albus and not for
desialated red cells, and sugar inhibition studies with desialated
erythrocytes did not confirm sugar specific binding.
Bacterial attachment through "lectin-like" receptors to mouse
peritoneal macrophages is followed by phagocytosis when the preparations
are allowed to warm up to 37°C (Weir and Ogmundsdottir, 1980). It is
not known whether the receptors on the other phagocytes examined in
this thesis also mediate phagocytosis. Peripheral blood leukocytes
express markedly fewer receptors than other cell types tested and
possibly insufficient ligand-receptor interactions may occur to allow
phagocytosis via the "zippering mechanism" of Griffin et al.. (1975b)
to take place. Although complement is not present in the experimental
system used, the possibility that complement components produced by
macrophages and also expressed on their surfaces (Brade and Bentley,
1980) are involved in the phagocytosis of unopsonised bacteria cannot
be excluded. Michl et: al_. (1976) was able to distinguish between phago¬
cytosis via Fc and complement receptors and phagocytosis by nonspecific
receptors/...
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receptors for latex and zymosan (which may in fact be specific sugar
recognising receptors, see Introduction, Part 12). They found that
2-deoxyglucose inhibited phagocytosis through Fc and complement
receptors but had no effect on ingestion of unopsonised particles.
Since internalisation via complement receptors is clearly a separate
event from phagocytosis by other receptors it would seem probable that
ingestion of unopsonised bacteria is indeed independent of complement.
However phagocytosis by "lectin-like" receptors and complement receptors
may be synergistic as has been suggested for Fc and complement receptors
(Ehlenberger and Nussenzweig, 1977). Putative "lectin-like" receptors
on human monocytes which recognise desialated erythrocytes were found
to act synergistically with complement receptors in inducing phagocytosis
of complement coated desialated sheep red cells (Czop et al., 1978).
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2.0 EFFECTS OF CHEMOATTRACTANTS AND OTHER PHARMACOLOGICAL MEDIATORS
ON MONONUCLEAR PHAGOCYTES
2.1 Effects of chemotactic factors on C3 and Fc receptor, expression
Using the rosette technique it was shown that the expression of
complement but not Fc receptors on human monocytes, mouse peritoneal
macrophages and guinea pig alveolar macrophages were enhanced by
chemoattractants in a dose- and time-dependent fashion (Figs. 14-23).
These observations confirm and extend the previous studies on the
eosinophil (Anwar and Kay, 1977b, 1978) which indicated that complement
receptor enhancement by agents which promote cell locomotion might be
a general biological phenomenon of phagocytic cells.
A major disadvantage of using the rosette technique in these studies,
is the difficulty in measuring the degree of binding between the phago¬
cyte membrane and individual indicator erythrocytes. For instance
treatment with various chemoattractants not only increased the percentage
of monocytes having 3 or more adherent red cells but the erythrocytes
appeared to be more firmly attached than that observed in the untreated
controls and also more red cells were bound per cell. This suggests
that chemotactic factors may increase the numbers of complement receptors
per cell or the affinity of the receptors for their ligands or both.
The percentage of monocyte complement rosettes can be plotted against
the concentration of complement coating the indicator red cells as shown
in Figs. 7, 8 and 10. By comparing the profiles of such graphs using
control monocytes/macrophages and chemoattractant stimulated cells,
further information into the alterations of complement receptor expres¬
sion and avidity may be obtained. Possible alterations in the numbers
of red cells bound per phagocyte could also be examined. However the
indicator cells are relatively large and steric hinderance effects may
be/...
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be important. More sensitive assays possibly using radiolabelled
complement components would overcome these problems and Scatchard plots
could be drawn which would allow the number of receptors per cell and
the affinity of. these receptors to be calculated. Initial attempts
using fluid phase C3 and radiolabelled anti-C3 were unfortunately
1 25
unsuccessful possibly because the radiolabel I was not properly
associated with the antibody.
Dose response curves and the time course of enhancement of human
monocyte complement receptors by casein using EAC or EAC1423b as indicator
cells were very similar (Figs. 14 and 15) suggesting that CR^ expression
is enhanced by chemotactic factors.
It should be noted that the amount of complement of IgG on the
indicator red cells was limited to give about 25-35% rosettes in the
untreated (control) monocyte/macrophage preparations. Even when optimal
conditions were used for complement receptor enhancement it was unusual
to achieve greater than 75% rosettes. In other words the degree of
enhancement was not directly proportional to the control level of
complement rosettes. Whether the control level of monocyte rosettes
was 20% or 50%, chemotactic factors such as casein or f-Met-Leu-Phe
increased the expression of complement receptors to a similar level
i.e. between 60 and 70% rosettes. This suggested that not only was
there a population of monocytes which express complement receptors
poorly as discussed previously in Part 1*4 but possibly the same popu¬
lation also has a diminished response to chemotactic factors as well.
Similar results were also found with mouse peritoneal macrophages.
These results are essentially in agreement with those of Cianciolo and
Snyderman (1981) who found that there is a subpopulation of human mono¬
cytes, consisting of about 60% of the total population of monocytes,
which/...
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which is capable of responding to any chemotactic factor. The remaining
monocytes were unresponsive to all chemotactic factors. The patterns
of enhancement by f-Met-Leu-Phe on each of the 3 cell types studied was
different. Guinea pig alveolar macrophages showed the highest response
although this was probably a reflection of the relative paucity of
complement receptors on these cells (see Discussion, Part 1.5). With
all the other phagocytes examined the amount of complement on the red
cells was limited to give between 25 and 35% rosettes, but only 17%
guinea pig alveolar macrophages expressed complement receptors with the
highest possible concentration of R3. However after incubation with
-7 -1
10 moles.1 f-Met-Leu-Phe, 37% of these cells formed rosettes with
EAC(R3) suggesting that there was a population of guinea pig alveolar
macrophages which only expressed complement receptors after treatment
with f-Met-Leu-Phe (at least under the conditions used here since it
may be significant that 37% of these cells formed rosettes with EAC
prepared with guinea pig serum).
Mouse peritoneal macrophages required a lower concentration of
f-Met-Leu-Phe to elicit a response than that required by guinea pig
—8 —1
alveolar macrophages or human monocytes. However at 10 moles.1 ,
mouse peritoneal macrophages had a diminished response to f-Met-Leu-Phe
whereas human monocytes and guinea pig alveolar macrophages had a
-9 -1
higher response at this dose than at 10 moles.1 (Figs. 17, 21 and
23). High dose inhibition was also observed with human monocytes at
-10 -1
10 moles.1 both in terms of chemotaxis and further complement
receptor expression (results not shown). Internalisation of ligands and
post receptor blockade may lead to deactivation of cells so that they
can no longer respond to chemotactic factors (Vitkauskas et al., 1980).
This is probably important in retaining cells at the site of inflammation.
Paradoxically/...
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Paradoxically high dose inhibition of complement receptor enhancement
would be disadvantageous in a local inflammatory response; however
this observation is possibly an artefact of the in vitro system. It
can be envisaged that in vivo macrophages will arrive at an inflammatory
focus with a high level of complement receptor expression as a result
of stimulation by chemoattractants. Thus maximal complement receptor
expression will have been attained by the time these cells are exposed
to inhibitory concentrations of chemotactic factors. In the in vitro
experimental system employed the cells with relatively low levels of
complement receptors were immediately exposed to an inhibitory dose of
chemoattractant and would thus be prevented from attaining further
complement receptor enhancement. Alternatively it may be that in vivo
such high levels of chemotactic factors may not occur. It should be
noted that such high levels of chemoattractants did not decrease cell
viability as assessed by trypan blue dye exclusion.
Casein on the other hand, was not as effective as f-Met-Leu-Phe in
inducing complement receptor enhancement on mouse peritoneal macrophages
as it was on human monocytes (Fig. 16 and 22). The observed differences
in response to chemotactic factors by each of the cell types may be
a reflection of the number of chemotactic receptors present on their
surface membranes.
As discussed previously there may be changes in membrane properties
after the cells have adhered to a substratum. However essentially
similar results were obtained when mouse peritoneal macrophages were
incubated with f-Met-Leu-Phe in suspension or as monolayers (Figs. 21
—8 — 1
and Table III) although at the highest concentration used (10 moles.1 )
a greater degree of enhancement was observed with the mouse macrophage
monolayers compared to the suspensions. Thus these adherent cells do
not/...
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not show high dose inhibition unlike the same cells in suspension.
Although it is not as yet known whether other cells do not show high
dose inhibition when they are adherent, this observation gives further
credence to the idea that high dose inhibition may not be important
in vivo. Wilkinson and Allan (1980) have made in vitro observations
of human monocytes moving in response to chemotactic factors and have
concluded that locomotion is a substratum-determined phenomenon
(although sensing of the chemotactic gradients is not). Chemotaxis,
phagocytosis and adherence by leukocytes involve similar processes in
that in all three cases protrusions of motile membrane are formed.
Dierich et al. (1977) have found that chemotactic factors had to be
surface bound before cells would undergo chemotaxis in vitro and they
suggested that in vivo cells would move up a concentration gradient of
chemoattractant by systemically attaching and dissociating from surface-
bound chemotaxins. Thus the response of adherent macrophages to chemo¬
tactic factors may be more relevant to the in vivo situation.
Heterogeneity of populations of monocytes and other macrophages was
first described by Walker (1976b) and varying responses to chemotactic
factors by different populations of monocytes has been demonstrated
(Arenson et al., 1980; Cianciolo and Snyderman, 1981). The ability of
monocytes and macrophages to respond to chemoattractants and show
enhanced expression of complement receptors appears to be another
functional difference between putative subsets of macrophages.
F-Met-Leu-Phe binds to neutrophils very rapidly (Aswanikumar
et al. , 1977; Williams et_ al., 1977) and within 5 minutes most of the
receptor sites are occupied. However binding of F-Met-Leu-Phe to
guinea pig peritoneal macrophages appeared to be slower, saturating at
about 20 minutes (Snyderman and Fudman, 1980). Complement receptor
enhancement is also relatively rapid (Figs. 15, 16 and 18) and would
appear/...
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appear to be an almost immediate consequence of chemotactic factors
interacting with their receptors on the leukocyte membrane. The effects
of f-Met-Leu-Phe on human leukocytes appears to depend on the cell
_8
type involved (Fig. 18). Neutrophils were maximally enhanced at 10
moles.1 1 (Kay ejt al., 1979) whereas monocytes required a higher concen¬
tration (10 ^ moles.1 ^) (Fig. 17) and eosinophils also required this
higher dose of f-Met-Leu-Phe to show a maximum response. Neutrophil
complement receptor enhancement was the most rapid and eosinophil, the
slowest. These differences in rates may reflect the kinetics of
chemotactic factor binding. The observed increase of complement
receptor expression by human eosinophils with f-Met-Leu-Phe was much
faster than that reported by Anwar and Kay (1978) for ECF-A or histamine.
The number of chemotactic factor binding sites present on the phagocyte
membrane may determine the rate of response as is indicated by the
results shown in Fig. 16. Since the rate of enhancement of human mono¬
cyte complement receptors was directly proportional to the concentration
of casein, this suggests that the number of ligand-receptor interactions
determines the rate as well as the degree of response to chemotactic
factors. The slower rate of enhancement by eosinophils may also be a
reflection of the lower density of C3b receptors found on these cells
(Anwar and Kay, 1977a).
The capacity of casein to attract human monocytes and other leuko¬
cytes in directional and random migration is well established (Keller
and Sorkin, 1967b) and it therefore seemed reasonable to use this agent
in many of the experiments described in this thesis. However a number
of other agents with chemotactic activity for monocytes gave comparable
increases in the percentages of complement rosettes (Figs. 17 and 19).
These included supernatants from lymphocytes cultured in the presence of
phytohaemagglutinin/...
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phytohaemagglutinin (PHA) (Snyderman et al.f 1972), a supernatant from
C. parvum (NCTC 10390) (Wilkinson et al., 1973) and several formyl
methionyl peptides (Showell et al., 1976). All these chemoattractants
have very different physicochemical properties; casein is an amphipathic
protein with a molecular weight of about 20,000 daltons (Wilkinson, 1972),
the C. parvum derived chemotactic factor appears to be lipid in nature
(Russell et al., 1976), the chemotactic agent in the supernatant of PHA
stimulated lymphocytes is a protein with a molecular weight of 12,500
daltons (Altman et al., 1974), and the formyl methionyl peptides are
relatively small molecular weight (200-300 daltons) amphipathic chemo¬
attractants (Wilkinson, 1979). Snyderman et al. (1972) found a certain
amount of monocyte chemotactic activity in supernatants from unstimulated
lymphocytes. In the present studies the highest concentration of the
unstimulated supernatants also gave enhancement of monocyte complement
rosettes. Kay et al. (1979) have shown that f-Met peptides promoted
monocyte migration in vitro and it appears that both chemotaxis and
complement receptor enhancement occured in parallel. This is indicated
by the observation that increasing the concentrations of f-Met peptides
promoted concomitant increases in both the degree of complement receptor
enhancement and the number of monocytes migrating through micropore
filters. In contrast the unformylated peptides Met-Leu-Phe and Met-Met-
Phe were inactive in both biological systems suggesting that the
specificity for formylation applies to both complement receptor enhance¬
ment and locomotion. Studies on the relative chemotactic activities
of various f-Met peptides have previously been reported for neutrophils
(Showell et al., 1976) - f-Met-Leu-Phe > f-Met-Met-Phe > f-Met-Phe and
similar results were obtained in these studies (Kay et al., 1979).
However/...
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However no previous work comparing the relative potencies of these
peptides for human monocyte chemotaxis had been undertaken. With mono¬
cytes about 100 fold more of these peptides was required to give
comparable biological effects to that of the neutrophil. Furthermore
with human monocytes f-Met-Phe had similar potency to f-Met-Met-Phe
both in cell locomotion and rosette enhancement. This is in contrast
to the report by Showell et al. (1976) in which F-Met-Met-Phe was
1900 fold more active than F-Met-Phe in promoting chemotaxis of rabbit
neutrophils. These observations all support the view that there is a
direct relationship between cell locomotion and enhancement of comple¬
ment receptors. It has been shown that casein (Keller and Sorkin,
1967b), the f-Met peptides (Showell et al., 1976) and the C. parvum
chemotactic factor (Russell et al., 1976) promote directional migration
as well as increasing the rate of cell movement. Human serum albumin
which is chemokinetic but not chemotactic (Wilkinson et al., 1977)
also increased complement receptor expression on human monocytes (Fig. 20)
suggesting that complement receptor enhancement is dependent on the
chemokinetic principle of chemoattractants rather than the chemotactic
principle. Thus agents which increase cell movement are important in
inducing increased expression of complement receptors on phagocytic
cells.
The apparent inability of casein or f-Met-Leu-Phe to alter Fc
receptors for IgG on human monocytes, mouse peritoneal macrophages or
guinea pig alveolar macrophages (Figs. 15, 21 and 23) is in agreement
with previous observations on the eosinophil where chemoattractants
affected the expression of complement but not Fc receptors (Anwar and
Kay, 1977b, 1978). Similarly Goetzl et al. (1980) showed that HETE's
increased/...
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increased complement but not Fc receptor expression on human eosinophil
and neutrophil membranes. The reasons for these apparent differences
between complement and Fc receptors is not clear at present but may be
explained by the experimental procedure. For instance optimal Fc (IgG)
rosettes were obtained at 4°C whereas 37°C is used for detection of
complement receptors. Also, in the time course experiment with human
monocytes (Fig. 15) a slight increase in Fc receptors was found but
this was not statistically significant. It is possible that there may
only be changes in affinity and not changes in numbers of Fc receptors
and this may not be detected in the present assay system. Further
studies using more sensitive techniques (e.g. immunofluorescence or
radiolabelled IgG) will be required before more definite conclusions
can be reached. Recent work by Capron et al. (1981) has shown that
eosinophil Fc receptors are increased following stimulation with the
chemotactic factors, ECF-A and histamine whereas neutrophil Fc
receptors are often decreased after incubation with these substances.
The reasons for these discrepancies between this work and previous
work by Anwar and Kay (1978) and Goetzl et al. (1980) are not clear
especially since they were using the same assay system. Gapron _et al.
(1981) suggested that the eosinophils which they were using were from
patients with slight eosinophilia whereas those which Anwar and Kay
(1978) used were from patients with more severe eosinophilia and there
may have been more immature cells present, possibly with deficient
Fc receptors. However this does not explain the observations that Fc
receptors on macrophages are not affected by chemoattractants. It may
be that although Fc receptors are enhanced by chemotactic factors, they
are also shed during the incubation period with the chemotactic agents
and/...
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and therefore no increase in Fc receptor expression would be observed.
Fc receptor shedding by human lymphocytes has been reported (Sandor
et al., 1979) and there appeared to be two populations of Fc receptors,
one which was shed and one which remained on the membrane. It may be
that chemotactic factors preferentially increase Fc receptors which
are then shed and/or increase the shedding rate.. Detection of Fc
receptor material in the medium (by blocking Fc rosettes of Fc receptor
bearing cells) would clarify this point.
Fc receptors for IgM and C3b> receptors on human monocytes are
also apparently unaffected by chemoattractants (Tables IV and V).
Since increases in these receptors were not observed using red cells
sensitised with IgM, it is further confirmation that increased C3b
rosette formation is due to enhanced complement receptors (CR^) and
not Fc (IgM) receptors. Thus chemotactic agents do not expose cryptic
binding sites of the Fc portion of IgM unlike Vibrio eholerae neura¬
minidase which apparently had this effect on rabbit and human monocytes
(Haegert, 1979a, b; this thesis, Fig. 5). Since no enhancement of
rosettes with EAC1423b^ cells was detected, presumably CR^ are not
affected nor are cryptic CR^ expressed after incubation with chemotactic
agents.
Thus there appears to be a selective enhancement of C3b receptors
(CR.j) by chemotactic or chemokinetic agents.
Following incubation with certain lymphokines, cultured macrophages
were found to have augmented the functional capacity of their complement
receptors in that the cells could phagocytose via complement receptors
as well as bind complement coated particles (Griffin and Griffin, 1980).
It is possible that this lymphokine has similar effects as chemotactic
factors/...
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factors as observed in the author's system. Increasing the numbers
of complement receptors on the surface of the macrophages and thereby
increasing the number of points of attachment may allow phagocytosis
to occur via the "zipper mechanism" as suggested by Griffin _et al.
(1975b) and Shaw and Griffin (1981) for Fc receptors. It is not as
yet known whether chemotactic factors also increase phagocytosis of
EAC by monocytes and macrophages as well as enhancing the binding of
these indicator red cells.
Since lymphocytes are also present with some of the cell prepar¬
ations chemotactic agents may be exerting their effects on the lympho¬
cytes and inducing lymphokine production which may then have an
enhancing effect on the complement receptors of- other leukocytes
present. However this is highly unlikely since (a) no lymphocytes are
present in the granulocyte preparations and their complement receptors
are enhanced by chemoattractants and (b) lymphokine production by
lymphocytes requires 2-3 days in culture, whereas the effects of chemo¬
tactic factors are evident within 5 minutes of incubation.
2.2 Effects of chemoattractants on "lectin-like" receptors
Concomitantly with the increase in complement receptors on mouse
peritoneal macrophages, the expression of "lectin-like" receptors is
decreased. The dose response curves for enhancement of complement
rosettes (Figs. 21 and 22) and inhibition of binding of Staph, albus
(Fig. 24) by f-Met-Leu-Phe and casein are very similar, suggesting that
there is a direct relationship between these events. In view of the
established specificity of the "lectin-like" receptors for mono¬
saccharides such as glucose and galactose (Figs. 12 and 13) it is
unlikely/...
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unlikely that the receptor is being directly inhibited by the formylated
peptide or casein. The "lectin-like" receptor and the binding sites
for these chemotactic factors may be closely related and internalisation
of the chemoattractant receptors (Vitkauskas et al.-, 1980; Niedel et al.,
1979) may also lead to the loss of the "lectin-like" receptor. Many
cell surface receptors are greatly reduced in number (down regulation)
after exposure of the cells to their ligand particularly in the case
of hormones and other substances inducing considerable changes in
their target cells (Tulkens et al., 1980).. Mouse peritoneal macro¬
phages elicited by intraperitoneal injection of C. parvum 4 days
previously also have decreased lectin-like receptor expression
(Dougherty, Glass, Stewart and Weir, unpublished observations) sugges¬
ting that activated macrophages may also have decreased expression of
these receptors. However it is not as yet clear whether the effects
observed are due to the increased influx of blood monocytes which have
fewer "lectin-like" receptors or whether activated macrophages do have
decreased expression. Stahl et al. (1980) have shown that mannose-
specific "lectin-like" receptors on rat alveolar macrophages are
continuously being recycled from the plasma membrane to lysosomal
membranes and back again to the plasma membrane, either in the presence
or absence of ligand. It is possible that the "lectin-like" receptors
described here also undergo recycling and it may be that chemotactic
factors increase both the rate of recycling and the intracellular pool
such that there is an apparent decrease in surface receptors. When
both the ligand (bacteria) for the lectin-like receptor and the chemo¬




2.3 Effects of pharmacological mediators on complement receptor
expression
The effects of various pharmacological mediators on monocyte
complement receptors were also examined.
Prostaglandins are involved in inflammatory reactions and are
synthesised and secreted by macrophages (Bray, 1980; Bonney et al.,
1980). In vivo prostaglandins of the E-series may be particularly
important since they regulate leukocytes under physiological conditions
(Gordon et al., 1976) and would appear to be the major prostaglandin
produced by macrophages in response to inflammatory stimuli (Bonney
et al_., 1980; see also Introduction, Part 4»0) . They bind to human
leukocytes possibly via specific receptors (Bourne and Melmon, 1971)
and influence various macrophage functions. For instance PGE^ enhanced
the specific activity of 5^ nucleotidase and acid phosphatase in
cultured human monocytes particularly in a subpopulation of monocytes
which were low density cells with a low specific activity of 5^ nucleo¬
tidase. This subpopulation of cells also secreted substantial amounts
of PGE2 compared to high density macrophages and it appeared that this
endogenous PGE2 was involved in the activation of monocytes in vitro
(Picker et al., 1980). Prostaglandins E^ and E^ were chemotactic for
mouse peritoneal macrophages at relatively high concentrations (3 x
—6
10 M) and inhibited spreading and adherence at lower concentrations
—8
(3 x 10 M) (Cantarow et al., 1978). However Gallin _et al. (1978) found
that PGE.J inhibited monocyte chemotaxis at a concentration of 1.4 x
-5
10 M. Phagocytosis of IgG coated particles by mouse peritoneal macro¬
phages was enhanced by PGE,, PGF, , PGF ' and PGA, (Razin et al., 1978).1 1a 2a 1




monocyte complement receptors (Fig. 26). At 10 M, PGE.^ showed maximal
activity whereas PGE^ had peak activity at 10 ^M. Thus these results
are as might have been expected from the chemotactic response to these
agents (Cantarow_et_al., 1978). It is of interest to note that PGE^ at
-5 -1
10 moles. 1 had a diminished effect on monocyte complement receptors
and also had a lower enhancing effect on phagocytosis of EA by macro-
phages (Razin _et al., 1978) and also inhibited monocyte chemotaxis
in vitro (Gallin et al., 1978). These results are in contrast to those
of Atkinson et al. (1977) who found that 3 x 10 PGE^ caused slight
inhibition of adherent rabbit alveolar macrophages.. The contrary results
observed may be due to species differences or to differences between
adherent cells and cells in suspension. PGF2a ^ad no effect on macro¬
phage chemotaxis, adhesion or spreading even at the highest concentrations
tested (10 ^M) (Cantarowjst al., 1978). However it has been shown that
-4 -1
PGF„ enhances leukocyte chemotaxis (Hill, 1978) and at 10 moles.1
za
PGF^ was found to enhance monocyte complement receptor expression.
Histamine receptors are reported to be present on guinea pig
alveolar macrophages and on other phagocytes (Diaz et al., 1979).
Similar results have been found on human peripheral blood monocytes
(Lesley M. Smart, unpublished observations). It is of interest to
note that histamine apparently increased the phagocytic capacity of
rat macrophages (Jancso, 1947). Although the numbers of histamine
receptors were not altered in atopic individuals (L.M. Smart, unpub¬
lished observations) complement receptor enhancement was apparently
altered in these individuals in response to histamine (Fig. 28). Mono¬
cytes from normal individuals were generally either unaffected by
histamine or showed decreased complement receptor expression whereas
many/..„
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many of the atopic patients had increased complement receptors on
their monocytes. Neutrophil complement receptors on cells from atopic
and non-atopic individuals showed varying responses to histamine which
is in contrast to the results of Anwar and Kay (1978) who found that
histamine had no effect on neutrophil complement receptors. The
reason for these discrepancies are not clear but in the author's
study the neutrophils came from normal individuals and patients with
slight eosinophilia whereas those of Anwar and Kay (1978) were from
patients with more severe eosinophilia and they may also have other
leukocyte defects.
A study by the author and co-workers (Glass et al., 1981a) has
suggested that complement receptors may be altered on monocytes in
neoplastic disease. The response of monocytes in chemotaxis is
diminished in patients with cancer (Boetcher and Leonard, 1974;
Hausman et al., 1975), particularly when metastases are also present
(Kay and McVie, 1977) and Fc receptors are also altered in cancer
patients (Rhodes, 1977). Low molecular weight fractions from human
lung cancer specimens, whilst having no effect on complement receptors
on normal human monocytes per se, prevented the enhancement of these
receptors in response to chemotactic factors. Thus quantitation of
complement receptor enhancement might provide a further variable for
studies of monocyte function in health and disease.
Bradykinin, a basic nonapeptide, is one of the vasoactive plasma
kinins. It is detectable in tissues in experimental anaphylactic
shock and has a slower action compared to that of histamine. In vitro
—5 —6
at relatively high concentrations (10 to 10 M) bradykinin inhibited




(10 to 10 M) it enhanced spreading (Fauve and Hevin, 1977) sugges¬
ting that macrophages may have bradykinin receptors. Agents which
increase the spreading activity of cells also inhibit chemotaxis
(see Introduction, Part 5.10). Although the effects of bradykinin on
mononuclear phagocyte chemotaxis have not been reported, at the concen¬
trations which inhibited macrophage spreading (and therefore might be
expected to enhance chemotaxis) also increased the expression of human
monocyte complement receptors, whereas at 10 which increased
spreading a lower level of complement receptor enhancement was observed.
Numerous reports have suggested that increased intracellular
levels of cyclic AMP (cAMP) inhibit their functions (see Bourne et al_. ,
1974 for a review). Cyclic nucleotide changes may also be involved
in the response of leukocytes to chemotactic factors and as discussed
below, prostaglandins, histamine, and bradykinin may be mediating their
effects on complement receptors by affecting cyclic nucleotide levels
in the leukocytes. • Simchowitz et al. (1980) has reported that chemo-
attractants induce a transient increase in intracellular cAMP in
neutrophils, although agents which lead to a generalised increase in
cAMP are inhibitory in chemotaxis; cGMP agonists, on the other hand,
enhanced locomotion (Hill, 1978).
PGE,j increased cyclic AMP levels in human monocytes (Gallin et al.,
1978) and both PGE.^ and pGE2 have been shown to increase adenyl cyclase
activity in human leukocytes (Bourne and Melman, 1972) and peritoneal
macrophages (Grunspan-Swirsky and Pick, 1979). B adrenergic receptors
have been demonstrated on rat peritoneal macrophages (Ikegami, 1977) and
human leukocyte intracellular cAMP levels.were increased after iso-
prenaline had interacted with specific cell membrane 8 adrenergic
receptors/...
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receptors linked to membrane bound adenyl cyclase (Bourne and Melman,
1971). Propanolol, a 8 adrenergic antagonist, inhibited the effects
of isoprenaline but not PGE^ or effects on cAMP levels, and the
effects of prostaglandins and isoprenaline were not additive,
suggesting that they act on separate receptors but activate the same
adenyl cyclase.
Ito et al. (1977) found that 8 adrenergic agents such as isopren¬
aline increased mouse splenic lymphocyte complement, receptors with
—6
peak activity at 10 M whereas dibutyrl cAMP or aminophylline (a phos¬
phodiesterase inhibitor) had no effect on these receptors. Since these
latter 2 agents increase intracellular cAMP concentrations beyond the
level of action of adenyl cyclase, these workers concluded that stimu¬
lation of this enzyme itself rather than cAMP levels affected complement
receptor expression. Histamine increases cAMP levels in leukocytes
(Bourne et al., 1974) and inhibits leukocyte chemotaxis (Hill, 1978).
Bradykinin increases both cAMP and cGMP levels in lung tissue, although
cAMP increases appear to be secondary to prostaglandin production
(Stoner et al., 1973). Seratonin increases cGMP levels in human mono¬
cytes and also enhances locomotion by these cells (Gallin jst al., 1978).
Similarly PGF2a a^so causes increased intracellular levels of cGMP
and enhances leukocyte locomotion (Hill, 1978). Thus agents which have
been shown to increase cGMP production in leukocytes (PGF_ , brady-2a
kinin and seratonin) also enhance monocyte complement receptors
whereas agents which increase cAMP levels (PGE^ and PGE2' histamine
and isoprenaline) have varying effects on complement receptor expres-
-5
sion. However isoprenaline at 10 M increases cGMP levels in human
neutrophils concomitantly with rises in cAMP levels (Hatch et al.,
1977)/...
255
1977) and at this concentration there is a moderate increase in
monocyte complement rosette formation suggesting that isoprenaline
may be exerting an effect through cGMP production at 10 ^M. The
changes in cGMP levels induced by isoprenaline are believed to result
from a-adrenergic stimulation by this agent which is a weak a-agonist
(Fleisch _et al.,.1972) and human leukocytes may have a-adrenergic
receptors (Logsden et al., 1972). The modulating action of intracellular
Q
nucleotides is dependent on the ratio of cAMP/cGMP (Goldberg _et al.,
-5
1973) and at 10 M the effects of isoprenaline on cGMP levels may
overpower any possibly effects that cAMP is having on complement
receptors. The enhancing effects brought about by raising cGMP levels
is in contrast to the results of Atkinson _et al. (1977) who found
8-bromo cGMP or carbachol (cholergic agonist) had no effect on
complement receptors on rabbit alveolar macrophage monolayers. This
may be due to species differences or experimental procedure since the
cGMP agonists were only incubated with the cells for 10 minutes whereas
in the author's studies, the various substances were incubated with
the cells for 1 hour.
Prostaglandins E^ and E2 enhanced monocyte complement rosettes in
contrast to histamine or isoprenaline which either had no effect or
decreased complement receptor expression on human monocytes. However
prostaglandins may also be chemotactic factors (Cantarow srt al., 1978)
unlike histamine or isoprenaline and might therefore be expected to
have different effects from these latter 2 agents.
The effects of cAMP and cGMP agonists were also tested for their
effects on neutrophil complement receptor enhancement by submaximal
doses of f-Met-Leu-Phe (Duncan, Glass, Stewart and Kay, unpublished
observations). cGMP agonists increased f-Met-Leu-Phe enhancement whereas
cAMP/...
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cAMP agonists inhibited enhancement. These results together with the
results presented in this thesis suggest that cyclic nucleotide levels
modulate phagocyte responsiveness to chemotactic factors in chemotaxis
(see Introduction, Part 5.12) and may also directly modulate complement
receptor expression. Chemotactic factors increase lysophophatidyl-
choline in leukocyte membranes by stimulating phospholipase (Hirata
et al., 1979) and this has been shown to have a direct effect on
guanyl cyclase activity (Shier et al., 1976). Thus increased cGMP levels
or simply stimulation of guanyl cyclase by chemotactic factors or
cGMP agonists may modulate the expression of complement receptors.
Further investigation into the role of cAMP levels or stimulation of
adenyl cyclase is necessary to elucidate their involvement in comple¬
ment receptor expression.
2.4 Possible mechanisms of receptor modulation
As described elsewhere (Anwar and Kay, 1978) possible explanations
of the mechanisms of complement receptor enhancement include "membrane
unfolding", "receptor externalisation" and "subunit association".
F-Met-Leu-Phe increases the cell volume of human neutrophils and this
is associated with an increase in cell surface area (O'Flaherty et al.,
1977) which may be due to unfolding of membrane pleats or ruffles.
Thus more complement receptors may be exposed. However it might be
expected that other receptors would be likewise increased, and this is
not the case since Fc receptors are apparently unaffected and "lectin-
like" receptors are decreased. Electron microscope studies could be
carried out to elucidate the role that increased cell surface area
may play in modulating receptor expression. Functional complement
receptors may be composed of inactive subunits which require aggregation
induced/...
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induced by chemotactic factors for efficient binding. Multiple
ligand-receptor cross-links are necessary for the binding of opsonised
particles (Phillips-Quagliata et al., 1971; Shaw and Griffin, 1981).
Kaplan et al. (1978) and Michl.-et al. (1979) have shown that complement
receptors are not normally mobile in the plane of macrophage membranes.
However with thioglycollate-induced macrophages, these receptors are
mobile and are also able to lead to phagocytosis in a similar way that
a T cell lymphokine induces complement receptor mediated phagocytosis
(Griffin and Griffin, 1979, 1980). These differences between CR^ and
Fc receptors in mobility may explain why chemotactic factors have no
effects on Fc receptors since they are able to aggregate and bind more
efficiently in the absence of any stimulating agent. Complement
receptors, on the other hand, may require an extra signal in order to
show enhanced receptor expression and augmented phagocytic capabilities.
The generation of new receptors is considered unlikely since optimal
enhancement occurs within 60 minutes. However Kohn and Twarog (1979)
have shown that new synthesis of complement receptors on Null cells
can occur within 15 minutes following stimulation with. cAMP agonists.
So possibly chemoattractants may increase de novo synthesis and
insertion of new complement receptors into the plasma membrane.
Experiments with protein synthesis inhibitors could clarify this issue.
Apart from increases in numbers of CR^s it is also possible that chemo¬
tactic factors may increase the binding affinity of these receptors
for their ligands, possibly by causing steric changes in these receptors.
Low density lipoprotein receptors on human fibroblasts are
constantly being recycled by insertion and endocytosis into and from
coated pits in the plasma membrane (Goldstein and Brown, 1977);
mannose specific "lectin-like" receptors are also recycled in a
similar/...
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similar manner (Stahl et_ al., 1980). If complement receptors are also
turned over in a similar fashion, chemotactic factors might increase
membrane recruitment of complement receptors either by enhancing the
insertion or blocking the endocytic removal of these receptors. It
has previously been suggested that the disappearance of the bacterial
cell wall sugar recognising "lectin-like" receptors may be due to
internalisation along with the chemotactic factor binding site. C3b
receptors and Fc receptors may also be internalised along with chemo-
attractants. Increased CR^ expression and the apparent inability of
f-Met-Leu-Phe and casein to alter the expression of Fc receptors may
be due to the resistance of these receptors (in contrast to "lectin-
like" receptors) to lysosomal enzyme degradation in endocytic vesicles.
These receptors may be rapidly recycled and re-expressed on the surface
of the macrophage. Temperature dependence studies (Figs. 32 - 35 and
Table VI) indicate that human monocyte and neutrophil complement
receptors are not enhanced at 4°C and mouse peritoneal macrophage
"lectin-like" receptors were not inhibitable at 4°C as would be
predicted if recycling was involved in the modulation of these receptors.
However pinocytosis of plasma membrane is directly proportional to
temperature (Silverstein, 1977) and Figs. 32 - 34 show that this is
not the case with complement receptor enhancement. Instead there is a
marked change in the slope of the graph between 23°C and 30°C.
Similarly increasing the length of incubation from 30 to 120 minutes
(Fig. 35) had no further effects at 23°C or 30°C. Endocytosis alone,
also cannot account for the observed increase in complement receptors.
An increase in the insertion of newly synthesised complement receptors
or receptors already present in a putative intracellular pool, and/or
a decrease in removal would also be necessary for the observed effects
on/...
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on complement receptor expression. (A recent report by Thrall et al.,
(1980) has described the appearance of a 54,000 dalton protein and the
disappearance of a 44,000 dalton protein in neutrophil membranes
following stimulation with f-Met-Leu-Phe or C5a. These membrane
alterations may be significant in terms of complement receptor enhance¬
ment or inhibition of "lectin-like" receptors.)
Complement receptor enhancement by human monocytes and neutrophils
appears to be reversible (Figs. 29 - 31). About thirty minutes after
the chemotactic factor is removed, the numbers of complement rosettes
returns to basal levels. The continuous presence of chemotactic
factor is therefore essential for maintenance of enhanced complement
receptor expression and the decreases observed may be due to turnover
of the newly expressed receptors, possibly by endocytosis or shedding
into the medium. It is possible that the leukocytes may then be capable
of responding to the stimuli again or else they may remain deactivated.
Vitkauskas et al. (1980) has shown that f-Met-Leu-Phe is internalised
after interacting with its receptor and removal of the plasma membrane
receptors and post receptor blockade renders neutrophils unresponsive
to further stimulation by chemoattractants. In vivo neutrophils are
relatively short-lived cells and do not differentiate any further once
they enter the tissues and presumably die there.. Monocytes, on the
other hand, enter the tissues and differentiate into macrophages and
may also become activated. Thus monocytes may respond to a further
chemotactic stimulus whereas neutrophils may not.
Expression of complement receptors appears to depend on membrane
fluidity unlike Fc receptors (Lay and Nussenzweig, 1968). Complement
receptor enhancement by monocytes and neutrophils (Figs. 32 - 34) is
also temperature dependent and there appears to be a threshold level
below/...
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below which it does not occur to any significant degree; only between
23°C and 37°C is a marked increase in complement receptor enhancement
observed. A unique fluid state of the membrane may be necessary for
the binding of chemotactic factors to the membrane. However binding of
radiolabelled formyl peptides to neutrophils does occur at 4°C
(Aswanikumar et al., 1977; Williams et al., 1978). It is more likely
that membrane fluidity is important in the transduction of the effects
of chemotactic factor-receptor interactions on complement receptor
expression. Arrhenius plots of enzyme functions in artificial membranes
•f* *4"
such as (Na K ) ATPase (Kimelberg and Papahadjopoulos, 1972) and in
biomembranes such as the lactose permease system of E. coli (Overath
et^ al., 1975) have yielded bi- and tri-phasic plots which seemed to
correlate with phase changes in the membranes dependent on the charac¬
teristic transition temperatures, Tc, of the surrounding lipid matrix.
However most biological membranes are heterogeneous in nature with many
different phospholipids in the bilayer interspersed with cholesterol and
protein, all of which might be expected to broaden any overall phase
change. The sharp change in the degree of complement receptor enhance¬
ment between 23°C and 37°C suggests that there might be localised
phase changes and the temperature dependence of complement receptor
enhancement may be dependent on such localised alterations in membrane
fluidity. Thus binding sites for chemoattractants may be intimately
associated with the lipid matrix of the leukocyte membrane and may
depend on a defined lipid environment in order to express their effects
as suggested by Wilkinson (1979) who found that perfringolysin and
phospholipase C, which are membrane modifying agents, decreased the
responsiveness of neutrophils to f-Met-Leu-Phe.
Membrane/...
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Membrane fluidity (Haak et al., 1979) may be altered by f-Met-Leu-
Phe following receptor-ligand interaction, possibly by altering phospho¬
lipid methylation in the plasma membrane (Pike and Snyderman, 1980;
Hirata _et al_. , 1979; Hirata and Axelrod, 1978).
Increases in membrane fluidity may increase complement receptor
expression by affecting the local environment of these receptors and
by doing so may alter their affinity for their ligand, C3b. Similarly
"lectin-like" receptors may show diminished expression because fluidity
changes have decreased their affinity for their ligands. Fc receptors
which are not so dependent on membrane fluidity may thus be unaffected.
Fluidity changes may also affect complement receptor enhancement by
increasing receptor mobility in the membrane and thus increasing the
probability of adequate cross-linking or possibly if complement
receptors are composed of inactive subunits which require aggregation
for efficient binding, increased fluidity may facilitate aggregation.
The use of radiolabelled complement components and membrane fluidity
probes may help to develop further our understanding of the phenomenon
of chemotactic factor induced modulation of surface receptors on
phagocytes.
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3.0 GENERAL CONCLUSIONS AND SUGGESTIONS FOR FURTHER STUDIES
Human peripheral blood monocytes, mouse peritoneal macrophages and
guinea pig alveolar macrophages were all relatively easily obtained in
sufficient quantities for the experimental procedures described here.
Human monocytes required further separation from granulocytes and red
blood cells but the other two cell types only required washing before
they could be used. Thus very few manipulations of the cells were
necessary, minimising possible selection of subpopulations or decreasing
the cell viability.
All three cell types examined, expressed C3b (GR^), Fc (IgG) and
lectin-like receptors although different levels of receptor expression
both between the cell types and within the individual populations were
evident. Receptors for the Fc portion of IgM were expressed on human
monocytes after neuraminidase treatment and their presence on other
cell types could be investigated. Lay and Nussenzweig (1969) detected
Fc (IgM) receptors on mouse peritoneal macrophages using homologous IgM
(these receptors did not require neuraminidase treatment for their
expression and were thus not cryptic). Possibly other cell types
including human monocytes, may express Fc (IgM) receptors for homo¬
logous IgM. The physiological role of these receptors in IgM
dependent cell mediated cytotoxicity and phagocytosis could be studied.
Human monocytes express C3b and C3b" (CR^ and CR^) but not C3d (CR^)
receptors and their presence (or absence) on other cell types could be
investigated. The use of homologous complement components may provide
more information on such receptors, especially since these would be
more relevant to the in vivo role of complement receptors. Mouse
peritoneal macrophages (Unkeless, 1980) and guinea pig peritoneal
macrophages/...
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macrophages (Leslie and Alexander, 1980) probably have distinct
receptor sites for two cytophilic subclasses of IgG. Presumably
guinea pig alveolar macrophages also possess two types of Fc receptor.
However, although human monocytes bind both IgG, and IgG^ (Alexander,
1980) , it is not as yet clear whether these cells also possess
different Fc receptors. By developing more sensitive assays, possibly
by preparing specific antibodies to the various receptors examined in
this thesis, the numbers and affinities of these receptors could be
determined and variations between and within populations could be
compared. Cell membrane fractionation of these receptors may also give
further information into their composition and possibly differences
between cell types may be detected. Both C3b and Fc (IgG) receptors
have been isolated (see Introduction, Part 9.8 and 10.7) using non-
ionic detergent cell lysates and affinity column chromatography.
Using similar methods it is hoped that "lectin-like" receptors may also
be isolated and characterised.
Different levels of expression of surface receptors may be impor¬
tant with respect to the physiological role of the phagocytes and may
reflect their maturation state and also the influence of their environ¬
ment. Tissue, macrophages derive ultimately from peripheral blood
monocytes (van Furth £t al., 1972; van Furth, 1980) and thus mouse
peritoneal and guinea pig alveolar macrophages comprise mainly of
more mature cells than the human peripheral blood monocyte population.
Within the latter population, promonocytes may also be present
(Meuret et al., 1974). All three cell types appear to be heterogeneous
in terms of size and function (Walker,1976b; Rhodes, 1975; Norris _et
alo, 1979; Pelus et al., 1981). Heterogeneity may represent subpopu-
lations or be a reflection of different maturation states of the cells.
Separation/...
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Separation of distinct subpopulations on the basis of cell size
is possible and work is in progress isolating such subpopulations by
counterflow centrifugation using a Beckman J21B centrifuge equipped
with an Elutriator rotor as described by Sanderson _et al_. (1976).
This method was used by Norris et al. (1979) for separating human
monocytes into functionally distinct subpopulations. Similar
differences in function have been described in tissue macrophages.
Gorcynski (1976) separated peritoneal exudate cells on bovine serum
albumin gradients and demonstrated two distinct subpopulations with
different-capacities for potentiating antibody or specific cell-
mediated immune responses. Studies on receptor expression in such
separated subpopulations could be carried out. Fc receptor expression
in different subpopulations has been investigated (Norris _et al^.,
1979) particularly with respect to the activation state of macrophages
(Moore and McBride, 1980). As far as the author knows there are no
reports in the literature on the possible heterogeneity of complement
receptor activities within populations or comparisons made between
populations such as resident and activated macrophages except on a
gross level (Bianco _et _al_. , 1975), although Atkinson _et al. (1977)
noted that small and medium sized rabbit alveolar macrophages formed
the most florid rosettes with complement coated erythrocytes whereas
the larger and multinucleated cells were poor rosette formers. Such
considerations may be important in terms of functional activation of
macrophages since thioglycollate elicited murine peritoneal macrophages
(Bianco j5t al^, 1975) and lymphokine stimulated mouse peritoneal macro¬
phages (Griffin and Griffin, 1979, 1980) and cultured human monocytes
(Newman et al., 1980) all ingest complement coated red cells whereas
resident/...
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whereas resident or peripheral blood mononuclear phagocytes only
bind and do not phagocytose EAC. In an inflammatory response macro¬
phage C3b receptors may be functionally altered so that they can
mediate phagocytosis. It is of interest to note that a few human
monocytes do ingest EAC and these may represent systemically activated
monocytes. Apparently only 37% of guinea pig alveolar macrophages
expressed complement receptors and only 17% recognised EAC prepared
with human complement. During an inflammatory reaction in the lung,
it might be expected that serum proteins including complement would
diffuse into the inflammatory site and thus complement receptors may
be of great importance under these conditions. Activated guinea pig
alveolar macrophages may express more complement receptors and thus be
able to remove opsonised particles more, readily at the site of injury.
Alveolar macrophages are the principle phagocytes of the lung and
serve to clear small inhaled particles deposited in the terminal
alveoli (Green, 1970). Thus "lectin-like" receptors on alveolar macro¬
phages may play an important role in the clearance of nonopsonised
particles including micro-organisms, allergens and potentially toxic
pollutants. The level of expression of "lectin-like" receptors on
guinea pig alveolar macrophages is relatively high compared to peri¬
pheral blood leukocytes though slightly lower than that of mouse
peritoneal macrophages.
C3b and "lectin-like" receptors can apparently be modulated by
substances which are known to promote migration of phagocytes in vitro.
CR.j but not CR^ were enhanced by chemotactic agents whereas "lectin-
like" receptors were inhibited by the same substances. Fc receptors
were apparently unaffected by chemoattractants but possibly more
sensitive/...
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sensitive assays may detect changes in these surface receptors.
Human monocytes, mouse peritoneal macrophages and guinea pig alveolar
macrophages each had different responses to chemotactic factors and
this may reflect functional differences between these cell types.
Within the populations there appeared to be heterogeneous responses
possibly by different subpopulations of cells. Again, more information
may be obtained through separation of whole populations into subgroups.
Certain pharmacological mediators other than chemotactic agents
also apparently enhanced the expression of complement receptors on
human monocytes and these results imply probable, changes in cGMP
levels or guanyl cyclase activity modulating the expression of comple¬
ment receptors, possibly together with alterations in intracellular
levels of cAMP. Temperature dependence studies suggested that membrane
fluidity was important both in the expression of complement receptors
and in the enhancement of these receptors. However further studies
into the mechanism of complement receptor modulation is necessary before
more definite conclusions can be drawn. It is not known whether cyclic
nucleotide levels are involved in the chemotactic factor modulation of
"lectin-like" receptors or whether this inhibition is dependent on
membrane fluidity. Further understanding may be achieved by the use
of a combination of various techniques which might include cell membrane
fractionation, the use of radiolabelled complement components or
ligands for the "lectin-like" receptors such as glycoproteins, and
membrane fluidity probes.
Complement receptor enhancement may be an important biological
phenomenon in terms of the events which surround (1) the directional
migration of cells into sites of inflammation and (11) the subsequent
adhesion/...
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adhesion of leukocytes to particles opsonised with complement i.e.
the phagocytes are primed for the adhesion process prior to their
actual attachment. However in this study, no attempts were made to
investigate the relevance of enhancement.of complement receptors
or the inhibition of "lectin-like" receptors to various other
recognised cellular processes, for example phagocytosis, release of
lysosomal enzymes and K-cell cytotoxicity.. Cellular mechanisms
dependent on complement receptors may be enhanced whereas those
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Leucoattractants enhance complement receptors on
human phagocytic cells
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SUMMARY
The N-formyl-methionyl peptides, F-Met-Leu-Phe, F-Met-Met-Phe and F-Met-Phe, when
tested at differing concentrations, proportionally increased both in vitro cell locomotion and the
expression of surface receptors for C3b on human peripheral blood neutrophils and monocytes.
In contrast, the unformylated peptides, Met-Leu-Phe and Me~-Met-Phe, had no chemotactic
or complement receptor-enhancing activity at comparable concentrations. Casein and supernatants
from human lymphocytes (cultured either in the presence or absence of phytohaemagglutinin),
also recognized as chemotactic agents for human neutrophils and monocytes, enhanced C3b
receptors on these cells in a similar dose-dependent fashion. These data, taken together with
our previous findings with the eosinophil, suggest that in addition to promoting cell locomotion a
further biological function of leucoattractants may be their capacity to render complement
receptors more freely available thereby increasing the magnitude of adhesion of phagocytic cells
to opsonized particles.
INTRODUCTION
We recently reported that eosinophil chemotactic factors (including the ECF-A tetrapeptides (Val-
Gly-Ser-Glu and Ala-Gly-Ser-Glu), histamine and imidazoleacetic acid) markedly enhanced the
expression of receptors for complement (C3b and C4) on human eosinophils (Anwar & Kay, 1977 and
1978). Therefore, it seemed important to determine whether other phagocytic cells, such as human
neutrophils and monocytes, undergo similar complement receptor enhancement following incubation
with substances known to promote their migration in vitro. If, in addition to promoting cell locomotion,
leucoattractants also render complement receptors more freely available this would provide a mechanism
whereby the degree of adhesion of phagocytic cells to opsonized particles was increased. The studies
reported here employed synthetic bacterial-associated N-formyl-methionyl peptides, as their chemical
structure is clearly defined and potent chemotactic activity well documented (Schiffman, Corcoran &
Wahl, 1975; Showell et al, 1976). In addition, we examined other recognized human neutrophil and
monocyte leucoattractants for complement receptor enhancement. These included supernatants from
cultured lymphocytes (Ward, Remold & David, 1969; Snyderman et al., 1972) and casein (Keller &
Sorkin, 1967).
MATERIALS AND METHODS
F-Met-Leu-Phe was a gift from Dr Dereck Hudson (Royal Postgraduate Medical School, London). F-Met-Met-Phe,
Met-Leu-Phe and Met-Met-Phe were gifts from Miles Laboratories (Stoke Poges). F-Met-Phe was obtained from Sigma
Chemical Company (St Louis, Missouri, U.S.A.). Other materials were obtained as follows. Preservative-free heparin (Evans
Medical, Liverpool); casein (BDH Chemicals Ltd, Poole); phytohaemagglutinin (PHA-P, Wellcome Reagents Ltd.,
Beckenham); dextran (I.omodex 70, Fisons Pharmaceuticals, Loughborough); Ficoll and Hypaque (Pharmacia, Uppsala,
Correspondence: Dr A. B. Kay, Department of Pathology, University of Edinburgh, The Medical School, Teviot Place,
Edinburgh EH8 9AG, Scotland.
0099-9104/79/1100-0294S02.00 © 1979 Blackwell Scientific Publications
294
Leucoattractants and complement receptors 295
Sweden); ovalbumin five times crystallized (Koch Light Laboratories, Colnbrook); cellulose nitrate filters, 8 and 0-45-/tm
pore size (Sartorius-Membrane Filters, Gottingen, West Germany); polycarbonate (Nucleopore) 5-/;m pore size filters
(Neuroprobe, Bethesda, Maryland, U.S.A.).
Preparation ofEACl423b (EAC). This has been described in detail elsewhere (Anwar & Kay, 1977) and was briefly as
follows. Dextrose-gelatin-Veronal buffer (DGVB2 +, pH 7-4) was used for washing sheep erythrocytes (E) during sensitization
and coating with various complement components and was prepared by mixing equal volumes of isotonic Veronal-buffered
saline (containing 0-0015 M Ca2 + , 0-0005 M Mg2 + and 0-1% gelatin-Veronal buffer (GVB2 +)) with 5% dextrose in water
containing the same concentration of Ca2 + and Mg2 +. The IgM fractions of rabbit antisera to sheep red cells were prepared
by Sephadex G-200 gel filtration (Shevach et al., 1972). Functionally pure human complement components were added
sequentially to EAM'ab to prepare C3b-coated cells. The amounts were as follows: 400 effective molecules of CI, 400 of C4,
50 of C2 and 500 (for neutrophils) or 400 (for monocytes) of C3. This amount of C4 was insufficient to give EACH rosettes
with neutrophils, eosinophils or monocytes (Anwar & Kay, 1977).
In some experiments fresh human AB serum diluted with DGVB2 + was used as a source of complement. Equal volumes
of EAMrab at a concentration of 1 x 10s cells/ml and human AB serum were mixed and incubated for 30 min at 37°C,
washed twice in DGVB2 + and resuspended in the same buffer to a concentration of 1 x 10s red blood cells/ml. The dilution
of fresh serum was adjusted to give between 20 and 30% of neutrophil or monocyte rosettes and was usually between 1 in 600
and 1 in 1000.
Neutrophils and monocytes. Blood from healthy volunteers was drawn into plastic tubes containing 10 units of preservative-
free heparin/ml. The red cells were sedimented with 70% dextran; 1 part dextran to 4 parts blood v/v for 60 min at room
temperature. The leucocyte-rich plasma was then layered over Ficoll-Hypaque (specific gravity 1-078) at 4°C in 15 ml
plastic conical centrifuge tubes and centrifuged at 4°C for 40 min at 400 g. The pellet, containing red blood cells and gran¬
ulocytes, was resuspended in 0-82% ammonium chloride as described (Boyle, 1968), to lyse the red cells. Monocytes,
usually from the same donors, were separated on Ficoll-Hypaque gradients according to the method of Boyum (1968). The
separated cells were finally washed twice in medium 199, pH 7-4, and the cell count adjusted to 2 x 106 cells/ml for neutro¬
phils or 1 x 106 monocytes/ml.
Lymphocyte supernatants. 'Stimulated lymphocyte supernatants' were prepared from suspensions of human peripheral
blood mononuclear cells, separated on a discontinuous gradient of Ficoll-Hypaque as described above, and contained 3 x 106
leucocytes/ml in medium 199. Under sterile conditions, and with added penicillin and streptomycin, 9 /A of PHA-P (0-5
//g/ml) were added to 3 ml of the mononuclear cell suspension. The cells were incubated for 3 days at 37°C in a humidified
atmosphere containing 5% CO2. After incubation the supernatants were harvested by centrifugation, divided into portions
and stored at — 70°C until use. The 'unstimulated lymphocytes' were prepared in an identical fashion with the exception that
PHA-P was added at the termination of the 3 day incubation period.
EAC rosettes. Equal volumes of neutrophils (2 x 106/ml) or monocytes (1 x 106/ml) and various concentrations of the
leucoattractants under study, or medium alone as control, were mixed and incubated in a shaking water bath at 37°C for 30
min. The cells were then washed twice in medium 199 and the numbers re-adjusted to their original concentration in the
same medium. A portion (0-1 ml) of EAC (1 x 10s/ml) was added to 0-1 ml of the leucocyte suspension, the mixtures centri¬
fuged at 100 g for 10 min at 4°C, and the pellets incubated at 37°C for 30 min. The pellet was gently resuspended and smears
prepared on clean glass slides in duplicate. These were dried quickly in air, fixed in 95% methanol and stained with May
Grunwald/Giemsa. Leucocytes with three or more adherent sheep red cells were termed rosettes. In each slide 200 neutro¬
phils or monocytes were counted and the increase in the percentage of rosetting cells following incubation with the various
leucoattractants was calculated.
Cell locomotion. The capacity of neutrophils or mononuclear cells to migrate towards a concentration gradient of various
leucoattractants has been described in detail elsewhere (Kay, Pepper & McKenzie, 1974; Campbell, 1977). For neutrophils
(Boyum, 1968), cellulose nitrate filters of 8 /;m pore size were employed using an incubation time of 90 min at 37°C. The cell
count was adjusted to 2 x 106/ml in medium 199 containing 0-5% ovalbumin at pH 7-4. Only those cells which had migrated
across the entire thickness of the micropore were counted. Cells were counted under a high power (x 40) objective and the
average number in five fields was recorded (mean cell count). Monocyte chemotaxis was measured using the double filter
technique (Campbell, 1977) with the exception that the 'Boyden chamber' supplied by Neuroprobe, Inc., Bethesda, Mary¬
land, was used instead of the Sykes-Moore type of chamber. In all experiments with neutrophils or monocytes the values
obtained from the controls (medium 199 alone) were subtracted from the values obtained with the various agents being
tested.
RESULTS
The percentage increases in C3b rosettes and the numbers of neutrophils migrating through the micro¬
pore filters were directly related to the concentrations of the formyl-methionyl peptides (Fig. 1). The
magnitude of these two biological events appeared to increase proportionally with increasing concentra¬
tions of the peptides. With F-Met-Leu-Phe appreciable activity was observed from 1CU8 to 10"10 mol/
1, but not at 10"11 mol/I. With F-Met-Met-Phe neutrophil chemotaxis and complement receptor
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Fig. 1. The association between the percentage increase in neutrophil C3b rosettes and neutrophil locomotion
by formylated and unformylated methionyl peptides. The symbols represent the concentration of the peptides
in mol/1 and are as follows: 10 + 5 (•), 10~6 (O), 10~7 (A), 10'8 (A), 10-9 (■), 10~'° (□) and 10"11 (v).
The results are the mean values of three experiments (five experiments with F-Met-Leu-Phe). Receptor
enhancement and chemotaxis were performed on cells from the same volunteers (with the exception of two
experiments with F-Met-Leu-Phe).
Fig. 2. The association between the percentage increase in monocyte C3b rosettes and monocyte locomotion
by formylated and unformylated methionyl peptides. The symbols represent the concentrations of the peptides
in mol/1 and are as follows: 10-5 (•), 10~6 (O), 10-7 (A), 10~8 (A) and 10~9 (■). The results are the mean
values of three experiments. Receptor enhancement and chemotaxis were performed on cells from the same
volunteers.
Table 1. Human neutrophil and monocyte complement receptor enhancement by
lymphocyte supernatants and casein. N = neutrophils, M = monocytes. The
results are the mean+ s.e. of three experiments. The lymphocyte supernatants and
casein were tested for neutrophil and monocyte chemotactic activity and gave
results comparable to that described in our previous study (Kay & McVie, 1977)




Lymphocyte supernatant N 64±4 49±4 34±2 16+8
(PHA-stimulated) M — 84± 5 52±7 — 2±3
Lymphocyte supernatant N 69± 3 33 ± 5 25± 5 1 ± 5
(unstimulated) M — 39 ± 7 11 ± 7 — 2± 3
Concentration (mg/ml)
3-0 2-0 1-5 1-0
Casein N 60± 11 64± 6 34± 3 23±5
M 97± 12 76± 17 — 39±4
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enhancement were observed at 10~7 aud 10""8 mol/1 and with F-Met-Phe at 10~5 and 10~6. The un-
formylated peptides, Met-Leu-Phe and Met-Met-Phe, gave virtually no responses either with neutro¬
phil C3b-receptor enhancement or chemotaxis.
Similar results were obtained with human blood monocytes (Fig. 2) although the concentrations of
the formyl-methionyl peptides required to demonstrate chemotaxis and complement receptor enhance¬
ment were higher than those required for the neutrophil. With F-Met-Leu-Phe activity was observed at
10-7 and 10"8 mol/1 with little enhancement and cell locomotion at 10~9 mol/1. With F-Met-Met-Phe
and F-Met-Phe a clear effect on cell locomotion and rosette expression was demonstrable at 10" 5 and
10~6 mol/1, but not at 10""7 mol/1. The unformylated peptides, Met-Leu-Phe and Met-Met-Phe, gave
very low values in monocyte complement receptor enhancement and monocyte chemotaxis.
Casein, previously shown to be a potent chemoattractant for neutrophils and monocytes (Keller &
Sorkin, 1967), also enhanced C3b receptors on these cell types (Table 1). Similar results were obtained
with cultured lymphocyte supernatants. A greater amount of neutrophil and monocyte chemotactic
activity was found in cultures prepared in the presence of PHA, although the 'unstimulated' lymphocyte
supernatants also promoted the migration of human leucocytes, as was previously shown (Snyderman
et al., 1972). Similarly, complement receptor enhancement was greater w ith 'stimulated' as compared to
'unstimulated' supernatants for both neutrophils and monocytes (Table 1).
The time-course of complement receptor enhancement on neutrophils and monocytes was similar,
maximal effect being observed between 30 and 60 min. Irrespective ofwhether the indicator red cells were
EAM with whole serum as a source of complement, or EAM and purified CI, C4, C2 and C3, the per¬
centage increase in rosettes either as a function of time or the concentration of chemoattractant, was
virtually identical for both neutrophils and monocytes.
DISCUSSION
I n this reportwe haveshown that formyl-methionyl peptides, in addition to promoting cell migration in vitro,
also increased the expression of C3b receptors on neutrophils (Fig. 1) and monocytes (Fig. 2). We have
therefore, confirmed previous reports on the leucoattractant properties of these compounds (Schiffman
et al., 1975; Showell et al., 1976) and shown that in addition they have a previously undescribed biological
activity—complement receptor enhancement. Both activities, i.e. leucoattraction and complement
receptor enhancement, occurred in parallel since increasing concentrations of the peptides promoted
concomitant increases in both the degree of receptor enhancement and the numbers of neutrophils or
monocytes migrating through the micropore filters. In contrast, the unformylated peptides, Met-Leu-
Phe and Met-Met-Phe, were inactive in both biological systems suggesting that the specificity for
formylation applies to both complement receptor enhancement and locomotion.
Enhancement of complement receptors by 'chemotactic factors' was first described using human
eosinophils (Anwar & Kay, 1977, 1978). In these reports we showed that receptors for C3b and C4
(but not C3d or IgG (Fc)) were 'enhanced' in the sense that previously recognized eosinophilotactic
agents such as the ECF-A tetrapeptides, histamine or imidazoleacetic acid produced an increase in the
percentage of eosinophils forming rosettes with the appropriate indicator red cells. As described else¬
where (Anwar & Kay, 1978) possible explanations of the mechanisms of complement receptor enhance¬
ment include 'membrane unfolding', 'receptor externalization' and 'subunit association'. The generation
of 'new' receptors during the incubation with chemotactic factors was considered unlikely since optimal
enhancement of eosinophil complement receptors was found to be between 30 and 60 min. A similar
time course for complement receptor enhancement on neutrophils and monocytes has also been observed
with neutrophils and monocytes (Glass, E.J., Salter, D.McG. & Kay, A. B., unpublished observations).
The term 'leucoattraction' and 'cell locomotion' has been used only in the sense that the various agents
which we tested produced migration of neutrophils and monocytes towards a gradient across a micropore
filter. Although we have drawn the general conclusion that agents which promote cell locomotion also
enhance complement receptors on the leucocytes they chemoattract, we cannot say whether this effect is
related to their chemotactic and/or chemokinetic principles. Showell et al. (1976), using the 'chequer-
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board' titration method previously described (Zigmond & Hirsch, 1973) to distinguish true chemotaxis
from chemokinesis, were able to show that F-methionyl peptides caused directional migration as well as
increasing the rate of cell movement. In order to establish whether the chemotactic and/or chemo-
kinetic property is necessary for complement receptor enhancement on human leucocytes further
studies will be required using substances which increase random migration, but are not chemotactic and
vice versa. For instance, Wilkinson et al. (1977) reported that mouse lymph node lymphocytes responded
in chemokinesis, but not chemotaxis, to human and bovine serum albumins.
The relative activities of the formylated peptides used in this study were, for neutrophils, F-Met-
Leu-Phe > F-Met-Met-Phe > F-Met-Phe. Similar results, in terms of relative potencies were observed
in the study by Showell et al. (1975) in which chemotaxis and lysosomal enzyme release from rabbit
neutrophils were tested. With monocytes about one hundred-fold more F-Met-Leu-Phe, F-Met-Met-
Phe or F-Met-Phe was required to give comparable biological effects to that of the neutrophil (Figs 1 and
2). Furthermore in the human monocyte studies (Fig. 2), F-Met-Phe had a similar potency to F-Met-Met
Phe in both cell locomotion and rosette enhancement. This is in contrast to the report of Showell et al.
(1976) in which F-Met-Met-Phe was found to be 1900 times more active than F-Met-Phe in promoting
chemotaxis of rabbit neutrophils.
We have not yet had the opportunity to examine fully the effects of chemotactic agents on cell surface
markers other than those for complement. However, in a previous report we showed that eosinophilo-
tactic agents had no apparent effect on IgG (Fc) receptors (Anwar & Kay, 1977 and 1978) and recent
preliminary data indicate that on neutrophils and monocytes these receptors are also unaffected by
leucoattractants (Salter, D.McG. & Glass, E.J., unpublished observations). Also, we have yet to ascer¬
tain whether, like eosinophils, complement receptor enhancement on neutrophils and monocytes
applies only to C3b and C4 and not C3d.
It is tempting to speculate that complement receptor enhancement may be an important biological
phenomenon in terms of the events which surround (i) the directional migration of cells into sites of
inflammation and (ii) the subsequent adhesion of leucocytes to particles opsonized by complement, i.e.
that leucocytes are primed for the adhesion process prior to their actual attachment. The N-formyl-
methionyl peptides and the other leucoattractants tested (Table 1) enhanced C3b receptors on those cells
in which they induced locomotion. Therefore, the present work, taken together with our previous
findings with the eosinophil (Anwar & Kay, 1977 and 1978), supports the general hypothesis that leuco¬
attractants enhance complement receptors on human phagocytic cells.
This work was supported by the Medical Research Council and the Cancer Research Campaign.
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SUMMARY
The capacity of various leucoattractants to enhance, or unfold, receptors for complement (C3b)
on human blood monocytes has been studied. A number of recognized monocyte chemoattrac¬
tants including casein, supernatants from C. parvum 10390 and from human lymphocytes (cul¬
tured either in the presence or absence of phytohaemagglutinin) and the formyl-methionyl
peptides, F-Met-Leu-Phe, F-Met-Met-Phe and F-Met-Phe, increased the percentage of mono¬
cytes which formed rosettes with IgM-sensitized sheep erythrocytes coated with complement.
Comparable results were achieved irrespective of whether purified components or whole serum
was used as a source of complement. In contrast, there was no significant increase in EAG (Fc)
rosettes with those doses of casein which gave enhancement of C3b receptors. A small degree of
complement receptor enhancement was observed with histamine but the unformylated peptides,
Met-Leu-Phe and Met-Met-Phe, were without apparent effect. Maximal receptor enhancement
was obtained at 30 min but when the leucoattractant was removed, enhancement was reversible,
returning to normal values in approximately 120 min. Monocyte complement receptor enhance¬
ment increased with temperatures between 0°C and 37°C.
These data (1) confirm and extend our previous findings on leucoattractant-induced enhance¬
ment of complement receptors on human monocytes; (2) indicate that the phenomenon may have
potential as a clinical test for monocyte function both in health and disease.
INTRODUCTION
We recently reported that complement receptors on human eosinophils were enhanced, or unfolded,
following incubation with various pharmacological mediators to which they migrate in chemotaxis and/or
chemokinesis. A number of eosinophilotactic agents, including the eosinophil chemotactic factor of
anaphylaxis (ECF-A) tetrapeptides (Val-Gly-Ser-Glu and Ala-Gly-Ser-Glu), histamine and one of its
major catabolites, imidazoleacetic acid, selectively enhanced receptors for complement (C3b and C4) on
human eosinophils in a dose- and time-dependent fashion (Anwar & Kay, 1977a; Anwar & Kay, 1978).
Later, in a short report we established that human neutrophils and monocytes undergo a similar enhance¬
ment of complement receptors following incubation with substances to which they are known to migrate
in vitro (Kay, Glass & Salter, 1979). This suggested that complement receptor enhancement by leuco¬
attractants may be a general biological phenomenon which might provide a mechanism whereby the
degree of adhesion of phagocytic cells to opsonized particles was increased.
For these reasons it seemed important to provide further information on leucoattractant-induced
complement receptor enhancement by various cell types and in the present report the monocyte has been
studied in detail. Thus, we have confirmed and expanded our original observations by studying the
Correspondence: Professor A.B. Kay, Department of Clinical Immunology, Cardiothoracic Institute, Fulham Road,
London SW3 6HP.
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effect of leucoattractants on both complement and IgG receptors, by undertaking time course experi¬
ments over a broad concentration range, examining a number of agents which promote monocyte
migration and determining whether the phenomenon is reversible and temperature-dependent.
MATERIALS AND METHODS
Materials. Materials were obtained as follows. Casein (BDH Chemicals Limited, Poole, Dorset); phytohaemagglutinin
(PHA-P, Wellcome Reagents Limited, Beckenham, Kent); C. parvum 10390 supernatant was a gift from Dr W. McBride
(Department of Bacteriology, Medical School, University of Edinburgh); histamine acid phosphate (BDH Chemicals
Limited, Poole, Dorset); F-Met-Leu-Phe was a gift from Dr Derek Hudson (Royal Postgraduate Medical School London),
F-Met-Met-Phe, Met-Leu-Phe and Met-Met-Phe were gifts from Miles Laboratories (Stoke Poges, England); F-Met-Phe
was obtained from Sigma Chemical Company (St Louis, Missouri, USA); preservative-free heparin (Evans Medical,
Liverpool); Ficoll and Hypaque (Pharmacia, Uppsala, Sweden).
Preparation ofEA, EAC1423b and 'EAC', This has been described elsewhere (Anwar & Kay, 1977b; Anwar & Kay, 1978)
and was briefly as follows. Dextrose-gelatin-veronal buffer (DGVB2+ pH 7.4 was used for washing sheep erythrocytes (E)
during sensitization and coating with complement. The buffer was prepared by mixing equal volumes of isotonic Veronal-
buffered saline (containing 0-0015 M Ca2+ 0-0005 M Mg2+ and 0-1% gelatin-Veronal buffer GVB2+) with 5% dextrose in
water containing the same concentration of Ca2 + and Mg2 +. The IgM and IgG fractions of rabbit antisera to sheep red cells
(A) were prepared by Sephadex G-200 gel filtration (Shevach et al., 1972). The IgG fraction was purified further by DEAE-
52 anion exchange chromatography (Fahey & Terry, 1978). Either IgG or IgM was used in the sensitization of E for the
preparations of EA'Gb or EA'm" respectively. The antibody concentration of EA'm6 selected was that which gave optimal
sensitization for haemolysis but no agglutination. For the preparation ofEA'cb the antibody concentration was diluted so as
to give approximately 30% monocyte rosettes. Functionally pure human complement components were added sequentially to
EA'm" to prepare C3b coated cells (EAC1423b). The amounts were as follows: 400 effective molecules of CI, 400 of C4, 50
of C2 and 400 of C3. This amount of C4 was insufficient to give EACH rosettes with monocytes (Anwar & Kay, 1978). In
some experiments fresh human AB serum was also used as a source of complement ('EAC'). Equal volumes of EA'm" at a
concentration of 1 x 10s cells/ml and human AB serum, diluted with DGVB2 + , were mixed and resuspended in the same
buffer to give a final concentration of 1 x 108 red blood cells/ml. The dilution of fresh serum was adjusted to give between
20 and 30% monocyte rosettes and was usually between 1 in 600 and 1 in 1000.
Monocytes. Blood from healthy donors was drawn into plastic tubes containing 10 units of preservative-free heparin/ml.
Monocytes were separated on Ficoll-Hypaque cushions according to the method ofBbyum (1968). The separated cells were
washed twice in Dulbecco's PBS (modified) (pH 7-2-7-4), containing preservative-free heparin (2 units/ml) and resuspended
in medium 199, pH 7-4, to a concentration of 1 x 102 monocytes/ml.
Lymphocyte supernatants. A cell suspension containing up to 90% lymphocytes was obtained using defibrinated blood as
described by Boyum (1976). The separated cells were resuspended to a concentration of 3 x 106 lymphocytes/ml in medium
199. Under sterile conditions, and with added penicillin and streptomycin, 9 /A of PHA-P (0-5) /rg/ml) were added to 3 ml
of the mononuclear cell suspension. The cells were incubated for 3 days at 37°C in a humidified atmosphere containing 5%
C02. After incubation the supernatants were harvested by centrifugation, aliquoted and stored at — 70°C until use. The
unstimulated lymphocyte supernatants were prepared in an identical fashion with the exception that PHA-P was added at
the end of the 3-day incubation period.
Complement (EAC) and IgG (EAa) rosettes. Equal volumes of monocytes (1 x 106/ml) and various concentrations of the
leucoattractants under study or medium alone as a control, were mixed and incubated in a shaking water bath usually at
37°C for 30 min. The cells were then washed twice in medium 199 and the numbers readjusted to their original concentration
in the same medium. A portion (0-1 ml) of EAC or EAg (1 x 10s/ml) was added to 0-1 ml for 10 min at 4°C and the pellets
incubated at 37°C for 20 min for EAC and 0°C for 30 min in the preparation of EAG. The pellet was resuspended gently in
medium 199 containing 1% formal-saline and smears prepared on clean glass slides in duplicate. These were dried quickly in
air, fixed in methanol and stained with May-Griinwald/Giemsa or fixed in 2-5% glutaraldehyde and stained using a-naphthyl
acetate histochemistry according to the method of Yam, Li & Crosby (1971). Comparison of these two methods by four inde¬
pendent observers revealed no statistical significance in differentiating monocytes from lymphocytes.
RESULTS
Casein enhanced the percentage ofmonocyte C3b rosettes in a dose-dependent fashion (Fig. 1) irrespec¬
tive of whether 'EAC' or EAC1423 were used as indicator cells. In contrast there was a small but
insignificant increase in the percentage of EAG (Fc) rosettes. With the highest dose of casein the mean
values for enhancement of Fc receptors was 13% whereas with 'EAC' and EAC1423 the increase was
92% and 100% respectively.
Enhancement of complement receptors by casein was also dependent on the time of incubation.
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Fig. 1. The effect of casein on monocyte C3b and IgG rosettes. (□) EAM1423, (ed) 'EAC', (e3) EAG. Each
column represents the mean±s.e.m. of three experiments. Casein was dissolved in distilled water and the pH
raised to 11 with 1 N NaOH. The pH was then adjusted to 7-4 with 1 N HC1. Nine parts of the casein solution
were then added to one part of 10-times concentrated medium 199 with HEPES buffer, pH 7-4.
Maximal effects were observed at about 30 min after which there was no further increase (Fig. 2).
Similar results were obtained irrespective ofwhether 'EAC' or EAC1423 were used as indicator red cells.
A small but insignificant increase in Fc receptors was also observed in this time course study and was
maximal after approximately 60 min. By 120 min this small increase had returned to the original value.
As the dose-response and time-course studies were essentially similar using either 'EAC' or EC1423,
'EAC' were used as indicator cells in further experiments.
Time (min)
Fig. 2. The time-course of the percentage enhancement of monocyte rosettes by casein using sensitized
erythrocytes coated with complement or IgG. (•—•) 'EAC', (O—O) EAMC1423, (■—■) EAC- Each point
represents the mean+s.e.m. of three experiments. The casein was prepared as in Fig. 1.
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Fig. 3. The time-course ofmonocyte complement receptor enhancement by increasing concentrations ofcasein.
(•—•) 3 mg/ml casein, (O—O), 2 mg/ml casein, (■—■) 1 mg/ml casein. Each point represents the mean
+ s.e.m. of three experiments. The indicator red cells were 'EAC' (prepared with whole serum as a source of
complement).
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Fig. 4. The effect of various leucoattractants on the expression of monocyte complement receptors. (•—•)
C. parvum 10390, (O—O) 'stimulated', (■-■) 'unstimulated', (□-□) histamine. Each point represents the
mean± s.e.m. of three experiments, except for histamine in which four experiments were performed. The C.
parvum 10390 supernatant was prepared from formaldehyde-killed C. parvum organisms which had been washed
twice in 0-9% NaCl, lyophilized and reconstituted in distilled water. The reconstituted material had a
concentration of 7 mg/ml dry weight which represented 3 x 10" organisms. The indicator red cells were
'EAC' as in Fig. 3.
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Fig. 5. The effect of formyl-methionyl peptides on the expression ofmonocyte complement receptors. (•—•)
F-Met-Leu-Phe, (O—O) Met-Leu-Phe, (■—■) F-Met-Met-Phe, (□—□) Met-Met-Phe, (a—A) F-Met-Phe.
Each point represents the mean+s.e.m. of three experiments. The peptides were dissolved in dimethyl
sulphoxide (DMSO) at a concentration of 10 ~2 mol/l and further diluted in medium 199 to the required
concentrations. At the highest dose used (10-5 mol/l) the concentration of DMSO was approximately 10~2
mol/l and at this concentration had no effect on cell viability as determined by trypan blue exclusion and
locomotion in vitro through micropore filters (Kay, Glass & Salter, 1979). The indicator red cells were 'EAC'
as in Fig. 3.
The effect of increasing doses of casein on the rate and degree of enhancement of monocyte comple¬
ment receptors is shown in Fig. 3. The degree of enhancement and the rate at which enhancement
occurred was dependent on the concentration of casein. Increasing the concentration of casein from 1
mg/ml to 2 mg/ml increased the rate ofmonocyte rosette enhancement three-fold. Further increase in the
concentration of casein up to 3 mg/ml had no apparent effect on the rate of complement receptor enhance¬
ment.
Other recognized monocyte chemoattractants were tested for their capacity to enhance monocyte
complement receptors. Supernatants from lymphocytes stimulated with PHA increased the numbers of
monocyte rosettes in a dose-dependent fashion (Fig. 4). In contrast, unstimulated lymphocyte super¬
natants had significantly less effect when tested at comparable dilutions. A leucoattractant elaborated
100
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Fig. 6. Reversibility ofmonocyte complement receptor enhancement. Each point represents the mean± s.e.m.
of three experiments. Monocytes were pre-incubated with 3 mg/ml of casein for 30 min at 37°C, centrifuged and
the cells resuspended in medium 199 to the original volume and incubated at 37°C for various time intervals
as shown. The indicator red cells were 'EAC' as in Fig. 3.
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Fig. 7. The effect of temperature on monocyte complement receptor enhancement. (•—•) 3 mg/ml casein,
(O—O) 2 mg/ml casein, (■—■) 1 mg/ml casein, (□—□) medium 199. Each point represents the mean+
s.e.m. of three experiments. The indicator red cells were 'EAC' as in Fig. 3.
from C. parvum 10390 also had a similar effect. Histamine gave a slight increase in the percentage of
monocyte complement rosettes at doses of 10"5 and 1CT6 mol/1.
A number of formyl-methionyl peptides were also tested for their effects on monocyte complement
receptors (Fig. 5). With F-Met-Leu-Phe activity was observed at 10"7 and 10"8 mol/1 with little
enhancement at 10"9 mol/1. F-Met-Met-Phe and F-Met-Phe were less active than F-Met-Leu-Phe
but both gave enhancement at 10~5 and 10~6 mol/1 but not at 10~7 mol/1. The unformylated
peptides, Met-Leu-Phe and Met-Met-Phe, were virtually inactive.
Monocyte complement receptor enhancement appeared to be reversible (Fig. 6). Following 30 min
incubation with casein the cells were washed and resuspended in medium 199. There was a gradual
decrease in monocyte rosette enhancement and by 120 min there was no discernible difference from the
controls. The experiments were reported with F-Met-Leu-Phe (10~7 mol/1) and gave virtually iden¬
tical results.
Monocyte complement receptor enhancement was also temperature dependent as shown in Fig. 7. At
0°C there was no increase in the percentage of rosettes formed with any of the concentrations of casein
used. However, at 23, 30 and 37°C, enhancement was observed and increased proportionally with the rise
in temperature. The increase in monocyte complement receptor enhancement was particularly marked
between 30°C and 37°C. The higher concentrations of casein gave correspondingly increased rosette
formation at these temperatures.
DISCUSSION
In a recent short report we established that leucoattractants enhance complement receptors on human
neutrophils and monocytes (Kay, Glass & Salter, 1979), and that these observations, taken together with
previous studies on the eosinophil (Anwar & Kay, 1977a; Anwar & Kay, 1978) indicated that comple¬
ment receptor enhancement by agents which promote cell locomotion might be a general biological
phenomenon. In the present report we have studied details of complement receptor enhancement on the
blood monocyte. It seemed important to extend our knowledge of complement receptors to human
monocytes since cells of the monocyte/macrophage series are not only specialized phagocytic cells but
also synthesize and secrete a variety of products into their immediate microenvironment. In addition,
quantification of the degree of complement receptor enhancement might provide a further variable for
studies of monocyte function both in health and disease.
The rosette method for identifying cell surface markers is a well established technique. However, a
major disadvantage, which applies particularly to the present study is the difficulty in measuring the
degree of binding between the monocyte membrane and individual indicator erythrocytes. For instance,
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treatment with the various leucoattractants not only increased the percentage ofmonocytes having three
or more adherent red cells but the red cell binding itself appeared far more 'firm' than that observed in
the untreated controls. Techniques that facilitate measurements of the binding affinity are required to
appreciate the full extent of the complement receptor enhancement phenomenon.
It should be noted that in the present experiments the amount of complement on the red cells was
limited to give approximately 25-35% rosettes in the untreated (control) monocyte suspensions. Even
when the amount of complement was increased or when optimal conditions were used for complement
receptor enhancement, it was unusual to achieve greater than 75% monocyte rosettes. This suggested
that there might be a population of monocytes which express complement receptors poorly. They may
be either immature cells or possibly an as yet unidentified subset.
The capacity of casein to attract human monocytes in directional and random motion is well estab¬
lished (Keller & Sorkin, 1967) and, therefore, it seemed reasonable to use this agent in the majority of
experiments. However, a number of other agents with chemotactic activity for monocytes gave compar¬
able increases in the percentages of complement rosettes (Figs 4 and 5). These included supernatants
from lymphocytes cultured in the presence of PHA (Snyderman et al., 1972), a supernatant from C.
parvum 10390 (Wilkinson, O'Neill & Wagshaw, 1973) and several formyl-methionyl peptides (Showell
et al., 1976). Snyderman et al. (1972) found a certain amount ofmonocyte chemotactic activity in super¬
natants from unstimulated lymphocytes. In the present study the highest concentration of the unstimu¬
lated supernatants also gave enhancement of monocyte complement rosettes. These observations all
support the view that there is a direct relationship between cell locomotion and enhancement of comple¬
ment receptors (Kay, Glass & Salter, 1979).
The apparent inability of casein and F-Met-Leu-Phe to alter receptors for IgG on the monocyte is in
agreement with previous observations on the eosinophil in which it was found that chemoattractants
affected the expression of complement but not Fc receptors (Anwar & Kay, 1977a; Anwar & Kay, 1978).
The reasons for these apparent differences between complement and IgG receptors is not clear at this time
but may be explained by the experimental procedure. For instance, optimal IgG rosettes are obtained at
0°C whereas 37°C is used for complement. Also, in the time course experiment (Fig. 2) a slight increase
in Fc receptors was found but this was statistically insignificant. Although it seems likely that IgG
receptors are not enhanced to the same degree as complement receptors, further studies using different
techniques for studying cell surface markers (i.e. immunofluorescence) will be required before firm
conclusions can be drawn.
We have considered the possibility that our observations might have been the result of unfolding of
receptors for IgM (Fc), rather than for complement, in a similar way that Vibrio cholerae neuraminidase
exposes cryptic sites for the Fc portion of IgM on rabbit and human monocytes (Haegert, 1979). It is
unlikely that our present findings can be explained in this way since, at least with human neutrophils and
eosinophils, receptor enhancement was observed with EAMC1423b and EAMC14 but not with
EAMC1423b' (i.e. C3b cells treated with the C3b inactivator (Law, Fearon & Levine, 1979)). Thus not all
complement intermediates prepared with EAM react in receptor enhancement (Anwar & Kay, 1978).
Comparable experiments with monocytes using red cells coated with various complement components
are in progress as are blocking studies with IgM.
Although we have drawn the general conclusion that agents which promote cell locomotion also
enhance complement receptors, we cannot say with certainty whether this effect is related to their
chemotactic and/or chemokinetic principles. It has been shown that casein (Keller & Sorkin, 1967), the
F-Met peptides (Showell et al., 1976) and C. parvum chemotactic factor (Russell et al., 1976) promote
directional migration as well as increasing the rate of cell movement. In order to establish that the
chemotactic, rather than the chemokinetic, principle is required for complement receptor enhancement,
further studies using substances which increase random migration, but are not chemotactic, are required.
As discussed elsewhere (Anwar & Kay, 1978) possible explanations of the mechanisms of complement
receptor enhancement include 'membrane unfolding', 'receptor externalization' and 'subunit association'.
The generation of new receptors was considered unlikely since optimal enhancement, at least with casein,
was achieved by 30 to 60 min.
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Complement receptor enhancement on the monocyte (and also the neutrophil (E. J. Glass, unpub¬
lished observation)) appears to be both reversible (Fig. 6) and temperature-dependent (Fig. 7). Although
these findings do not support any single mechanism (see above) they may be useful observations in our
endeavours to provide insight into the mechanism of complement receptor enhancement. For instance, it
is reasonable to suppose that during receptor enhancement there is an alteration in membrane fluidity
which is both reversible (Fig. 6) and probably occurs in the upper temperature range, i.e. between 30°C
and 37°C (Fig. 7). By the use of a combination of various techniques which might include cell membrane
fractionation, the use of radiolabelled complement components and membrane fluidity probes we hope
to develop further our knowledge of this phenomenon.
At the present time one of our principal interests relates to the possibility of complement receptor
enhancement as a useful clinical laboratory test. For instance, although the response to histamine is
usually small there is a marked enhancement of monocyte complement receptors by this agent in a few
individuals (E. J. Glass, unpublished observation). The reasons for such variations between apparently
healthy individuals are presently unclear but the possibility that it may be related to their atopic state is
being explored. Also, the effect of tumour-derived products on complement receptor enhancement by
normal monocytes is the subject of study in progress (Glass & Kay, 1979), details of which will be the
subject of a separate report.
This work was supported by the Cancer Research Campaign.
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SUMMARY
We have studied the effect of dialysates from lung cancer homogenates to alter both the
expression of complement (C3b) receptors per se and also to inhibit leucoattractant-
induced enhancement of complement rosettes on monocytes from healthy individuals.
Enhancement and enhancement-inhibition by tumour extracts were compared with
material derived from normal lung excised some distance from the tumour. There was no
significant difference between tumour homogenate (TH) and normal lung homogenate
(NLH) in terms of enhancement of complement rosettes per se. In contrast, TH produced
a dose- and time-dependent inhibition of leucoattractant-induced enhancement of C3b
rosettes which was significantly different from that obtained with NLH. This enhance¬
ment-inhibition was observed with four undifferentiated, four squamous and three adeno¬
carcinomas of lung. The degree of enhancement-inhibition was not related to the type of
tumour or varying accompanying histological features such as necrosis and the degree of
infiltration with inflammatory cells. Following gel filtration on Sephadex G-50 each type
of cancer gave a major peak of inhibitory activity which eluted with molecules having an
apparent molecular size of approximately 3,000 daltons. A second larger peak
(8,000-10,000 daltons) was also detectable with extracts from the undifferentiated and
adenocarcinomas. These results support previous findings, mainly from experimental
animals, indicating that 'anti-macrophage/monocyte principles' are elaborated from
certain tumour types.
INTRODUCTION
It is a widely-held view that cells of the lymphoid series, particularly mononuclear phagocytes, are
principal effector cells in tumour immunity. Although the role of lymphoid cells in immunological
surveillance of tumours in general, and ofmacrophages in particular, is controversial, it s'eems likely
that some tumours, at some stage in their development, are susceptible to destruction by mononuc¬
lear phagocytes. Macrophages are prominent in syngeneic animal tumours (Evans & Alexander,
1972) and, in mice, can inhibit tumour growth when inoculated together with tumour cells (Bennett,
1965). Macrophages can also enhance the inhibition of tumour progression mediated by BCG
(Hopper & Pimm, 1976).
A number of investigators have reported that tumour-derived material from experimentally-
induced neoplasms inhibit macrophage function both in vivo and in vitro. In general, the inhibitory
activity has been associated with molecules having a molecular size of less than 10,000 (Fauve et al.,
1974; North, Kirstein & Tuttle, 1976; Pike & Snyderman, 1976; Nelson & Nelson, 1978; Normann
& Cornelius, 1978). As a result of these observations in animals and studies in man which indicate
* Present address and correspondence: Professor A. B. Kay, Director, Department ofClinical Immunology,
Cardiothoracic Institute, Fulham Road, London SW3 6HP.
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that monocyte locomotion is defective in certain solid tumours such as genito-urinary neoplasms
and malignant melanoma (Boetcher & Leonard, 1974; Hausman et at., 1975), we have attempted to
establish whether human tumours elaborate 'anti-macrophage' principle(s) comparable to those
previously described in mice and rats. We chose to study extracts from lung cancers since fresh
material was readily available and because our previous work indicated that the advanced stage of
this disease was also associated with a defect in the locomotion of peripheral blood monocytes (Kay
& McVie, 1977).
Rather than employing inhibition of monocyte locomotion as our test system we have used a
newly developed assay of monocyte function - complement receptor enhancement (Glass & Kay,
1980). 'Complement receptor enhancement' is the term we have given to increased expression (or
unfolding) of C3b receptors on human leucocytes following incubation with leucoattractants. The
phenomenon was first described with eosinophils and 'eosinophilotactic' agents such as histamine
and ECF-A tetrapeptides (Anwar & Kay, 1977, 1978). However, we have also shown that
complement receptor enhancement is a property of human neutrophils and monocytes following
incubation of these cells with various chemoattractants such as formyl-methionyl peptides, lym-
phokines and casein (Glass & Kay, 1980; Kay, Glass & Salter, 1979). Thus complement receptor
enhancement is induced by leucoattractants and occurs in parallel with cell locomotion. We believe
that this apparent increase in the density of complement receptors may be indicative of a general
biological phenomenon whereby the degree of adhesion of phagocytic cells to opsonized particles is
increased.
In the present report we provide evidence that dialysates from a number of human lung cancer
homogenates, when compared to dialysates from normal lung, inhibit casein-induced enhancement
ofmonocyte complement receptors. Furthermore, the inhibitory principles appear to have a similar




Materials were obtained as follows: casein (BDH Chemicals Ltd, Poole, England); preservative-free
heparin (Evans Medical, Liverpool, England); Ficoll and Hypaque, Sephadex G-50 (Pharmacia,
Uppsala, Sweden).
Methods
Homogenatesfrom lung cancer andnormal lung controls. Fresh surgical specimens were obtained
at thoracotomy and placed directly into sterile plastic bags. A portion of approximately 5 g was
removed from the tumour mass in such a way as not to jeopardize the histological diagnosis. A
portion of normal tissue of comparable size to the tumour was taken from the periphery of the lobe
or bronchopulmonary segment. Portions of the normal lung, as well as the tumour mass, were
prepared for routine histopathological sections. The unfixed tissue was either stored at — 80°C or
prepared immediately in the following way: samples of tumour, or normal lung, were cut into small
fragments of approximately 200-400 mg and placed in 5-15 ml of PBS. The materials were frozen
and thawed six times, centrifuged at 1,800 g for 10 min to remove particulate matter and the
supernatants dialysed against PBS (twice the volume) for 18 hr at 4°C. The protein concentration of
the dialysates was determined by the Coomassie blue method and the samples divided into portions
of approximately 1 ml and stored at — 80°C until use.
The various histological features of the tumours were assessed by two independent pathologists
and graded (0, +, +, + +, + + +) as shown in Table 1. The portions of normal lung from the
periphery of the sections were free ofmicroscopically detectable tumour cells.
Preparation ofEA, EAC1423b and 'EAC'. This has been described in detail elsewhere (Anwar &
Kay, 1977, 1978) and was briefly as follows. Dextrose-gelatin-veronal buffer (DGVB2+, pH 7-4)
was used for washing sheep erythrocytes (E) during sensitization and coating with complement. The
buffer was prepared by mixing equal volumes of isotonic veronal-buffered saline (containing 0 0015
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m Ca2+, 0 0005 m Mg2+ and 01% gelatin-veronal buffer, GVB2+) with 5% dextrose in water
containing the same concentration ofCa2+ and Mg2+. The IgM and IgG fractions of rabbit antisera
to sheep red cells (A) were prepared by Sephadex G-200 gel filtration (Shevach et at., 1972). The IgG
fraction was further purified by DEAE-52 anion exchange chromatography (Fahey & Terry, 1978).
Either IgG or IgM was used in the sensitization of E for the preparations of EAJ.ab or EAJj'1'
respectively. The antibody concentration of EA™b selected was that which gave optimal sensitiza¬
tion for haemolysis but no agglutination. For the preparation of EAJ?b, the antibody concentration
was diluted so as to give approximately 30% monocyte rosettes. Functionally pure human comple¬
ment components were added sequentially to EA™b to prepare C3b-coated cells (EAC 1423b). The
amounts were as follows: 400 effective molecules of CI, 400 of C4, 50 of C2 and 400 of C3. This
amount of C4 was insufficient to give EAC14 rosettes with monocytes (Anwar & Kay, 1978). In
most experiments fresh human AB serum was also used as a source of complement ('EAC'). Equal
volumes of EA™b were used at a concentration of 1 x 108 red blood cells/ml. The dilution of fresh
serum was adjusted to give between 20 and 30% monocyte rosettes and was usually between 1 in 600
and 1 in 1,000.
Monocytes. Blood from healthy donors was drawn into plastic tubes containing 10 units of
preservative-free heparin/ml. Monocytes were separated on Ficoll-Hypaque cushions according to
the method of Boyum (1968). The separated cells were washed twice in Dulbecco's PBS (modified)
(pH 7-2-7-4), containing preservative-free heparin (2 units/ml) and resuspended in medium 199, pH
7-4, to a concentration of 1 x 106 monocytes/ml.
Complement (EAC) and IgG (EAc) rosettes and rosette enhancement. For the experiments
described in Table 2 equal volumes ofmonocytes (1 x 106/ml) and various concentrations of casein
or medium alone were mixed and incubated in a shaking water bath, usually at 37°C for 30min. The
cells were then washed twice in medium 199 and the numbers readjusted to their original concentra¬
tion in the same medium. A portion (0-1 ml) of EAC or EAG (lxl 08/ml) was added to 0-1 ml ofcells
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0 = Nil; + =very slight; -t- = slight; + + =moderate; + + + = marked. The
tumour type was assessed independently by two histopathologists.
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Rosettes (%)
'EAC' EAm 1423b EAg
Medium 199 25 + 4 23 + 1 30 + 3
Casein
1 mg/ml 34 + 5 35+1 31+4
2 mg/ml 42 + 2 41 + 2 30 + 4
3 mg/ml 48 + 6 46 + 2 34+ 5
Red cell intermediates were sensitized with
IgM and prepared either with whole serum
('EAC') as a source of complement or with
purified components (EAM1423b) or with IgG
(EAg). The results represent the mean ±1
s.e.m. of three experiments.
and centrifuged at 100g for 10min at 4°C and the pellets incubated at 37°C for 20 min for EAC and
0°C for 30 min in the preparation of EAG. The pellet was gently resuspended in medium 199
containing 1% formal-saline and smears prepared on clean glass slides in duplicate. These were
dried quickly in air, fixed in methanol and stained with May-Griinwald/Giemsa or fixed in 2-5%
glutaraldehyde and stained using a-naphthyl acetate histochemistry according to the method of
Yam, Li & Crosby (1971). Comparison of these two methods by four independent observers
revealed no statistical significance in differentiating monocytes from lymphocytes.
Inhibition of casein-induced enhancement by tumour or normal lung homogenates. Monocytes
were prepared as described above and divided into 14 portions of OT ml each containing 1 x 106
monocytes/ml. The experimental design is shown in Fig. 1. Two tubes were required for 'enhance¬
ment by casein alone' [(B —C/C) x 100] and this was performed as described for Table 2 (but with
the addition of a 30-min incubation period at 37°C, after which the cells were centrifuged (300# for
10 min at 4°C) prior to the addition of 01 ml ofmedium 199 (C) or casein (B) - Fig. 1). Monocyte
suspensions were also incubated with dilutions of tumour extract (25 gg protein/ml - two tubes, 50
/tg/ml - two tubes, 100 /tg/ml - two tubes) and normal lung homogenates (25 gg protein/ml - two
tubes, 50 gg/m\ - two tubes, 100 gg/ml - two tubes). Three of the monocyte preparations treated
with tumour extract (i.e. 25, 50 and 100 /tg/ml) and three treated with normal lung (i.e. 25, 50 and
100 /tg/ml) were then incubated with either medium 199 or casein (3 mg/ml). Enhancement, and
enhancement-inhibition were calculated as described in Fig. 1.
Gel filtration. Samples (0-75 ml) of either tumour or normal lung extract were applied to a
column of Sephadex G-50 (1-5 x 100 cm). The column was calibrated with molecular markers (blue
dextran, cytochrome c and vitamin Bi2) in phosphate-buffered saline (pH 7-2) and 1-ml fractions
collected. Every third fraction was tested for inhibition of casein-induced monocyte complement
receptor enhancement using 0- 1-ml amounts as described in Fig. 1.
RESULTS
Enhancement ofcomplement rosettes
The capacity of casein, a recognized monocyte leucoattractant, to enhance the percentage of
monocyte C3b rosettes is shown in Table 2. The effect was dose-dependent and demonstrable when
either 'EAC' or EAM 1423b were used as indicator erythrocytes. In contrast, there was a small but
statistically insignificant increase in the percentage of EAG (Fc) rosettes. When expressed as a
percentage increase, enhancement of Fc receptors by the highest dose of casein was only 13%



















30 min at 37°C,
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Medium 199 (C) Casein (B) Medium 1 39 (D) Caseir (A)
Incubate for 30 min at 37°C, centrifuge and resuspend
Add 'EAC' , centrifuge, incubate for 20 min at 37°C
Count rosettes (%)
Enhancement by casein alone = ^4 x 100
D — c
Enhancement by tumour or normal lung alone = —-— x 100
Inhibition of casein-induced enhancement by tumour or normal lung = 100 - 7^—x 100
ID —O )
Fig. 1. Schematic outline of the methodology for monocyte complement receptor enhancement and enhance¬
ment inhibition by tumour and normal lung homogenates.
whereas with 'EAC' or EAM 1423b the increases were 92 and 100% respectively. Because of the
similar results obtained using either 'EAC' or EAM 1423b in terms of the dose response by casein
(and also, as reported elsewhere, as a function of time (Glass & Kay, 1980)) for convenience 'EAC'
were used as indicator cells in further experiments.
Inhibition ofenhancement
A dialysable extract from a homogenate of an adenocarcinoma of the bronchus was tested both for
its effect on the percentage of monocyte complement rosettes and for its capacity to inhibit
casein-induced monocyte complement receptor enhancement. The tumour extract, at concentra¬
tions of 25, 50 and 100 pg protein/ml, was compared with microscopically normal lung from the
same resected specimen. Neither the tumour homogenate (TH) nor the normal lung homogenate
(NLH) significantly influenced the percentage of rosettes with 'EAC'. In contrast, the TH inhibited
casein-induced enhancement in a dose-dependent fashion which at the highest concentration (100
fig protein/ml) was significantly different from NLH (L<005).
The time course of inhibition enhancement by TH and NLH from another adenocarcinoma of
the bronchus is shown in Fig. 2. The percentage increase was maximal at 30 min with no further
inhibition being observed up to 2 hr at which time the experiment was terminated. Inhibition by
NLH was considerably less and when expressed as the mean of three experiments was virtually
negligible.
Various histological types
Undifferentiated. The effect ofTH and NLH from four patients with undifferentiated carcinoma
of the bronchus on monocyte complement rosettes and casein-induced enhancement is shown in
Fig. 3. The percentage enhancement of the normal donor monocytes by casein was comparable to
that achieved in the experiments described in Table 2. Both TH and NLH promoted some
complement receptor enhancement per se although the differences between them, at the three
concentrations tested, were not significant. Furthermore, the dose-response with NLH was 'flat'
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Fig. 2. The time course of inhibition of leucoattractant-induced enhancement of monocyte complement
receptors by tumour and normal lung homogenates. Each point represents the mean +1 s.e.m. of three
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Fig. 3. Inhibition of leucoattractant-induced enhancement of monocyte complement rosettes by homogenates
from various lung cancers. (•) Tumour and (o) normal lung homogenate. Each point represents the mean + 1
s.e.m. of four undifferentiated tumours, four squamous and three adenocarcinomas of lung. The P values were
calculated from Student's t-test. The experimental design is outlined in Fig. 1.
and with TH there was apparent inhibition at higher doses. In contrast, TH when compared to
NLH gave significant inhibition ofcasein-induced enhancement at the highest concentration tested.
The inhibitory effect ofTH increased in proportion to the concentration ofTH. Some inhibition of
enhancement was observed with NLH but the dose-response was not linear, less effect being
observed at 100 ug, than with 50 protein/ml. The individual data (not shown) indicate that
although there was considerable variation in the amount of inhibition achieved by the four
undifferentiated tumours, the general pattern of increased enhancement inhibition by TH, as
compared to NLH, was sustained.
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Squamous. Comparable results were obtained with four squamous carcinomas of the bronchus
(Fig. 3). With these tumours the difference between TH and NLH in terms of their effects on
receptors per se was negligible although with both materials there was a slight increased percentage
change from control but this did not appear to be related to the concentration of the extracts. By
contrast, inhibition of casein-induced enhancement by these tumour extracts increased with dose
and, at both the 50 and 100 ^g concentrations, was significantly different from NLH. NLH from the
squamous tumour resections gave very little enhancement-inhibition, even at the higher concentra¬
tions.
Adenocarcinoma. Three adenocarcinomas of the bronchus were tested in a comparable manner
(Fig. 3). The NLH from these resections gave a dose-dependent increase in monocyte complement
rosettes per se, but the effects were not significantly different from TH. With enhancement-inhibition
there was a marked and statistically significant difference between TH and NLH at the 50 and 100
pg protein concentrations. The individual results (not shown) indicate that the variations in
observed effects were wide, but the general pattern of dose-dependent inhibition of casein-induced
enhancement by TH, as compared to NLH, was sustained.
Gelfiltration ofhomogenates
TH and NLH from one undifferentiated (patient 1), one squamous (patient 5) and one adenocar¬
cinoma (patient 11) were passed separately through a column of Sephadex G-50, previously
calibrated with molecular markers. Fractions were tested for inhibition of enhancement as de¬
scribed in the methodology (Fig. 4).
Virtually all the fractions tested, irrespective of whether they were TH- or NLH-derived, gave
inhibition of enhancement although in some the values were below zero. Because of the high
'background' activity with the normal lung homogenates only those peaks having maximal
enhancement-inhibition of 40% or more were considered as having appreciable biological activity.
Using this 'cut-off' point it could be seen that with the undifferentiated tumour there were two peaks
ofactivity ofapproximately 3,000 and 8,000 daltons respectively. The squamous tumour also had a
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Fig. 4. Sephadex G-50 gel filtration ofhomogenates from lung cancer and normal lung. The points are the mean
of three assays of inhibition of leucoattractant-induced enhancement.
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peak at 3,000 and the adenocarcinoma had inhibitory activities at 3,000 and 10,000 daltons
approximately. Thus all three tumour types had a peak molecular weight at 3,000 and the
undifferentiated and adenocarcinoma had activities between 8,000-10,000 daltons. NLH from each
tumour type did not give peaks of greater than 35% and in most measurements it was less than 20%
enhancement-inhibition.
DISCUSSION
The main purpose of the experiments reported here was to determine whether factors derived from
human lung cancer affected leucoattractant-mediated increase in complement receptor 'density' of
blood monocytes from healthy individuals. Although we have provided evidence for the presence of
such inhibitory principles we cannot say with certainty whether they are tumour-associated or
tumour-derived. It is of note that there did not appear to be an association between the degree of
inhibition and the histological features of the tumours (Table 1). For example, tumour nos. 3, 4 and
11 had little or no associated chronic inflammatory cells or infiltration with polymorphonuclear
leucocytes but they all gave considerable inhibition of enhancement of complement receptors.
Similarly, tumour nos. 2 and 11 had little or no necrosis but considerable inhibitory activity could be
derived from the tumour mass. Thus the inhibitory properties of the tumour dialysate would not
appear to be directly attributable to the degree of acute and chronic inflammation, necrosis or
fibrosis associated with the neoplastic lesion.
We have so far only examined the effect of TH on casein-induced complement receptor
enhancement on the blood monocyte and are unable to say whether a similar effect would be
demonstrable (a) with other blood leucocytes such as neutrophils and eosinophils and (b) with other
appropriate C-receptor-enhancing chemoattractants. Because of limitations in the supply of
tumour extract we felt that priority should be given to preliminary studies on the possible
heterogeneity of the activities as assessed by gel filtration chromatography. As shown in Fig. 4 each
tumour contained at least two peaks of inhibitory activity although NLH did not give inhibition of
> 40%. Taking 40% inhibition as a reasonable cut-off point it can be seen that the only substantial
peaks of inhibitory activity are in the tumour extracts. All three tumour types shared one peak
which eluted just before the vitamin Bi2 molecular marker and had an estimated molecular size of
3,000 daltons. The undifferentiated and adenocarcinoma tumour extracts both had a higher peak of
inhibitory activity at approximately 8,000-10,000 daltons. The squamous tumour also had a peak
at 8,000-10,000 daltons but maximal activity was just >40%. This aspect of the study clearly
requires expansion to include more detailed protein-separation techniques.
It is generally agreed that there is no clear association between clinical prognosis and the
histological types of various forms of lung cancer. There was no evidence from the present study
that the degree of inhibitory activity was related to the histological type.
There is formidable literature on the relation between macrophages and cancer and, as men¬
tioned in the Introduction, there are a number of animal studies which support the view that
tumours elaborate anti-macrophage material. Snyderman and his colleagues reported that mouse
tumours inhibited macrophage mobilization in the peritoneal cavity and that a number of cell lines
produce a factor of molecular weight between 6,000-10,000 daltons which inhibits macrophage
chemotaxis in vitro (Pike & Snyderman, 1976; Snyderman & Pike, 1976). The agent was heat-stable
and had peak inhibitory activity 3 days after administration. When the factor was injected together
with tumour cells into syngeneic mice there was an increase in tumour dissemination when
compared to the effect of the tumour alone. Fauve et at. (1974) have demonstrated that mouse
teratocarcinoma and other tumour cells in culture elaborate a factor of between 1,000 and 10,000
which inhibits local inflammation in vivo, and these same cells in vitro were found to prevent direct
contact by normal peritoneal macrophages. Nelson & Nelson (1978) have described a similar factor
produced by murine fibrosarcoma cells which depressed delayed-type hypersensitivity reactions in
vivo and inhibited macrophage chemotaxis in vitro. It is believed to be glycopeptide in nature and
associated with an RNA fragment. North et al. (1976) reported that in the serum of tumour-bearing
mice there was a dialysable factor which depressed macrophage-mediated resistance to infection.
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In the present report we have described lowmolecular weight material derived from human lung
cancers which inhibits leucoattractant-induced enhancement of complement receptors on normal
human monocytes and in this respect may be analogous to factors described in animals which
depress macrophage function. Further studies are required to characterize these principles more
fully and to explore the possibility that active immunity to them may have therapeutic potential.
This work was supported by the Cancer Research Campaign.
REFERENCES
Anwar. A.R.E. & Kay, A.B. (1977) Membrane
receptors for IgG and complement (C4, C3b and
C3d) on human eosinophils and neutrophils and
their relation to eosinophilia. J. Immunol 119, 976.
Anwar. A.R.E. & Kay, A.B. (1978) Enhancement of
human eosinophil complement receptors by phar¬
macologic mediators. J. Immunol. 121, 1245.
Bennett, B. (1965) Specific suppression of tumour
growth by isolated peritoneal macrophages from
immunized mice. J. Immunol. 95, 656.
Boetcher, D.A. & Leonard, E.L. (1974) Abnormal
monocyte chemotactic response in cancer patients.
J. Natl. Cancer Inst. 52, 1091.
Boyum, A. (1968) Isolation of leucocytes from human
blood. Further observations. Methyl cellulose, dex-
tran and ficoll as erythrocyte aggregating agents.
Scand. J. clin. Lab. Invest. 21 (Suppl. 97), 31.
Evans, R. & Alexander, P. (1972) Mechanisms of
immunologically specific killing of tumour cells by
macrophages. Nature, 236, 168.
Fahey, J.L. & Terry, E.W. (1978) Ion exchange chro¬
matography, and gel filtration. In Handbook of
Experimental Immunology 3rd edn (ed. by D. M.
Weir), chapter 8. Blackwell, Oxford.
Fauve, R.M., Hevin, B., Jacob, H., Faillard, J.A. &
Jacob, F. (1974) Anti-inflammatory effects ofmur¬
ine malignant cells. Proc. Natl Acad. Sci. USA, 71,
4052.
Glass, E.J. & Kay, A.B. (1980) Enhanced expression
of human monocyte complement (C3b) receptors
by chemoattractants. Clin. exp. Immunol 39, 768.
Hausman, M.S., Brosman, S., Snyderman, R.,
Mickey, M.R. & Fahey, J. (1975) Defective mono¬
cyte function in patients with genito-urinary car¬
cinoma. J. Natl. Cancer Inst. 55, 1047.
Hopper, D.G. & Pimm, M.V. (1976) Silica abrogation
of mycobacterial adjuvant suppression of tumour
growth in rats and athymic mice. Cancer Immunol
Immunother. 1, 143.
Kay, A.B., Glass, E.J. & Salter, D.McG. (1979)
Leucoattractants enhance complement receptors
on human phagocytic cells. Clin. exp. Immunol 38,
294.
Kay, A.B. & McVie, J.G. (1977) Monocyte chemo-
taxis in bronchial carcinoma and cigarette smokers.
Br. J. Cancer, 36, 461.
Nelson, M. & Nelson, D.S. (1978) Macrophages and
resistance to tumours. I. Inhibition of delayed-type
hypersensitivity reactions by tumour cells and by
soluble products affecting macrophages. Immuno¬
logy, 34, 277.
Normann, S.J. & Cornelius, E.L. (1978) Concurrent
depression of tumour macrophage infiltration and
systemic inflammation by progressive cancer
growth. Cancer Res. 38, 3453.
North, R.J., Kirstein, D.P. & Tuttle, R.L. (1976)
Subversion of host defence mechanisms by murine
tumours. I. A circulating factor that suppresses
macrophage-mediated resistance to infection. J.
exp. Med. 143, 559.
Pike. M.C. & Snyderman, R. (1976) Depression of
macrophage function by a factor produced by neo¬
plasms: a mechanism for abrogation of immune
surveillance. J. Immunol 117, 1243.
Shevach, E.M., Herberman, R., Frank, M.M. &
Green, I. (1972) Receptors for complement and
immunoglobulin on human leukaemic cells and
human lymphoblastoid lines. J. clin. Invest. 51,
1933.
Snyderman, R. & Pike, M.C. (1976) An inhibitor of
macrophage chemotaxis produced by neoplasms.
Science, 192, 370.
Yam, L.T., Li, C.I. & Crosby, W.H. (1971) Cytoche-
mical identification ofmonocytes and granulocytes.
Am. J. din. Pathol 55, 283.
